id	sid	tid	token	lemma	pos
fnp-2616	1	1	deposits	deposit	NOUN
fnp-2616	1	2	of	of	ADP
fnp-2616	1	3	disease	disease	NOUN
fnp-2616	1	4	-	-	PUNCT
fnp-2616	1	5	associated	associate	VERB
fnp-2616	1	6	alpha	alpha	NOUN
fnp-2616	1	7	-	-	PUNCT
fnp-2616	1	8	synuclein	synuclein	NOUN
fnp-2616	1	9	may	may	AUX
fnp-2616	1	10	be	be	AUX
fnp-2616	1	11	present	present	ADJ
fnp-2616	1	12	in	in	ADP
fnp-2616	1	13	the	the	DET
fnp-2616	1	14	dura	dura	NOUN
fnp-2616	1	15	mater	mater	NOUN
fnp-2616	1	16	in	in	ADP
fnp-2616	1	17	lewy	lewy	ADJ
fnp-2616	1	18	body	body	NOUN
fnp-2616	1	19	disorders	disorder	NOUN
fnp-2616	1	20	:	:	PUNCT
fnp-2616	1	21	implications	implication	NOUN
fnp-2616	1	22	for	for	ADP
fnp-2616	1	23	potential	potential	ADJ
fnp-2616	1	24	inadvertent	inadvertent	ADJ
fnp-2616	1	25	transmission	transmission	NOUN
fnp-2616	1	26	by	by	ADP
fnp-2616	1	27	surgery	surgery	NOUN
fnp-2616	1	28	feel	feel	VERB
fnp-2616	1	29	free	free	ADJ
fnp-2616	1	30	to	to	PART
fnp-2616	1	31	add	add	VERB
fnp-2616	1	32	comments	comment	NOUN
fnp-2616	1	33	by	by	ADP
fnp-2616	1	34	clicking	click	VERB
fnp-2616	1	35	these	these	DET
fnp-2616	1	36	icons	icon	NOUN
fnp-2616	1	37	on	on	ADP
fnp-2616	1	38	the	the	DET
fnp-2616	1	39	sidebar	sidebar	NOUN
fnp-2616	1	40	free	free	ADJ
fnp-2616	1	41	neuropathology	neuropathology	PROPN
fnp-2616	1	42	1:6	1:6	NUM
fnp-2616	1	43	(	(	PUNCT
fnp-2616	1	44	2020	2020	NUM
fnp-2616	1	45	)	)	PUNCT
fnp-2616	1	46	original	original	ADJ
fnp-2616	1	47	paper	paper	NOUN
fnp-2616	1	48	deposits	deposit	NOUN
fnp-2616	1	49	of	of	ADP
fnp-2616	1	50	disease	disease	NOUN
fnp-2616	1	51	-	-	PUNCT
fnp-2616	1	52	associated	associate	VERB
fnp-2616	1	53	alpha	alpha	NOUN
fnp-2616	1	54	-	-	PUNCT
fnp-2616	1	55	synuclein	synuclein	NOUN
fnp-2616	1	56	may	may	AUX
fnp-2616	1	57	be	be	AUX
fnp-2616	1	58	present	present	ADJ
fnp-2616	1	59	in	in	ADP
fnp-2616	1	60	the	the	DET
fnp-2616	1	61	dura	dura	NOUN
fnp-2616	1	62	mater	mater	NOUN
fnp-2616	1	63	in	in	ADP
fnp-2616	1	64	lewy	lewy	ADJ
fnp-2616	1	65	body	body	NOUN
fnp-2616	1	66	disorders	disorder	NOUN
fnp-2616	1	67	:	:	PUNCT
fnp-2616	1	68	implications	implication	NOUN
fnp-2616	1	69	for	for	ADP
fnp-2616	1	70	potential	potential	ADJ
fnp-2616	1	71	inadvertent	inadvertent	ADJ
fnp-2616	1	72	transmission	transmission	NOUN
fnp-2616	1	73	by	by	ADP
fnp-2616	1	74	surgery	surgery	NOUN
fnp-2616	1	75	ellen	ellen	PROPN
fnp-2616	1	76	gelpi	gelpi	PROPN
fnp-2616	1	77	md1,2	md1,2	NOUN
fnp-2616	1	78	,	,	PUNCT
fnp-2616	1	79	naomi	naomi	PROPN
fnp-2616	1	80	p.	p.	PROPN
fnp-2616	1	81	visanji	visanji	PROPN
fnp-2616	1	82	phd3	phd3	PROPN
fnp-2616	1	83	,	,	PUNCT
fnp-2616	1	84	selma	selma	PROPN
fnp-2616	1	85	hönigschnabl	hönigschnabl	PROPN
fnp-2616	1	86	md4	md4	PROPN
fnp-2616	1	87	,	,	PUNCT
fnp-2616	1	88	angelika	angelika	PROPN
fnp-2616	1	89	reiner	reiner	PROPN
fnp-2616	1	90	md4	md4	PROPN
fnp-2616	1	91	,	,	PUNCT
fnp-2616	1	92	peter	peter	PROPN
fnp-2616	1	93	fischer	fischer	PROPN
fnp-2616	1	94	md5	md5	PROPN
fnp-2616	1	95	,	,	PUNCT
fnp-2616	1	96	anthony	anthony	PROPN
fnp-2616	1	97	e.	e.	PROPN
fnp-2616	1	98	lang	lang	PROPN
fnp-2616	1	99	md3	md3	PROPN
fnp-2616	1	100	,	,	PUNCT
fnp-2616	1	101	herbert	herbert	PROPN
fnp-2616	1	102	budka	budka	PROPN
fnp-2616	1	103	md1	md1	PROPN
fnp-2616	1	104	,	,	PUNCT
fnp-2616	1	105	gabor	gabor	PROPN
fnp-2616	1	106	g.	g.	PROPN
fnp-2616	1	107	kovacs	kovacs	PROPN
fnp-2616	1	108	md3,6,7	md3,6,7	PROPN
fnp-2616	1	109	1	1	NUM
fnp-2616	1	110	division	division	NOUN
fnp-2616	1	111	of	of	ADP
fnp-2616	1	112	neuropathology	neuropathology	NOUN
fnp-2616	1	113	and	and	CCONJ
fnp-2616	1	114	neurochemistry	neurochemistry	NOUN
fnp-2616	1	115	,	,	PUNCT
fnp-2616	1	116	department	department	NOUN
fnp-2616	1	117	of	of	ADP
fnp-2616	1	118	neurology	neurology	NOUN
fnp-2616	1	119	,	,	PUNCT
fnp-2616	1	120	medical	medical	ADJ
fnp-2616	1	121	university	university	PROPN
fnp-2616	1	122	of	of	ADP
fnp-2616	1	123	vienna	vienna	PROPN
fnp-2616	1	124	,	,	PUNCT
fnp-2616	1	125	vienna	vienna	PROPN
fnp-2616	1	126	,	,	PUNCT
fnp-2616	1	127	austria	austria	NOUN
fnp-2616	1	128	2	2	NUM
fnp-2616	1	129	neurological	neurological	ADJ
fnp-2616	1	130	tissue	tissue	NOUN
fnp-2616	1	131	bank	bank	NOUN
fnp-2616	1	132	of	of	ADP
fnp-2616	1	133	the	the	DET
fnp-2616	1	134	biobanc	biobanc	NOUN
fnp-2616	1	135	-	-	PUNCT
fnp-2616	1	136	hospital	hospital	NOUN
fnp-2616	1	137	clinic	clinic	NOUN
fnp-2616	1	138	-	-	PUNCT
fnp-2616	1	139	idibaps	idibap	NOUN
fnp-2616	1	140	,	,	PUNCT
fnp-2616	1	141	barcelona	barcelona	PROPN
fnp-2616	1	142	,	,	PUNCT
fnp-2616	1	143	spain	spain	PROPN
fnp-2616	1	144	3	3	NUM
fnp-2616	1	145	edmond	edmond	PROPN
fnp-2616	1	146	j.	j.	PROPN
fnp-2616	1	147	safra	safra	PROPN
fnp-2616	1	148	program	program	PROPN
fnp-2616	1	149	in	in	ADP
fnp-2616	1	150	parkinson	parkinson	NOUN
fnp-2616	1	151	’s	’s	PART
fnp-2616	1	152	disease	disease	NOUN
fnp-2616	1	153	and	and	CCONJ
fnp-2616	1	154	the	the	DET
fnp-2616	1	155	morton	morton	PROPN
fnp-2616	1	156	and	and	CCONJ
fnp-2616	1	157	gloria	gloria	PROPN
fnp-2616	1	158	shulman	shulman	PROPN
fnp-2616	1	159	movement	movement	PROPN
fnp-2616	1	160	disorders	disorder	NOUN
fnp-2616	1	161	clinic	clinic	PROPN
fnp-2616	1	162	,	,	PUNCT
fnp-2616	1	163	toronto	toronto	PROPN
fnp-2616	1	164	western	western	PROPN
fnp-2616	1	165	hospital	hospital	PROPN
fnp-2616	1	166	,	,	PUNCT
fnp-2616	1	167	toronto	toronto	PROPN
fnp-2616	1	168	,	,	PUNCT
fnp-2616	1	169	ontario	ontario	PROPN
fnp-2616	1	170	,	,	PUNCT
fnp-2616	1	171	canada	canada	PROPN
fnp-2616	1	172	4	4	NUM
fnp-2616	1	173	institute	institute	PROPN
fnp-2616	1	174	of	of	ADP
fnp-2616	1	175	pathology	pathology	PROPN
fnp-2616	1	176	,	,	PUNCT
fnp-2616	1	177	danube	danube	PROPN
fnp-2616	1	178	hospital	hospital	PROPN
fnp-2616	1	179	of	of	ADP
fnp-2616	1	180	vienna	vienna	PROPN
fnp-2616	1	181	,	,	PUNCT
fnp-2616	1	182	austria	austria	PROPN
fnp-2616	1	183	5	5	NUM
fnp-2616	1	184	department	department	NOUN
fnp-2616	1	185	of	of	ADP
fnp-2616	1	186	psychiatry	psychiatry	NOUN
fnp-2616	1	187	,	,	PUNCT
fnp-2616	1	188	medical	medical	ADJ
fnp-2616	1	189	research	research	NOUN
fnp-2616	1	190	society	society	PROPN
fnp-2616	1	191	vienna	vienna	PROPN
fnp-2616	1	192	d.c	d.c	PROPN
fnp-2616	1	193	.	.	PROPN
fnp-2616	1	194	,	,	PUNCT
fnp-2616	1	195	danube	danube	PROPN
fnp-2616	1	196	hospital	hospital	PROPN
fnp-2616	1	197	,	,	PUNCT
fnp-2616	1	198	vienna	vienna	PROPN
fnp-2616	1	199	,	,	PUNCT
fnp-2616	1	200	austria	austria	PROPN
fnp-2616	1	201	6	6	NUM
fnp-2616	1	202	laboratory	laboratory	NOUN
fnp-2616	1	203	medicine	medicine	NOUN
fnp-2616	1	204	program	program	PROPN
fnp-2616	1	205	&	&	CCONJ
fnp-2616	1	206	krembil	krembil	PROPN
fnp-2616	1	207	brain	brain	PROPN
fnp-2616	1	208	institute	institute	PROPN
fnp-2616	1	209	,	,	PUNCT
fnp-2616	1	210	university	university	NOUN
fnp-2616	1	211	health	health	NOUN
fnp-2616	1	212	network	network	NOUN
fnp-2616	1	213	,	,	PUNCT
fnp-2616	1	214	toronto	toronto	PROPN
fnp-2616	1	215	,	,	PUNCT
fnp-2616	1	216	ontario	ontario	PROPN
fnp-2616	1	217	,	,	PUNCT
fnp-2616	1	218	canada	canada	PROPN
fnp-2616	1	219	;	;	PUNCT
fnp-2616	1	220	7	7	NUM
fnp-2616	1	221	department	department	NOUN
fnp-2616	1	222	of	of	ADP
fnp-2616	1	223	laboratory	laboratory	NOUN
fnp-2616	1	224	medicine	medicine	NOUN
fnp-2616	1	225	and	and	CCONJ
fnp-2616	1	226	pathobiology	pathobiology	NOUN
fnp-2616	1	227	and	and	CCONJ
fnp-2616	1	228	tanz	tanz	NOUN
fnp-2616	1	229	centre	centre	NOUN
fnp-2616	1	230	for	for	ADP
fnp-2616	1	231	research	research	NOUN
fnp-2616	1	232	in	in	ADP
fnp-2616	1	233	neurodegenerative	neurodegenerative	ADJ
fnp-2616	1	234	disease	disease	NOUN
fnp-2616	1	235	,	,	PUNCT
fnp-2616	1	236	university	university	NOUN
fnp-2616	1	237	of	of	ADP
fnp-2616	1	238	toronto	toronto	PROPN
fnp-2616	1	239	corresponding	corresponding	PROPN
fnp-2616	1	240	author	author	NOUN
fnp-2616	1	241	:	:	PUNCT
fnp-2616	1	242	professor	professor	NOUN
fnp-2616	1	243	gabor	gabor	PROPN
fnp-2616	1	244	g	g	PROPN
fnp-2616	1	245	kovacs	kovacs	PROPN
fnp-2616	1	246	md	md	PROPN
fnp-2616	1	247	phd	phd	PROPN
fnp-2616	1	248	frcpc	frcpc	PROPN
fnp-2616	1	249	·	·	PUNCT
fnp-2616	1	250	laboratory	laboratory	NOUN
fnp-2616	1	251	medicine	medicine	NOUN
fnp-2616	1	252	program	program	PROPN
fnp-2616	1	253	·	·	PUNCT
fnp-2616	1	254	toronto	toronto	PROPN
fnp-2616	1	255	general	general	PROPN
fnp-2616	1	256	hospital	hospital	PROPN
fnp-2616	1	257	·	·	PUNCT
fnp-2616	1	258	university	university	NOUN
fnp-2616	1	259	health	health	NOUN
fnp-2616	1	260	network	network	NOUN
fnp-2616	1	261	·	·	PUNCT
fnp-2616	1	262	200	200	NUM
fnp-2616	1	263	elizabeth	elizabeth	PROPN
fnp-2616	1	264	street	street	PROPN
fnp-2616	1	265	·	·	PUNCT
fnp-2616	1	266	toronto	toronto	PROPN
fnp-2616	1	267	on	on	ADP
fnp-2616	1	268	·	·	PUNCT
fnp-2616	1	269	canada	canada	X
fnp-2616	1	270	·	·	PUNCT
fnp-2616	2	1	m5	m5	NOUN
fnp-2616	2	2	g	g	PROPN
fnp-2616	2	3	2c4	2c4	NUM
fnp-2616	2	4	gabor.kovacs@uhnresearch.ca	gabor.kovacs@uhnresearch.ca	NOUN
fnp-2616	2	5	submitted	submit	VERB
fnp-2616	2	6	:	:	PUNCT
fnp-2616	2	7	09	09	NUM
fnp-2616	2	8	january	january	NOUN
fnp-2616	2	9	2020	2020	NUM
fnp-2616	2	10	accepted	accept	VERB
fnp-2616	2	11	:	:	PUNCT
fnp-2616	2	12	06	06	NUM
fnp-2616	2	13	february	february	NOUN
fnp-2616	2	14	2020	2020	NUM
fnp-2616	2	15	published	publish	VERB
fnp-2616	2	16	:	:	PUNCT
fnp-2616	2	17	12	12	NUM
fnp-2616	2	18	february	february	NOUN
fnp-2616	2	19	2020	2020	NUM
fnp-2616	3	1	https://doi.org/10.17879/freeneuropathology-2020-2616	https://doi.org/10.17879/freeneuropathology-2020-2616	PROPN
fnp-2616	3	2	keywords	keyword	NOUN
fnp-2616	3	3	:	:	PUNCT
fnp-2616	3	4	alpha	alpha	NOUN
fnp-2616	3	5	-	-	PUNCT
fnp-2616	3	6	synuclein	synuclein	NOUN
fnp-2616	3	7	,	,	PUNCT
fnp-2616	3	8	dura	dura	NOUN
fnp-2616	3	9	mater	mater	NOUN
fnp-2616	3	10	,	,	PUNCT
fnp-2616	3	11	lymphatic	lymphatic	ADJ
fnp-2616	3	12	drainage	drainage	NOUN
fnp-2616	3	13	,	,	PUNCT
fnp-2616	3	14	prion	prion	NOUN
fnp-2616	3	15	,	,	PUNCT
fnp-2616	3	16	propagation	propagation	NOUN
fnp-2616	3	17	,	,	PUNCT
fnp-2616	3	18	transmission	transmission	NOUN
fnp-2616	3	19	abstract	abstract	ADJ
fnp-2616	3	20	deposition	deposition	NOUN
fnp-2616	3	21	of	of	ADP
fnp-2616	3	22	alpha	alpha	NOUN
fnp-2616	3	23	-	-	PUNCT
fnp-2616	3	24	synuclein	synuclein	NOUN
fnp-2616	3	25	in	in	ADP
fnp-2616	3	26	the	the	DET
fnp-2616	3	27	brain	brain	NOUN
fnp-2616	3	28	is	be	AUX
fnp-2616	3	29	a	a	DET
fnp-2616	3	30	hallmark	hallmark	NOUN
fnp-2616	3	31	of	of	ADP
fnp-2616	3	32	lewy	lewy	ADJ
fnp-2616	3	33	body	body	NOUN
fnp-2616	3	34	disorders	disorder	NOUN
fnp-2616	3	35	.	.	PUNCT
fnp-2616	4	1	alpha	alpha	PROPN
fnp-2616	4	2	-	-	PUNCT
fnp-2616	4	3	synuclein	synuclein	NOUN
fnp-2616	4	4	has	have	AUX
fnp-2616	4	5	been	be	AUX
fnp-2616	4	6	considered	consider	VERB
fnp-2616	4	7	to	to	PART
fnp-2616	4	8	show	show	VERB
fnp-2616	4	9	prion	prion	NOUN
fnp-2616	4	10	-	-	PUNCT
fnp-2616	4	11	like	like	ADJ
fnp-2616	4	12	properties	property	NOUN
fnp-2616	4	13	.	.	PUNCT
fnp-2616	5	1	prion	prion	NOUN
fnp-2616	5	2	diseases	disease	NOUN
fnp-2616	5	3	can	can	AUX
fnp-2616	5	4	be	be	AUX
fnp-2616	5	5	transmitted	transmit	VERB
fnp-2616	5	6	by	by	ADP
fnp-2616	5	7	the	the	DET
fnp-2616	5	8	transplantation	transplantation	NOUN
fnp-2616	5	9	of	of	ADP
fnp-2616	5	10	cadaveric	cadaveric	ADJ
fnp-2616	5	11	dura	dura	NOUN
fnp-2616	5	12	mater	mater	NOUN
fnp-2616	5	13	causing	cause	VERB
fnp-2616	5	14	iatrogenic	iatrogenic	ADJ
fnp-2616	5	15	creutzfeldt	creutzfeldt	ADJ
fnp-2616	5	16	-	-	PUNCT
fnp-2616	5	17	jakob	jakob	ADJ
fnp-2616	5	18	disease	disease	NOUN
fnp-2616	5	19	.	.	PUNCT
fnp-2616	6	1	recent	recent	ADJ
fnp-2616	6	2	observations	observation	NOUN
fnp-2616	6	3	of	of	ADP
fnp-2616	6	4	amyloid	amyloid	NOUN
fnp-2616	6	5	-	-	PUNCT
fnp-2616	6	6	β	β	NOUN
fnp-2616	6	7	deposition	deposition	NOUN
fnp-2616	6	8	in	in	ADP
fnp-2616	6	9	dural	dural	ADJ
fnp-2616	6	10	grafts	graft	NOUN
fnp-2616	6	11	support	support	VERB
fnp-2616	6	12	the	the	DET
fnp-2616	6	13	seeding	seed	VERB
fnp-2616	6	14	properties	property	NOUN
fnp-2616	6	15	of	of	ADP
fnp-2616	6	16	amyloid	amyloid	NOUN
fnp-2616	6	17	-	-	PUNCT
fnp-2616	6	18	β	β	NOUN
fnp-2616	6	19	.	.	PUNCT
fnp-2616	7	1	here	here	ADV
fnp-2616	7	2	we	we	PRON
fnp-2616	7	3	assessed	assess	VERB
fnp-2616	7	4	the	the	DET
fnp-2616	7	5	presence	presence	NOUN
fnp-2616	7	6	of	of	ADP
fnp-2616	7	7	alpha	alpha	NOUN
fnp-2616	7	8	-	-	PUNCT
fnp-2616	7	9	synuclein	synuclein	NOUN
fnp-2616	7	10	in	in	ADP
fnp-2616	7	11	dura	dura	NOUN
fnp-2616	7	12	mater	mater	NOUN
fnp-2616	7	13	samples	sample	NOUN
fnp-2616	7	14	as	as	ADP
fnp-2616	7	15	a	a	DET
fnp-2616	7	16	potential	potential	ADJ
fnp-2616	7	17	transmissible	transmissible	ADJ
fnp-2616	7	18	seed	seed	NOUN
fnp-2616	7	19	source	source	NOUN
fnp-2616	7	20	.	.	PUNCT
fnp-2616	8	1	we	we	PRON
fnp-2616	8	2	immunostained	immunostaine	VERB
fnp-2616	8	3	32	32	NUM
fnp-2616	8	4	postmortem	postmortem	NOUN
fnp-2616	8	5	dura	dura	NOUN
fnp-2616	8	6	mater	mater	NOUN
fnp-2616	8	7	samples	sample	NOUN
fnp-2616	8	8	;	;	PUNCT
fnp-2616	8	9	16	16	NUM
fnp-2616	8	10	cases	case	NOUN
fnp-2616	8	11	with	with	ADP
fnp-2616	8	12	lewy	lewy	ADJ
fnp-2616	8	13	-	-	PUNCT
fnp-2616	8	14	body	body	NOUN
fnp-2616	8	15	disorder	disorder	NOUN
fnp-2616	8	16	(	(	PUNCT
fnp-2616	8	17	lbd	lbd	PROPN
fnp-2616	8	18	)	)	PUNCT
fnp-2616	8	19	showing	show	VERB
fnp-2616	8	20	different	different	ADJ
fnp-2616	8	21	pathology	pathology	NOUN
fnp-2616	8	22	stages	stage	NOUN
fnp-2616	8	23	and	and	CCONJ
fnp-2616	8	24	16	16	NUM
fnp-2616	8	25	non	non	ADJ
fnp-2616	8	26	-	-	ADJ
fnp-2616	8	27	lbd	lbd	ADJ
fnp-2616	8	28	cases	case	NOUN
fnp-2616	8	29	for	for	ADP
fnp-2616	8	30	phosphorylated	phosphorylate	VERB
fnp-2616	8	31	(	(	PUNCT
fnp-2616	8	32	ser129	ser129	PROPN
fnp-2616	8	33	)	)	PUNCT
fnp-2616	8	34	and	and	CCONJ
fnp-2616	8	35	disease	disease	NOUN
fnp-2616	8	36	-	-	PUNCT
fnp-2616	8	37	associated	associate	VERB
fnp-2616	8	38	(	(	PUNCT
fnp-2616	8	39	5g4	5g4	NUM
fnp-2616	8	40	)	)	PUNCT
fnp-2616	8	41	alpha	alpha	NOUN
fnp-2616	8	42	-	-	PUNCT
fnp-2616	8	43	synuclein	synuclein	NOUN
fnp-2616	8	44	.	.	PUNCT
fnp-2616	9	1	disease	disease	NOUN
fnp-2616	9	2	-	-	PUNCT
fnp-2616	9	3	associated	associate	VERB
fnp-2616	9	4	alpha	alpha	NOUN
fnp-2616	9	5	-	-	PUNCT
fnp-2616	9	6	synuclein	synuclein	NOUN
fnp-2616	9	7	aggregates	aggregate	NOUN
fnp-2616	9	8	were	be	AUX
fnp-2616	9	9	identified	identify	VERB
fnp-2616	9	10	in	in	ADP
fnp-2616	9	11	intradural	intradural	ADJ
fnp-2616	9	12	nerve	nerve	NOUN
fnp-2616	9	13	fibres	fibre	NOUN
fnp-2616	9	14	and	and	CCONJ
fnp-2616	9	15	associated	associate	VERB
fnp-2616	9	16	with	with	ADP
fnp-2616	9	17	a	a	DET
fnp-2616	9	18	vessel	vessel	NOUN
fnp-2616	9	19	in	in	ADP
fnp-2616	9	20	a	a	DET
fnp-2616	9	21	single	single	ADJ
fnp-2616	9	22	lbd	lbd	PROPN
fnp-2616	9	23	-	-	PUNCT
fnp-2616	9	24	braak	braak	PROPN
fnp-2616	9	25	stage	stage	NOUN
fnp-2616	9	26	4	4	NUM
fnp-2616	9	27	case	case	NOUN
fnp-2616	9	28	.	.	PUNCT
fnp-2616	10	1	we	we	PRON
fnp-2616	10	2	conclude	conclude	VERB
fnp-2616	10	3	that	that	SCONJ
fnp-2616	10	4	alpha	alpha	NOUN
fnp-2616	10	5	-	-	PUNCT
fnp-2616	10	6	synuclein	synuclein	NOUN
fnp-2616	10	7	is	be	AUX
fnp-2616	10	8	detectable	detectable	ADJ
fnp-2616	10	9	,	,	PUNCT
fnp-2616	10	10	although	although	SCONJ
fnp-2616	10	11	rarely	rarely	ADV
fnp-2616	10	12	,	,	PUNCT
fnp-2616	10	13	in	in	ADP
fnp-2616	10	14	dura	dura	NOUN
fnp-2616	10	15	mater	mater	NOUN
fnp-2616	10	16	samples	sample	NOUN
fnp-2616	10	17	in	in	ADP
fnp-2616	10	18	patients	patient	NOUN
fnp-2616	10	19	with	with	ADP
fnp-2616	10	20	lbd	lbd	PROPN
fnp-2616	10	21	.	.	PUNCT
fnp-2616	11	1	the	the	DET
fnp-2616	11	2	risk	risk	NOUN
fnp-2616	11	3	of	of	ADP
fnp-2616	11	4	potential	potential	ADJ
fnp-2616	11	5	transmissibility	transmissibility	NOUN
fnp-2616	11	6	of	of	ADP
fnp-2616	11	7	dural	dural	ADJ
fnp-2616	11	8	alpha	alpha	NOUN
fnp-2616	11	9	-	-	PUNCT
fnp-2616	11	10	synuclein	synuclein	NOUN
fnp-2616	11	11	deserves	deserve	VERB
fnp-2616	11	12	assessment	assessment	NOUN
fnp-2616	11	13	by	by	ADP
fnp-2616	11	14	complementary	complementary	ADJ
fnp-2616	11	15	experimental	experimental	ADJ
fnp-2616	11	16	studies	study	NOUN
fnp-2616	11	17	.	.	PUNCT
fnp-2616	12	1	introduction	introduction	NOUN
fnp-2616	12	2	neurodegenerative	neurodegenerative	ADJ
fnp-2616	12	3	diseases	disease	NOUN
fnp-2616	12	4	are	be	AUX
fnp-2616	12	5	considered	consider	VERB
fnp-2616	12	6	protein	protein	NOUN
fnp-2616	12	7	-	-	PUNCT
fnp-2616	12	8	misfolding	misfolde	VERB
fnp-2616	12	9	disorders	disorder	NOUN
fnp-2616	12	10	.	.	PUNCT
fnp-2616	13	1	as	as	SCONJ
fnp-2616	13	2	described	describe	VERB
fnp-2616	13	3	in	in	ADP
fnp-2616	13	4	prion	prion	NOUN
fnp-2616	13	5	diseases	disease	NOUN
fnp-2616	13	6	,	,	PUNCT
fnp-2616	13	7	the	the	DET
fnp-2616	13	8	host	host	NOUN
fnp-2616	13	9	physiological	physiological	ADJ
fnp-2616	13	10	protein	protein	NOUN
fnp-2616	13	11	adopts	adopt	VERB
fnp-2616	13	12	an	an	DET
fnp-2616	13	13	abnormal	abnormal	ADJ
fnp-2616	13	14	conformation	conformation	NOUN
fnp-2616	13	15	(	(	PUNCT
fnp-2616	13	16	seed	seed	NOUN
fnp-2616	13	17	)	)	PUNCT
fnp-2616	13	18	,	,	PUNCT
fnp-2616	13	19	capable	capable	ADJ
fnp-2616	13	20	of	of	ADP
fnp-2616	13	21	inducing	induce	VERB
fnp-2616	13	22	misfolding	misfolding	NOUN
fnp-2616	13	23	and	and	CCONJ
fnp-2616	13	24	aggregation	aggregation	NOUN
fnp-2616	13	25	of	of	ADP
fnp-2616	13	26	the	the	DET
fnp-2616	13	27	neighboring	neighboring	NOUN
fnp-2616	13	28	molecules	molecule	NOUN
fnp-2616	13	29	(	(	PUNCT
fnp-2616	13	30	e.g.	e.g.	ADV
fnp-2616	13	31	for	for	ADP
fnp-2616	13	32	prion	prion	NOUN
fnp-2616	13	33	protein	protein	NOUN
fnp-2616	13	34	:	:	PUNCT
fnp-2616	13	35	the	the	DET
fnp-2616	13	36	physiological	physiological	ADJ
fnp-2616	13	37	prpc	prpc	NOUN
fnp-2616	13	38	converting	convert	VERB
fnp-2616	13	39	to	to	ADP
fnp-2616	13	40	disease	disease	NOUN
fnp-2616	13	41	-	-	PUNCT
fnp-2616	13	42	associated	associate	VERB
fnp-2616	13	43	prpsc	prpsc	NOUN
fnp-2616	13	44	,	,	PUNCT
fnp-2616	13	45	and	and	CCONJ
fnp-2616	13	46	prpsc	prpsc	NOUN
fnp-2616	13	47	recruiting	recruit	VERB
fnp-2616	13	48	more	more	ADJ
fnp-2616	13	49	prpc	prpc	NOUN
fnp-2616	13	50	)	)	PUNCT
fnp-2616	13	51	.	.	PUNCT
fnp-2616	14	1	in	in	ADP
fnp-2616	14	2	prion	prion	NOUN
fnp-2616	14	3	disease	disease	NOUN
fnp-2616	14	4	,	,	PUNCT
fnp-2616	14	5	strong	strong	ADJ
fnp-2616	14	6	clinical	clinical	ADJ
fnp-2616	14	7	,	,	PUNCT
fnp-2616	14	8	epidemiological	epidemiological	ADJ
fnp-2616	14	9	and	and	CCONJ
fnp-2616	14	10	experimental	experimental	ADJ
fnp-2616	14	11	evidence	evidence	NOUN
fnp-2616	14	12	has	have	AUX
fnp-2616	14	13	demonstrated	demonstrate	VERB
fnp-2616	14	14	human	human	ADJ
fnp-2616	14	15	and	and	CCONJ
fnp-2616	14	16	interspecies	interspecie	NOUN
fnp-2616	14	17	transmissibility	transmissibility	NOUN
fnp-2616	14	18	of	of	ADP
fnp-2616	14	19	prpsc(1	prpsc(1	PROPN
fnp-2616	14	20	)	)	PUNCT
fnp-2616	14	21	.	.	PUNCT
fnp-2616	15	1	for	for	ADP
fnp-2616	15	2	several	several	ADJ
fnp-2616	15	3	other	other	ADJ
fnp-2616	15	4	proteins	protein	NOUN
fnp-2616	15	5	associated	associate	VERB
fnp-2616	15	6	with	with	ADP
fnp-2616	15	7	neurodegenerative	neurodegenerative	ADJ
fnp-2616	15	8	conditions	condition	NOUN
fnp-2616	15	9	,	,	PUNCT
fnp-2616	15	10	such	such	ADJ
fnp-2616	15	11	as	as	ADP
fnp-2616	15	12	amyloid	amyloid	NOUN
fnp-2616	15	13	-	-	PUNCT
fnp-2616	15	14	β	β	X
fnp-2616	15	15	(	(	PUNCT
fnp-2616	15	16	aβ	aβ	NOUN
fnp-2616	15	17	)	)	PUNCT
fnp-2616	15	18	,	,	PUNCT
fnp-2616	15	19	tau	tau	PROPN
fnp-2616	15	20	,	,	PUNCT
fnp-2616	15	21	alpha	alpha	NOUN
fnp-2616	15	22	-	-	PUNCT
fnp-2616	15	23	synuclein	synuclein	NOUN
fnp-2616	15	24	,	,	PUNCT
fnp-2616	15	25	and	and	CCONJ
fnp-2616	15	26	tar	tar	NOUN
fnp-2616	15	27	dna	dna	NOUN
fnp-2616	15	28	binding	bind	VERB
fnp-2616	15	29	protein	protein	NOUN
fnp-2616	15	30	(	(	PUNCT
fnp-2616	15	31	tdp-43	tdp-43	NOUN
fnp-2616	15	32	)	)	PUNCT
fnp-2616	15	33	,	,	PUNCT
fnp-2616	15	34	properties	property	NOUN
fnp-2616	15	35	similar	similar	ADJ
fnp-2616	15	36	to	to	ADP
fnp-2616	15	37	those	those	PRON
fnp-2616	15	38	of	of	ADP
fnp-2616	15	39	prp	prp	PROPN
fnp-2616	15	40	have	have	AUX
fnp-2616	15	41	been	be	AUX
fnp-2616	15	42	shown	show	VERB
fnp-2616	15	43	predominantly	predominantly	ADV
fnp-2616	15	44	in	in	ADP
fnp-2616	15	45	an	an	DET
fnp-2616	15	46	experimental	experimental	ADJ
fnp-2616	15	47	setting	setting	NOUN
fnp-2616	15	48	(	(	PUNCT
fnp-2616	15	49	2	2	NUM
fnp-2616	15	50	)	)	PUNCT
fnp-2616	15	51	.	.	PUNCT
fnp-2616	16	1	the	the	DET
fnp-2616	16	2	potential	potential	NOUN
fnp-2616	16	3	of	of	ADP
fnp-2616	16	4	aβ	aβ	NOUN
fnp-2616	16	5	peptides	peptide	NOUN
fnp-2616	16	6	to	to	PART
fnp-2616	16	7	be	be	AUX
fnp-2616	16	8	transmitted	transmit	VERB
fnp-2616	16	9	between	between	ADP
fnp-2616	16	10	humans	human	NOUN
fnp-2616	16	11	has	have	AUX
fnp-2616	16	12	been	be	AUX
fnp-2616	16	13	a	a	DET
fnp-2616	16	14	topic	topic	NOUN
fnp-2616	16	15	of	of	ADP
fnp-2616	16	16	great	great	ADJ
fnp-2616	16	17	interest	interest	NOUN
fnp-2616	16	18	for	for	ADP
fnp-2616	16	19	public	public	ADJ
fnp-2616	16	20	health	health	NOUN
fnp-2616	16	21	.	.	PUNCT
fnp-2616	17	1	young	young	ADJ
fnp-2616	17	2	adults	adult	NOUN
fnp-2616	17	3	with	with	ADP
fnp-2616	17	4	iatrogenic	iatrogenic	ADJ
fnp-2616	17	5	creutzfeldt	creutzfeldt	ADJ
fnp-2616	17	6	-	-	PUNCT
fnp-2616	17	7	jakob	jakob	ADJ
fnp-2616	17	8	-	-	PUNCT
fnp-2616	17	9	disease	disease	NOUN
fnp-2616	17	10	(	(	PUNCT
fnp-2616	17	11	cjd	cjd	NOUN
fnp-2616	17	12	)	)	PUNCT
fnp-2616	17	13	following	follow	VERB
fnp-2616	17	14	cadaveric	cadaveric	ADJ
fnp-2616	17	15	pituitary	pituitary	NOUN
fnp-2616	17	16	-	-	PUNCT
fnp-2616	17	17	derived	derive	VERB
fnp-2616	17	18	growth	growth	NOUN
fnp-2616	17	19	hormone	hormone	NOUN
fnp-2616	17	20	in	in	ADP
fnp-2616	17	21	childhood	childhood	NOUN
fnp-2616	17	22	were	be	AUX
fnp-2616	17	23	found	find	VERB
fnp-2616	17	24	to	to	PART
fnp-2616	17	25	have	have	VERB
fnp-2616	17	26	aβ	aβ	ADP
fnp-2616	17	27	deposits	deposit	NOUN
fnp-2616	17	28	in	in	ADP
fnp-2616	17	29	the	the	DET
fnp-2616	17	30	brain	brain	NOUN
fnp-2616	17	31	parenchyma	parenchyma	NOUN
fnp-2616	17	32	and	and	CCONJ
fnp-2616	17	33	blood	blood	NOUN
fnp-2616	17	34	vessels	vessel	NOUN
fnp-2616	17	35	(	(	PUNCT
fnp-2616	17	36	3	3	NUM
fnp-2616	17	37	,	,	PUNCT
fnp-2616	17	38	5	5	NUM
fnp-2616	17	39	,	,	PUNCT
fnp-2616	17	40	6	6	NUM
fnp-2616	17	41	)	)	PUNCT
fnp-2616	17	42	,	,	PUNCT
fnp-2616	17	43	as	as	ADV
fnp-2616	17	44	well	well	ADV
fnp-2616	17	45	as	as	ADP
fnp-2616	17	46	in	in	ADP
fnp-2616	17	47	iatrogenic	iatrogenic	ADJ
fnp-2616	17	48	cjd	cjd	NOUN
fnp-2616	17	49	after	after	ADP
fnp-2616	17	50	dura	dura	NOUN
fnp-2616	17	51	grafting	grafting	NOUN
fnp-2616	17	52	(	(	PUNCT
fnp-2616	17	53	4	4	NUM
fnp-2616	17	54	)	)	PUNCT
fnp-2616	17	55	.	.	PUNCT
fnp-2616	18	1	two	two	NUM
fnp-2616	18	2	studies	study	NOUN
fnp-2616	18	3	have	have	AUX
fnp-2616	18	4	reported	report	VERB
fnp-2616	18	5	the	the	DET
fnp-2616	18	6	presence	presence	NOUN
fnp-2616	18	7	of	of	ADP
fnp-2616	18	8	aβ	aβ	DET
fnp-2616	18	9	deposits	deposit	NOUN
fnp-2616	18	10	in	in	ADP
fnp-2616	18	11	dura	dura	NOUN
fnp-2616	18	12	mater	mater	NOUN
fnp-2616	18	13	samples	sample	NOUN
fnp-2616	18	14	of	of	ADP
fnp-2616	18	15	postmortem	postmortem	NOUN
fnp-2616	18	16	brains	brain	NOUN
fnp-2616	18	17	of	of	ADP
fnp-2616	18	18	patients	patient	NOUN
fnp-2616	18	19	with	with	ADP
fnp-2616	18	20	alzheimer	alzheimer	PROPN
fnp-2616	18	21	’s	’s	PART
fnp-2616	18	22	disease	disease	NOUN
fnp-2616	18	23	(	(	PUNCT
fnp-2616	18	24	ad	ad	NOUN
fnp-2616	18	25	)	)	PUNCT
fnp-2616	18	26	and	and	CCONJ
fnp-2616	18	27	other	other	ADJ
fnp-2616	18	28	neurodegenerative	neurodegenerative	ADJ
fnp-2616	18	29	pathologies	pathology	NOUN
fnp-2616	18	30	(	(	PUNCT
fnp-2616	18	31	7	7	NUM
fnp-2616	18	32	,	,	PUNCT
fnp-2616	18	33	8)	8)	NUM
fnp-2616	18	34	.	.	PUNCT
fnp-2616	19	1	additionally	additionally	ADV
fnp-2616	19	2	,	,	PUNCT
fnp-2616	19	3	neurosurgical	neurosurgical	ADJ
fnp-2616	19	4	procedures	procedure	NOUN
fnp-2616	19	5	and	and	CCONJ
fnp-2616	19	6	dural	dural	ADJ
fnp-2616	19	7	grafting	grafting	NOUN
fnp-2616	19	8	during	during	ADP
fnp-2616	19	9	childhood	childhood	NOUN
fnp-2616	19	10	or	or	CCONJ
fnp-2616	19	11	teenage	teenage	ADJ
fnp-2616	19	12	years	year	NOUN
fnp-2616	19	13	have	have	AUX
fnp-2616	19	14	been	be	AUX
fnp-2616	19	15	related	relate	VERB
fnp-2616	19	16	to	to	ADP
fnp-2616	19	17	increased	increase	VERB
fnp-2616	19	18	cerebral	cerebral	ADJ
fnp-2616	19	19	amyloid	amyloid	NOUN
fnp-2616	19	20	angiopathy	angiopathy	ADJ
fnp-2616	19	21	(	(	PUNCT
fnp-2616	19	22	caa	caa	NOUN
fnp-2616	19	23	)	)	PUNCT
fnp-2616	19	24	decades	decade	NOUN
fnp-2616	19	25	later	later	ADV
fnp-2616	19	26	(	(	PUNCT
fnp-2616	19	27	9	9	NUM
fnp-2616	19	28	,	,	PUNCT
fnp-2616	19	29	10	10	NUM
fnp-2616	19	30	)	)	PUNCT
fnp-2616	19	31	.	.	PUNCT
fnp-2616	20	1	these	these	DET
fnp-2616	20	2	findings	finding	NOUN
fnp-2616	20	3	indicate	indicate	VERB
fnp-2616	20	4	that	that	SCONJ
fnp-2616	20	5	dura	dura	NOUN
fnp-2616	20	6	mater	mater	NOUN
fnp-2616	20	7	grafts	graft	NOUN
fnp-2616	20	8	could	could	AUX
fnp-2616	20	9	be	be	AUX
fnp-2616	20	10	also	also	ADV
fnp-2616	20	11	a	a	DET
fnp-2616	20	12	source	source	NOUN
fnp-2616	20	13	of	of	ADP
fnp-2616	20	14	aβ	aβ	NOUN
fnp-2616	20	15	seeds	seed	NOUN
fnp-2616	20	16	capable	capable	ADJ
fnp-2616	20	17	of	of	ADP
fnp-2616	20	18	inducing	induce	VERB
fnp-2616	20	19	the	the	DET
fnp-2616	20	20	aggregation	aggregation	NOUN
fnp-2616	20	21	of	of	ADP
fnp-2616	20	22	aβ	aβ	PRON
fnp-2616	20	23	in	in	ADP
fnp-2616	20	24	the	the	DET
fnp-2616	20	25	cns	cns	NOUN
fnp-2616	20	26	of	of	ADP
fnp-2616	20	27	the	the	DET
fnp-2616	20	28	graft	graft	NOUN
fnp-2616	20	29	recipients	recipient	NOUN
fnp-2616	20	30	.	.	PUNCT
fnp-2616	21	1	lewy	lewy	PROPN
fnp-2616	21	2	-	-	PUNCT
fnp-2616	21	3	body	body	NOUN
fnp-2616	21	4	disorders	disorder	NOUN
fnp-2616	21	5	(	(	PUNCT
fnp-2616	21	6	lbd	lbd	PROPN
fnp-2616	21	7	)	)	PUNCT
fnp-2616	21	8	and	and	CCONJ
fnp-2616	21	9	multiple	multiple	ADJ
fnp-2616	21	10	system	system	NOUN
fnp-2616	21	11	atrophy	atrophy	NOUN
fnp-2616	21	12	(	(	PUNCT
fnp-2616	21	13	msa	msa	PROPN
fnp-2616	21	14	)	)	PUNCT
fnp-2616	21	15	are	be	AUX
fnp-2616	21	16	characterized	characterize	VERB
fnp-2616	21	17	by	by	ADP
fnp-2616	21	18	the	the	DET
fnp-2616	21	19	accumulation	accumulation	NOUN
fnp-2616	21	20	of	of	ADP
fnp-2616	21	21	alpha	alpha	NOUN
fnp-2616	21	22	-	-	PUNCT
fnp-2616	21	23	synuclein	synuclein	NOUN
fnp-2616	21	24	.	.	PUNCT
fnp-2616	22	1	a	a	DET
fnp-2616	22	2	growing	grow	VERB
fnp-2616	22	3	body	body	NOUN
fnp-2616	22	4	of	of	ADP
fnp-2616	22	5	experimental	experimental	ADJ
fnp-2616	22	6	evidence	evidence	NOUN
fnp-2616	22	7	supports	support	VERB
fnp-2616	22	8	prion	prion	NOUN
fnp-2616	22	9	-	-	PUNCT
fnp-2616	22	10	like	like	ADJ
fnp-2616	22	11	propagation	propagation	NOUN
fnp-2616	22	12	in	in	ADP
fnp-2616	22	13	alpha	alpha	NOUN
fnp-2616	22	14	-	-	PUNCT
fnp-2616	22	15	synucleinopathies	synucleinopathie	NOUN
fnp-2616	22	16	(	(	PUNCT
fnp-2616	22	17	11	11	NUM
fnp-2616	22	18	-	-	SYM
fnp-2616	22	19	13	13	NUM
fnp-2616	22	20	)	)	PUNCT
fnp-2616	22	21	.	.	PUNCT
fnp-2616	23	1	observations	observation	NOUN
fnp-2616	23	2	in	in	ADP
fnp-2616	23	3	a	a	DET
fnp-2616	23	4	small	small	ADJ
fnp-2616	23	5	number	number	NOUN
fnp-2616	23	6	of	of	ADP
fnp-2616	23	7	subjects	subject	NOUN
fnp-2616	23	8	with	with	ADP
fnp-2616	23	9	parkinson`s	parkinson`s	ADJ
fnp-2616	23	10	disease	disease	NOUN
fnp-2616	23	11	(	(	PUNCT
fnp-2616	23	12	pd	pd	NOUN
fnp-2616	23	13	)	)	PUNCT
fnp-2616	23	14	treated	treat	VERB
fnp-2616	23	15	with	with	ADP
fnp-2616	23	16	fetal	fetal	ADJ
fnp-2616	23	17	mesencephalic	mesencephalic	ADJ
fnp-2616	23	18	dopaminergic	dopaminergic	ADJ
fnp-2616	23	19	grafts	graft	NOUN
fnp-2616	23	20	in	in	ADP
fnp-2616	23	21	the	the	DET
fnp-2616	23	22	striatum	striatum	NOUN
fnp-2616	23	23	,	,	PUNCT
fnp-2616	23	24	who	who	PRON
fnp-2616	23	25	years	year	NOUN
fnp-2616	23	26	later	later	ADV
fnp-2616	23	27	were	be	AUX
fnp-2616	23	28	found	find	VERB
fnp-2616	23	29	to	to	PART
fnp-2616	23	30	have	have	VERB
fnp-2616	23	31	alpha	alpha	NOUN
fnp-2616	23	32	-	-	PUNCT
fnp-2616	23	33	synuclein	synuclein	NOUN
fnp-2616	23	34	positive	positive	ADJ
fnp-2616	23	35	lbs	lbs	NOUN
fnp-2616	23	36	in	in	ADP
fnp-2616	23	37	grafted	graft	VERB
fnp-2616	23	38	neurons	neuron	NOUN
fnp-2616	23	39	,	,	PUNCT
fnp-2616	23	40	first	first	ADV
fnp-2616	23	41	suggested	suggest	VERB
fnp-2616	23	42	the	the	DET
fnp-2616	23	43	potential	potential	NOUN
fnp-2616	23	44	of	of	ADP
fnp-2616	23	45	alpha	alpha	NOUN
fnp-2616	23	46	-	-	PUNCT
fnp-2616	23	47	synuclein	synuclein	NOUN
fnp-2616	23	48	propagation	propagation	NOUN
fnp-2616	23	49	from	from	ADP
fnp-2616	23	50	host	host	NOUN
fnp-2616	23	51	to	to	ADP
fnp-2616	23	52	graft	graft	NOUN
fnp-2616	23	53	cells	cell	NOUN
fnp-2616	23	54	(	(	PUNCT
fnp-2616	23	55	14	14	NUM
fnp-2616	23	56	,	,	PUNCT
fnp-2616	23	57	15	15	NUM
fnp-2616	23	58	)	)	PUNCT
fnp-2616	23	59	.	.	PUNCT
fnp-2616	24	1	while	while	SCONJ
fnp-2616	24	2	experimental	experimental	ADJ
fnp-2616	24	3	studies	study	NOUN
fnp-2616	24	4	have	have	AUX
fnp-2616	24	5	also	also	ADV
fnp-2616	24	6	successfully	successfully	ADV
fnp-2616	24	7	demonstrated	demonstrate	VERB
fnp-2616	24	8	the	the	DET
fnp-2616	24	9	transmission	transmission	NOUN
fnp-2616	24	10	potential	potential	NOUN
fnp-2616	24	11	of	of	ADP
fnp-2616	24	12	msa	msa	PROPN
fnp-2616	24	13	alpha	alpha	PROPN
fnp-2616	24	14	-	-	PUNCT
fnp-2616	24	15	synuclein	synuclein	NOUN
fnp-2616	24	16	in	in	ADP
fnp-2616	24	17	genetically	genetically	ADV
fnp-2616	24	18	modified	modify	VERB
fnp-2616	24	19	mouse	mouse	NOUN
fnp-2616	24	20	models	model	NOUN
fnp-2616	24	21	(	(	PUNCT
fnp-2616	24	22	16	16	NUM
fnp-2616	24	23	)	)	PUNCT
fnp-2616	24	24	,	,	PUNCT
fnp-2616	24	25	observations	observation	NOUN
fnp-2616	24	26	in	in	ADP
fnp-2616	24	27	humans	human	NOUN
fnp-2616	24	28	argue	argue	VERB
fnp-2616	24	29	against	against	ADP
fnp-2616	24	30	a	a	DET
fnp-2616	24	31	human	human	NOUN
fnp-2616	24	32	-	-	PUNCT
fnp-2616	24	33	to	to	ADP
fnp-2616	24	34	-	-	PUNCT
fnp-2616	24	35	human	human	ADJ
fnp-2616	24	36	iatrogenic	iatrogenic	ADJ
fnp-2616	24	37	transmission	transmission	NOUN
fnp-2616	24	38	of	of	ADP
fnp-2616	24	39	msa	msa	PROPN
fnp-2616	24	40	and	and	CCONJ
fnp-2616	24	41	pd	pd	PROPN
fnp-2616	24	42	(	(	PUNCT
fnp-2616	24	43	17	17	NUM
fnp-2616	24	44	)	)	PUNCT
fnp-2616	24	45	.	.	PUNCT
fnp-2616	25	1	given	give	VERB
fnp-2616	25	2	the	the	DET
fnp-2616	25	3	potential	potential	ADJ
fnp-2616	25	4	implications	implication	NOUN
fnp-2616	25	5	for	for	ADP
fnp-2616	25	6	public	public	ADJ
fnp-2616	25	7	health	health	NOUN
fnp-2616	25	8	,	,	PUNCT
fnp-2616	25	9	we	we	PRON
fnp-2616	25	10	posit	posit	VERB
fnp-2616	25	11	that	that	DET
fnp-2616	25	12	thorough	thorough	ADJ
fnp-2616	25	13	assessment	assessment	NOUN
fnp-2616	25	14	of	of	ADP
fnp-2616	25	15	the	the	DET
fnp-2616	25	16	potential	potential	ADJ
fnp-2616	25	17	transmissibility	transmissibility	NOUN
fnp-2616	25	18	of	of	ADP
fnp-2616	25	19	all	all	DET
fnp-2616	25	20	neurodegenerative	neurodegenerative	ADJ
fnp-2616	25	21	proteinopathies	proteinopathie	NOUN
fnp-2616	25	22	is	be	AUX
fnp-2616	25	23	essential	essential	ADJ
fnp-2616	25	24	(	(	PUNCT
fnp-2616	25	25	18	18	NUM
fnp-2616	25	26	)	)	PUNCT
fnp-2616	25	27	.	.	PUNCT
fnp-2616	26	1	therefore	therefore	ADV
fnp-2616	26	2	,	,	PUNCT
fnp-2616	26	3	in	in	ADP
fnp-2616	26	4	this	this	DET
fnp-2616	26	5	study	study	NOUN
fnp-2616	26	6	,	,	PUNCT
fnp-2616	26	7	we	we	PRON
fnp-2616	26	8	assessed	assess	VERB
fnp-2616	26	9	human	human	ADJ
fnp-2616	26	10	postmortem	postmortem	NOUN
fnp-2616	26	11	dura	dura	NOUN
fnp-2616	26	12	mater	mater	NOUN
fnp-2616	26	13	samples	sample	NOUN
fnp-2616	26	14	,	,	PUNCT
fnp-2616	26	15	some	some	PRON
fnp-2616	26	16	of	of	ADP
fnp-2616	26	17	which	which	PRON
fnp-2616	26	18	have	have	AUX
fnp-2616	26	19	been	be	AUX
fnp-2616	26	20	previously	previously	ADV
fnp-2616	26	21	shown	show	VERB
fnp-2616	26	22	to	to	PART
fnp-2616	26	23	harbor	harbor	VERB
fnp-2616	26	24	aβ	aβ	PRON
fnp-2616	26	25	deposits	deposit	NOUN
fnp-2616	26	26	(	(	PUNCT
fnp-2616	26	27	7	7	NUM
fnp-2616	26	28	)	)	PUNCT
fnp-2616	26	29	,	,	PUNCT
fnp-2616	26	30	for	for	ADP
fnp-2616	26	31	the	the	DET
fnp-2616	26	32	presence	presence	NOUN
fnp-2616	26	33	of	of	ADP
fnp-2616	26	34	alpha	alpha	NOUN
fnp-2616	26	35	-	-	PUNCT
fnp-2616	26	36	synuclein	synuclein	NOUN
fnp-2616	26	37	aggregates	aggregate	NOUN
fnp-2616	26	38	,	,	PUNCT
fnp-2616	26	39	which	which	PRON
fnp-2616	26	40	may	may	AUX
fnp-2616	26	41	represent	represent	VERB
fnp-2616	26	42	seeds	seed	NOUN
fnp-2616	26	43	with	with	ADP
fnp-2616	26	44	the	the	DET
fnp-2616	26	45	potential	potential	NOUN
fnp-2616	26	46	of	of	ADP
fnp-2616	26	47	propagating	propagate	VERB
fnp-2616	26	48	further	further	ADJ
fnp-2616	26	49	synucleinopathy	synucleinopathy	NOUN
fnp-2616	26	50	.	.	PUNCT
fnp-2616	27	1	material	material	NOUN
fnp-2616	27	2	and	and	CCONJ
fnp-2616	27	3	methods	method	NOUN
fnp-2616	27	4	formalin	formalin	NOUN
fnp-2616	27	5	-	-	PUNCT
fnp-2616	27	6	fixed	fix	VERB
fnp-2616	27	7	and	and	CCONJ
fnp-2616	27	8	paraffin	paraffin	NOUN
fnp-2616	27	9	-	-	PUNCT
fnp-2616	27	10	embedded	embed	VERB
fnp-2616	27	11	postmortem	postmortem	NOUN
fnp-2616	27	12	tissue	tissue	NOUN
fnp-2616	27	13	samples	sample	NOUN
fnp-2616	27	14	of	of	ADP
fnp-2616	27	15	the	the	DET
fnp-2616	27	16	dura	dura	NOUN
fnp-2616	27	17	mater	mater	NOUN
fnp-2616	27	18	from	from	ADP
fnp-2616	27	19	the	the	DET
fnp-2616	27	20	left	left	ADJ
fnp-2616	27	21	temporal	temporal	ADJ
fnp-2616	27	22	and	and	CCONJ
fnp-2616	27	23	posterior	posterior	ADJ
fnp-2616	27	24	region	region	NOUN
fnp-2616	27	25	as	as	ADV
fnp-2616	27	26	well	well	ADV
fnp-2616	27	27	as	as	ADP
fnp-2616	27	28	cross	cros	NOUN
fnp-2616	27	29	-	-	NOUN
fnp-2616	27	30	sections	section	NOUN
fnp-2616	27	31	from	from	ADP
fnp-2616	27	32	the	the	DET
fnp-2616	27	33	area	area	NOUN
fnp-2616	27	34	of	of	ADP
fnp-2616	27	35	the	the	DET
fnp-2616	27	36	superior	superior	ADJ
fnp-2616	27	37	sagittal	sagittal	ADJ
fnp-2616	27	38	sinus	sinu	NOUN
fnp-2616	27	39	and	and	CCONJ
fnp-2616	27	40	confluence	confluence	NOUN
fnp-2616	27	41	of	of	ADP
fnp-2616	27	42	sinuses	sinus	NOUN
fnp-2616	27	43	(	(	PUNCT
fnp-2616	27	44	7	7	NUM
fnp-2616	27	45	)	)	PUNCT
fnp-2616	27	46	,	,	PUNCT
fnp-2616	27	47	were	be	AUX
fnp-2616	27	48	cut	cut	VERB
fnp-2616	27	49	into	into	ADP
fnp-2616	27	50	5	5	NUM
fnp-2616	27	51	-	-	PUNCT
fnp-2616	27	52	micrometer	micrometer	NOUN
fnp-2616	27	53	thick	thick	ADJ
fnp-2616	27	54	sections	section	NOUN
fnp-2616	27	55	.	.	PUNCT
fnp-2616	28	1	this	this	DET
fnp-2616	28	2	study	study	NOUN
fnp-2616	28	3	was	be	AUX
fnp-2616	28	4	approved	approve	VERB
fnp-2616	28	5	by	by	ADP
fnp-2616	28	6	the	the	DET
fnp-2616	28	7	ethics	ethic	NOUN
fnp-2616	28	8	committee	committee	PROPN
fnp-2616	28	9	of	of	ADP
fnp-2616	28	10	the	the	DET
fnp-2616	28	11	medical	medical	ADJ
fnp-2616	28	12	university	university	PROPN
fnp-2616	28	13	of	of	ADP
fnp-2616	28	14	vienna	vienna	PROPN
fnp-2616	28	15	.	.	PUNCT
fnp-2616	29	1	brains	brain	NOUN
fnp-2616	29	2	were	be	AUX
fnp-2616	29	3	previously	previously	ADV
fnp-2616	29	4	evaluated	evaluate	VERB
fnp-2616	29	5	neuropathologically	neuropathologically	ADV
fnp-2616	29	6	and	and	CCONJ
fnp-2616	29	7	a	a	DET
fnp-2616	29	8	final	final	ADJ
fnp-2616	29	9	primary	primary	ADJ
fnp-2616	29	10	diagnosis	diagnosis	NOUN
fnp-2616	29	11	and	and	CCONJ
fnp-2616	29	12	concomitant	concomitant	ADJ
fnp-2616	29	13	pathologies	pathology	NOUN
fnp-2616	29	14	were	be	AUX
fnp-2616	29	15	recorded	record	VERB
fnp-2616	29	16	.	.	PUNCT
fnp-2616	30	1	fixation	fixation	NOUN
fnp-2616	30	2	time	time	NOUN
fnp-2616	30	3	of	of	ADP
fnp-2616	30	4	dura	dura	NOUN
fnp-2616	30	5	mater	mater	NOUN
fnp-2616	30	6	samples	sample	NOUN
fnp-2616	30	7	ranged	range	VERB
fnp-2616	30	8	from	from	ADP
fnp-2616	30	9	3	3	NUM
fnp-2616	30	10	to	to	PART
fnp-2616	30	11	10	10	NUM
fnp-2616	30	12	years	year	NOUN
fnp-2616	30	13	.	.	PUNCT
fnp-2616	31	1	immunohistochemistry	immunohistochemistry	NOUN
fnp-2616	31	2	of	of	ADP
fnp-2616	31	3	the	the	DET
fnp-2616	31	4	dura	dura	NOUN
fnp-2616	31	5	mater	mater	NOUN
fnp-2616	31	6	samples	sample	NOUN
fnp-2616	31	7	was	be	AUX
fnp-2616	31	8	performed	perform	VERB
fnp-2616	31	9	on	on	ADP
fnp-2616	31	10	an	an	DET
fnp-2616	31	11	automated	automate	VERB
fnp-2616	31	12	immunostainer	immunostainer	NOUN
fnp-2616	31	13	(	(	PUNCT
fnp-2616	31	14	dako	dako	PROPN
fnp-2616	31	15	autostainer	autostainer	PROPN
fnp-2616	31	16	link	link	PROPN
fnp-2616	31	17	48	48	NUM
fnp-2616	31	18	,	,	PUNCT
fnp-2616	31	19	glostrup	glostrup	NOUN
fnp-2616	31	20	,	,	PUNCT
fnp-2616	31	21	denmark	denmark	NOUN
fnp-2616	31	22	)	)	PUNCT
fnp-2616	31	23	using	use	VERB
fnp-2616	31	24	two	two	NUM
fnp-2616	31	25	different	different	ADJ
fnp-2616	31	26	anti	anti	ADJ
fnp-2616	31	27	-	-	ADJ
fnp-2616	31	28	alpha	alpha	ADJ
fnp-2616	31	29	-	-	PUNCT
fnp-2616	31	30	synuclein	synuclein	NOUN
fnp-2616	31	31	antibodies	antibodie	VERB
fnp-2616	31	32	:	:	PUNCT
fnp-2616	31	33	clone	clone	NOUN
fnp-2616	31	34	5g4	5g4	NUM
fnp-2616	31	35	(	(	PUNCT
fnp-2616	31	36	1:4000	1:4000	NUM
fnp-2616	31	37	)	)	PUNCT
fnp-2616	31	38	,	,	PUNCT
fnp-2616	31	39	roboscreen	roboscreen	PROPN
fnp-2616	31	40	,	,	PUNCT
fnp-2616	31	41	leipzig	leipzig	PROPN
fnp-2616	31	42	,	,	PUNCT
fnp-2616	31	43	germany	germany	PROPN
fnp-2616	31	44	;	;	PUNCT
fnp-2616	31	45	specific	specific	ADJ
fnp-2616	31	46	for	for	ADP
fnp-2616	31	47	disease	disease	NOUN
fnp-2616	31	48	-	-	PUNCT
fnp-2616	31	49	associated	associate	VERB
fnp-2616	31	50	forms	form	NOUN
fnp-2616	31	51	and	and	CCONJ
fnp-2616	31	52	the	the	DET
fnp-2616	31	53	phospho	phospho	ADJ
fnp-2616	31	54	-	-	PUNCT
fnp-2616	31	55	specific	specific	ADJ
fnp-2616	31	56	anti	anti	ADJ
fnp-2616	31	57	-	-	ADJ
fnp-2616	31	58	alpha	alpha	ADJ
fnp-2616	31	59	-	-	PUNCT
fnp-2616	31	60	synuclein	synuclein	NOUN
fnp-2616	31	61	phosphorylated	phosphorylate	VERB
fnp-2616	31	62	at	at	ADP
fnp-2616	31	63	serine	serine	NOUN
fnp-2616	31	64	129	129	NUM
fnp-2616	31	65	(	(	PUNCT
fnp-2616	31	66	wako	wako	PROPN
fnp-2616	31	67	)	)	PUNCT
fnp-2616	31	68	(	(	PUNCT
fnp-2616	31	69	1:2000	1:2000	NUM
fnp-2616	31	70	)	)	PUNCT
fnp-2616	31	71	.	.	PUNCT
fnp-2616	32	1	in	in	ADP
fnp-2616	32	2	addition	addition	NOUN
fnp-2616	32	3	,	,	PUNCT
fnp-2616	32	4	we	we	PRON
fnp-2616	32	5	performed	perform	VERB
fnp-2616	32	6	immunohistochemical	immunohistochemical	ADJ
fnp-2616	32	7	staining	stain	VERB
fnp-2616	32	8	to	to	PART
fnp-2616	32	9	depict	depict	VERB
fnp-2616	32	10	the	the	DET
fnp-2616	32	11	nerve	nerve	NOUN
fnp-2616	32	12	fibres	fibre	NOUN
fnp-2616	32	13	within	within	ADP
fnp-2616	32	14	the	the	DET
fnp-2616	32	15	connective	connective	ADJ
fnp-2616	32	16	tissue	tissue	NOUN
fnp-2616	32	17	of	of	ADP
fnp-2616	32	18	the	the	DET
fnp-2616	32	19	dura	dura	NOUN
fnp-2616	32	20	mater	mater	NOUN
fnp-2616	32	21	:	:	PUNCT
fnp-2616	32	22	anti	anti	ADJ
fnp-2616	32	23	-	-	ADJ
fnp-2616	32	24	neurofilament	neurofilament	ADJ
fnp-2616	32	25	protein	protein	NOUN
fnp-2616	32	26	(	(	PUNCT
fnp-2616	32	27	nfp	nfp	PROPN
fnp-2616	32	28	)	)	PUNCT
fnp-2616	32	29	,	,	PUNCT
fnp-2616	32	30	clone	clone	NOUN
fnp-2616	32	31	2f11	2f11	NOUN
fnp-2616	32	32	(	(	PUNCT
fnp-2616	32	33	1:800	1:800	NUM
fnp-2616	32	34	)	)	PUNCT
fnp-2616	32	35	,	,	PUNCT
fnp-2616	32	36	dako	dako	PROPN
fnp-2616	32	37	;	;	PUNCT
fnp-2616	32	38	pgp	pgp	NOUN
fnp-2616	32	39	9.5	9.5	NUM
fnp-2616	32	40	(	(	PUNCT
fnp-2616	32	41	1:100	1:100	NUM
fnp-2616	32	42	)	)	PUNCT
fnp-2616	32	43	,	,	PUNCT
fnp-2616	32	44	dako	dako	PROPN
fnp-2616	32	45	,	,	PUNCT
fnp-2616	32	46	rabbit	rabbit	NOUN
fnp-2616	32	47	polyclonal	polyclonal	NOUN
fnp-2616	32	48	;	;	PUNCT
fnp-2616	32	49	anti	anti	ADJ
fnp-2616	32	50	-	-	ADJ
fnp-2616	32	51	tyrosine	tyrosine	ADJ
fnp-2616	32	52	hydroxylase	hydroxylase	NOUN
fnp-2616	32	53	,	,	PUNCT
fnp-2616	32	54	clone	clone	NOUN
fnp-2616	32	55	1b5	1b5	NUM
fnp-2616	32	56	(	(	PUNCT
fnp-2616	32	57	1:200	1:200	NUM
fnp-2616	32	58	)	)	PUNCT
fnp-2616	32	59	,	,	PUNCT
fnp-2616	32	60	novocastra	novocastra	PROPN
fnp-2616	32	61	,	,	PUNCT
fnp-2616	32	62	newcastle	newcastle	PROPN
fnp-2616	32	63	,	,	PUNCT
fnp-2616	32	64	uk	uk	PROPN
fnp-2616	32	65	;	;	PUNCT
fnp-2616	32	66	and	and	CCONJ
fnp-2616	32	67	anti	anti	ADJ
fnp-2616	32	68	-	-	ADJ
fnp-2616	32	69	phosphorylated	phosphorylate	VERB
fnp-2616	32	70	neurofilaments	neurofilament	NOUN
fnp-2616	32	71	,	,	PUNCT
fnp-2616	32	72	clone	clone	NOUN
fnp-2616	32	73	smi31	smi31	NOUN
fnp-2616	32	74	(	(	PUNCT
fnp-2616	32	75	1:5000	1:5000	NUM
fnp-2616	32	76	)	)	PUNCT
fnp-2616	32	77	,	,	PUNCT
fnp-2616	32	78	former	former	ADJ
fnp-2616	32	79	covance	covance	NOUN
fnp-2616	32	80	research	research	NOUN
fnp-2616	32	81	products	product	NOUN
fnp-2616	32	82	,	,	PUNCT
fnp-2616	32	83	princeton	princeton	PROPN
fnp-2616	32	84	,	,	PUNCT
fnp-2616	32	85	nj	nj	PROPN
fnp-2616	32	86	,	,	PUNCT
fnp-2616	32	87	usa	usa	PROPN
fnp-2616	32	88	,	,	PUNCT
fnp-2616	32	89	and	and	CCONJ
fnp-2616	32	90	for	for	ADP
fnp-2616	32	91	blood	blood	NOUN
fnp-2616	32	92	and	and	CCONJ
fnp-2616	32	93	lymphatic	lymphatic	ADJ
fnp-2616	32	94	vascular	vascular	ADJ
fnp-2616	32	95	endothelia	endothelia	NOUN
fnp-2616	32	96	(	(	PUNCT
fnp-2616	32	97	anti	anti	ADJ
fnp-2616	32	98	-	-	ADJ
fnp-2616	32	99	cd34	cd34	ADJ
fnp-2616	32	100	,	,	PUNCT
fnp-2616	32	101	clone	clone	NOUN
fnp-2616	32	102	qbend/10	qbend/10	NOUN
fnp-2616	32	103	(	(	PUNCT
fnp-2616	32	104	1:100	1:100	NUM
fnp-2616	32	105	)	)	PUNCT
fnp-2616	32	106	,	,	PUNCT
fnp-2616	32	107	novocastra	novocastra	ADJ
fnp-2616	32	108	;	;	PUNCT
fnp-2616	32	109	and	and	CCONJ
fnp-2616	32	110	podoplanin	podoplanin	PROPN
fnp-2616	32	111	(	(	PUNCT
fnp-2616	32	112	1:3000	1:3000	NUM
fnp-2616	32	113	)	)	PUNCT
fnp-2616	32	114	,	,	PUNCT
fnp-2616	32	115	rabbit	rabbit	NOUN
fnp-2616	32	116	polyclonal	polyclonal	NOUN
fnp-2616	32	117	)	)	PUNCT
fnp-2616	32	118	.	.	PUNCT
fnp-2616	33	1	dako	dako	PROPN
fnp-2616	33	2	flex	flex	ADJ
fnp-2616	33	3	system	system	NOUN
fnp-2616	33	4	(	(	PUNCT
fnp-2616	33	5	peroxidase	peroxidase	NOUN
fnp-2616	33	6	/	/	SYM
fnp-2616	33	7	dab	dab	PROPN
fnp-2616	33	8	)	)	PUNCT
fnp-2616	33	9	was	be	AUX
fnp-2616	33	10	used	use	VERB
fnp-2616	33	11	for	for	ADP
fnp-2616	33	12	visualization	visualization	NOUN
fnp-2616	33	13	of	of	ADP
fnp-2616	33	14	antibody	antibody	NOUN
fnp-2616	33	15	reactions	reaction	NOUN
fnp-2616	33	16	.	.	PUNCT
fnp-2616	34	1	samples	sample	NOUN
fnp-2616	34	2	were	be	AUX
fnp-2616	34	3	assessed	assess	VERB
fnp-2616	34	4	blind	blind	ADJ
fnp-2616	34	5	to	to	ADP
fnp-2616	34	6	the	the	DET
fnp-2616	34	7	neuropathological	neuropathological	ADJ
fnp-2616	34	8	diagnosis	diagnosis	NOUN
fnp-2616	34	9	.	.	PUNCT
fnp-2616	35	1	the	the	DET
fnp-2616	35	2	presence	presence	NOUN
fnp-2616	35	3	or	or	CCONJ
fnp-2616	35	4	absence	absence	NOUN
fnp-2616	35	5	of	of	ADP
fnp-2616	35	6	each	each	DET
fnp-2616	35	7	specific	specific	ADJ
fnp-2616	35	8	immunoreactivity	immunoreactivity	NOUN
fnp-2616	35	9	was	be	AUX
fnp-2616	35	10	recorded	record	VERB
fnp-2616	35	11	.	.	PUNCT
fnp-2616	36	1	in	in	ADP
fnp-2616	36	2	addition	addition	NOUN
fnp-2616	36	3	,	,	PUNCT
fnp-2616	36	4	double	double	ADJ
fnp-2616	36	5	immunofluorescence	immunofluorescence	NOUN
fnp-2616	36	6	combining	combine	VERB
fnp-2616	36	7	pgp	pgp	NOUN
fnp-2616	36	8	9.5	9.5	NUM
fnp-2616	36	9	and	and	CCONJ
fnp-2616	36	10	5g4	5g4	NUM
fnp-2616	36	11	antibodies	antibody	NOUN
fnp-2616	36	12	and	and	CCONJ
fnp-2616	36	13	immunofluorescence	immunofluorescence	NOUN
fnp-2616	36	14	staining	stain	VERB
fnp-2616	36	15	with	with	ADP
fnp-2616	36	16	nfp	nfp	PROPN
fnp-2616	36	17	and	and	CCONJ
fnp-2616	36	18	5g4	5g4	NUM
fnp-2616	36	19	on	on	ADP
fnp-2616	36	20	adjacent	adjacent	ADJ
fnp-2616	36	21	tissue	tissue	NOUN
fnp-2616	36	22	sections	section	NOUN
fnp-2616	36	23	was	be	AUX
fnp-2616	36	24	performed	perform	VERB
fnp-2616	36	25	in	in	ADP
fnp-2616	36	26	one	one	NUM
fnp-2616	36	27	selected	select	VERB
fnp-2616	36	28	case	case	NOUN
fnp-2616	36	29	.	.	PUNCT
fnp-2616	37	1	results	result	NOUN
fnp-2616	37	2	we	we	PRON
fnp-2616	37	3	analyzed	analyze	VERB
fnp-2616	37	4	postmortem	postmortem	NOUN
fnp-2616	37	5	dura	dura	NOUN
fnp-2616	37	6	mater	mater	NOUN
fnp-2616	37	7	samples	sample	NOUN
fnp-2616	37	8	from	from	ADP
fnp-2616	37	9	32	32	NUM
fnp-2616	37	10	donors	donor	NOUN
fnp-2616	37	11	(	(	PUNCT
fnp-2616	37	12	50	50	NUM
fnp-2616	37	13	%	%	NOUN
fnp-2616	37	14	females	female	NOUN
fnp-2616	37	15	)	)	PUNCT
fnp-2616	37	16	aged	age	VERB
fnp-2616	37	17	between	between	ADP
fnp-2616	37	18	84	84	NUM
fnp-2616	37	19	and	and	CCONJ
fnp-2616	37	20	87	87	NUM
fnp-2616	37	21	years	year	NOUN
fnp-2616	37	22	(	(	PUNCT
fnp-2616	37	23	mean	mean	NOUN
fnp-2616	37	24	84.9	84.9	NUM
fnp-2616	37	25	)	)	PUNCT
fnp-2616	37	26	from	from	ADP
fnp-2616	37	27	the	the	DET
fnp-2616	37	28	vienna	vienna	NOUN
fnp-2616	37	29	transdanube	transdanube	NOUN
fnp-2616	37	30	aging	age	VERB
fnp-2616	37	31	(	(	PUNCT
fnp-2616	37	32	vita	vita	NOUN
fnp-2616	37	33	)	)	PUNCT
fnp-2616	37	34	study	study	NOUN
fnp-2616	37	35	(	(	PUNCT
fnp-2616	37	36	19	19	NUM
fnp-2616	37	37	)	)	PUNCT
fnp-2616	37	38	.	.	PUNCT
fnp-2616	38	1	table	table	NOUN
fnp-2616	38	2	1	1	NUM
fnp-2616	38	3	:	:	PUNCT
fnp-2616	38	4	demographic	demographic	ADJ
fnp-2616	38	5	and	and	CCONJ
fnp-2616	38	6	neuropathological	neuropathological	ADJ
fnp-2616	38	7	features	feature	NOUN
fnp-2616	38	8	of	of	ADP
fnp-2616	38	9	the	the	DET
fnp-2616	38	10	study	study	NOUN
fnp-2616	38	11	cohort	cohort	NOUN
fnp-2616	38	12	abbreviations	abbreviation	NOUN
fnp-2616	38	13	:	:	PUNCT
fnp-2616	38	14	ad	ad	NOUN
fnp-2616	38	15	:	:	PUNCT
fnp-2616	38	16	alzheimer	alzheimer	PROPN
fnp-2616	38	17	’s	’s	PART
fnp-2616	38	18	disease	disease	NOUN
fnp-2616	38	19	;	;	PUNCT
fnp-2616	38	20	pd	pd	ADJ
fnp-2616	38	21	:	:	PUNCT
fnp-2616	38	22	parkinson	parkinson	NOUN
fnp-2616	38	23	’s	’s	PART
fnp-2616	38	24	disease	disease	NOUN
fnp-2616	38	25	;	;	PUNCT
fnp-2616	38	26	copd	copd	NOUN
fnp-2616	38	27	:	:	PUNCT
fnp-2616	38	28	chronic	chronic	ADJ
fnp-2616	38	29	obstructive	obstructive	ADJ
fnp-2616	38	30	pulmonary	pulmonary	ADJ
fnp-2616	38	31	disease	disease	NOUN
fnp-2616	38	32	;	;	PUNCT
fnp-2616	38	33	ad	ad	NOUN
fnp-2616	38	34	-	-	PUNCT
fnp-2616	38	35	np	np	NOUN
fnp-2616	38	36	:	:	PUNCT
fnp-2616	38	37	alzheimer	alzheimer	PROPN
fnp-2616	38	38	’s	’s	PART
fnp-2616	38	39	disease	disease	NOUN
fnp-2616	38	40	neuropathological	neuropathological	ADJ
fnp-2616	38	41	changes	change	NOUN
fnp-2616	38	42	;	;	PUNCT
fnp-2616	38	43	caa	caa	NOUN
fnp-2616	38	44	:	:	PUNCT
fnp-2616	38	45	cerebral	cerebral	ADJ
fnp-2616	38	46	amyloid	amyloid	NOUN
fnp-2616	38	47	angiopathy	angiopathy	NOUN
fnp-2616	38	48	;	;	PUNCT
fnp-2616	38	49	agd	agd	PROPN
fnp-2616	38	50	:	:	PUNCT
fnp-2616	38	51	argyrophilic	argyrophilic	ADJ
fnp-2616	38	52	grain	grain	NOUN
fnp-2616	38	53	disease	disease	NOUN
fnp-2616	38	54	;	;	PUNCT
fnp-2616	38	55	hs	hs	NUM
fnp-2616	38	56	:	:	PUNCT
fnp-2616	38	57	hippocampal	hippocampal	ADJ
fnp-2616	38	58	sclerosis	sclerosis	NOUN
fnp-2616	38	59	;	;	PUNCT
fnp-2616	38	60	part	part	NOUN
fnp-2616	38	61	:	:	PUNCT
fnp-2616	38	62	primary	primary	ADJ
fnp-2616	38	63	age	age	NOUN
fnp-2616	38	64	-	-	PUNCT
fnp-2616	38	65	related	relate	VERB
fnp-2616	38	66	tauopathy	tauopathy	NOUN
fnp-2616	38	67	;	;	PUNCT
fnp-2616	38	68	svd	svd	PROPN
fnp-2616	38	69	:	:	PUNCT
fnp-2616	38	70	small	small	ADJ
fnp-2616	38	71	vessel	vessel	NOUN
fnp-2616	38	72	disease	disease	NOUN
fnp-2616	38	73	;	;	PUNCT
fnp-2616	38	74	cbd	cbd	NOUN
fnp-2616	38	75	:	:	PUNCT
fnp-2616	38	76	corticobasal	corticobasal	NOUN
fnp-2616	38	77	degeneration	degeneration	NOUN
fnp-2616	38	78	.	.	PUNCT
fnp-2616	39	1	n.a	n.a	PROPN
fnp-2616	39	2	.	.	PROPN
fnp-2616	39	3	:	:	PUNCT
fnp-2616	39	4	not	not	PART
fnp-2616	39	5	available	available	ADJ
fnp-2616	39	6	;	;	PUNCT
fnp-2616	39	7	n.e	n.e	PROPN
fnp-2616	39	8	.	.	PUNCT
fnp-2616	39	9	:	:	PUNCT
fnp-2616	39	10	not	not	PART
fnp-2616	39	11	evaluable	evaluable	ADJ
fnp-2616	39	12	due	due	ADP
fnp-2616	39	13	to	to	ADP
fnp-2616	39	14	unsteady	unsteady	ADJ
fnp-2616	39	15	immunoreactivity	immunoreactivity	NOUN
fnp-2616	39	16	these	these	DET
fnp-2616	39	17	cases	case	NOUN
fnp-2616	39	18	were	be	AUX
fnp-2616	39	19	analyzed	analyze	VERB
fnp-2616	39	20	in	in	ADP
fnp-2616	39	21	a	a	DET
fnp-2616	39	22	previous	previous	ADJ
fnp-2616	39	23	study	study	NOUN
fnp-2616	39	24	for	for	ADP
fnp-2616	39	25	the	the	DET
fnp-2616	39	26	presence	presence	NOUN
fnp-2616	39	27	of	of	ADP
fnp-2616	39	28	aβ	aβ	PRON
fnp-2616	39	29	deposits	deposit	NOUN
fnp-2616	39	30	neuropathological	neuropathological	ADJ
fnp-2616	39	31	diagnoses	diagnosis	NOUN
fnp-2616	39	32	included	include	VERB
fnp-2616	39	33	16	16	NUM
fnp-2616	39	34	cases	case	NOUN
fnp-2616	39	35	with	with	ADP
fnp-2616	39	36	alpha	alpha	NOUN
fnp-2616	39	37	-	-	PUNCT
fnp-2616	39	38	synuclein	synuclein	NOUN
fnp-2616	39	39	pathology	pathology	NOUN
fnp-2616	39	40	(	(	PUNCT
fnp-2616	39	41	table	table	NOUN
fnp-2616	39	42	1	1	NUM
fnp-2616	39	43	;	;	PUNCT
fnp-2616	39	44	six	six	NUM
fnp-2616	39	45	cases	case	NOUN
fnp-2616	39	46	with	with	ADP
fnp-2616	39	47	amygdala	amygdala	NOUN
fnp-2616	39	48	predominant	predominant	ADJ
fnp-2616	39	49	lewy	lewy	PROPN
fnp-2616	39	50	body	body	PROPN
fnp-2616	39	51	pathology	pathology	NOUN
fnp-2616	39	52	,	,	PUNCT
fnp-2616	39	53	one	one	NUM
fnp-2616	39	54	msa	msa	PROPN
fnp-2616	39	55	case	case	NOUN
fnp-2616	39	56	,	,	PUNCT
fnp-2616	39	57	single	single	ADJ
fnp-2616	39	58	cases	case	NOUN
fnp-2616	39	59	of	of	ADP
fnp-2616	39	60	braak	braak	NOUN
fnp-2616	39	61	stage	stage	NOUN
fnp-2616	39	62	1	1	NUM
fnp-2616	39	63	,	,	PUNCT
fnp-2616	39	64	stage	stage	NOUN
fnp-2616	39	65	2	2	NUM
fnp-2616	39	66	,	,	PUNCT
fnp-2616	39	67	stage	stage	NOUN
fnp-2616	39	68	3	3	NUM
fnp-2616	39	69	,	,	PUNCT
fnp-2616	39	70	stage	stage	NOUN
fnp-2616	39	71	5	5	NUM
fnp-2616	39	72	and	and	CCONJ
fnp-2616	39	73	stage	stage	NOUN
fnp-2616	39	74	6	6	NUM
fnp-2616	39	75	,	,	PUNCT
fnp-2616	39	76	and	and	CCONJ
fnp-2616	39	77	four	four	NUM
fnp-2616	39	78	cases	case	NOUN
fnp-2616	39	79	with	with	ADP
fnp-2616	39	80	braak	braak	ADJ
fnp-2616	39	81	stage	stage	NOUN
fnp-2616	39	82	4	4	NUM
fnp-2616	39	83	of	of	ADP
fnp-2616	39	84	pd	pd	NOUN
fnp-2616	39	85	-	-	PUNCT
fnp-2616	39	86	related	relate	VERB
fnp-2616	39	87	pathology	pathology	NOUN
fnp-2616	39	88	)	)	PUNCT
fnp-2616	39	89	(	(	PUNCT
fnp-2616	39	90	20	20	NUM
fnp-2616	39	91	)	)	PUNCT
fnp-2616	39	92	;	;	PUNCT
fnp-2616	39	93	and	and	CCONJ
fnp-2616	39	94	16	16	NUM
fnp-2616	39	95	cases	case	NOUN
fnp-2616	39	96	without	without	ADP
fnp-2616	39	97	lb	lb	DET
fnp-2616	39	98	pathology	pathology	NOUN
fnp-2616	39	99	but	but	CCONJ
fnp-2616	39	100	other	other	ADJ
fnp-2616	39	101	neuropathological	neuropathological	ADJ
fnp-2616	39	102	conditions	condition	NOUN
fnp-2616	39	103	.	.	PUNCT
fnp-2616	40	1	nerve	nerve	NOUN
fnp-2616	40	2	fibers	fiber	NOUN
fnp-2616	40	3	were	be	AUX
fnp-2616	40	4	detected	detect	VERB
fnp-2616	40	5	mainly	mainly	ADV
fnp-2616	40	6	by	by	ADP
fnp-2616	40	7	nfp	nfp	PROPN
fnp-2616	40	8	immunohistochemistry	immunohistochemistry	NOUN
fnp-2616	40	9	in	in	ADP
fnp-2616	40	10	all	all	DET
fnp-2616	40	11	cases	case	NOUN
fnp-2616	40	12	in	in	ADP
fnp-2616	40	13	variable	variable	ADJ
fnp-2616	40	14	distribution	distribution	NOUN
fnp-2616	40	15	:	:	PUNCT
fnp-2616	40	16	large	large	ADJ
fnp-2616	40	17	nerves	nerve	NOUN
fnp-2616	40	18	surrounding	surround	VERB
fnp-2616	40	19	large	large	ADJ
fnp-2616	40	20	vessels	vessel	NOUN
fnp-2616	40	21	(	(	PUNCT
fnp-2616	40	22	fig	fig	NOUN
fnp-2616	40	23	.	.	PUNCT
fnp-2616	41	1	1a	1a	NUM
fnp-2616	41	2	,	,	PUNCT
fnp-2616	41	3	b	b	X
fnp-2616	41	4	)	)	PUNCT
fnp-2616	41	5	or	or	CCONJ
fnp-2616	41	6	smaller	small	ADJ
fnp-2616	41	7	nerve	nerve	NOUN
fnp-2616	41	8	branches	branch	NOUN
fnp-2616	41	9	in	in	ADP
fnp-2616	41	10	between	between	ADP
fnp-2616	41	11	both	both	DET
fnp-2616	41	12	dura	dura	NOUN
fnp-2616	41	13	layers	layer	NOUN
fnp-2616	41	14	(	(	PUNCT
fnp-2616	41	15	fig	fig	NOUN
fnp-2616	41	16	.	.	PUNCT
fnp-2616	42	1	1c	1c	NOUN
fnp-2616	42	2	,	,	PUNCT
fnp-2616	42	3	d	d	NOUN
fnp-2616	42	4	)	)	PUNCT
fnp-2616	42	5	.	.	PUNCT
fnp-2616	42	6	)	)	PUNCT
fnp-2616	42	7	.	.	PUNCT
fnp-2616	43	1	these	these	DET
fnp-2616	43	2	patterns	pattern	NOUN
fnp-2616	43	3	were	be	AUX
fnp-2616	43	4	also	also	ADV
fnp-2616	43	5	observed	observe	VERB
fnp-2616	43	6	by	by	ADP
fnp-2616	43	7	immunofluorescence	immunofluorescence	NOUN
fnp-2616	43	8	(	(	PUNCT
fnp-2616	43	9	fig	fig	NOUN
fnp-2616	43	10	.	.	PUNCT
fnp-2616	44	1	2	2	NUM
fnp-2616	44	2	)	)	PUNCT
fnp-2616	44	3	.	.	PUNCT
fnp-2616	45	1	no	no	DET
fnp-2616	45	2	immunoreactivity	immunoreactivity	NOUN
fnp-2616	45	3	for	for	ADP
fnp-2616	45	4	tyrosine	tyrosine	NOUN
fnp-2616	45	5	-	-	PUNCT
fnp-2616	45	6	hydroxylase	hydroxylase	NOUN
fnp-2616	45	7	could	could	AUX
fnp-2616	45	8	be	be	AUX
fnp-2616	45	9	detected	detect	VERB
fnp-2616	45	10	.	.	PUNCT
fnp-2616	46	1	cd34	cd34	PROPN
fnp-2616	46	2	and	and	CCONJ
fnp-2616	46	3	podoplanin	podoplanin	PROPN
fnp-2616	46	4	also	also	ADV
fnp-2616	46	5	gave	give	VERB
fnp-2616	46	6	negative	negative	ADJ
fnp-2616	46	7	results	result	NOUN
fnp-2616	46	8	.	.	PUNCT
fnp-2616	47	1	figure	figure	VERB
fnp-2616	47	2	1	1	NUM
fnp-2616	47	3	a	a	NOUN
fnp-2616	47	4	-	-	PUNCT
fnp-2616	47	5	d	d	NOUN
fnp-2616	47	6	:	:	PUNCT
fnp-2616	47	7	histologic	histologic	ADJ
fnp-2616	47	8	appearance	appearance	NOUN
fnp-2616	47	9	of	of	ADP
fnp-2616	47	10	dura	dura	NOUN
fnp-2616	47	11	mater	mater	NOUN
fnp-2616	47	12	consisting	consist	VERB
fnp-2616	47	13	of	of	ADP
fnp-2616	47	14	two	two	NUM
fnp-2616	47	15	lamellae	lamellae	NOUN
fnp-2616	47	16	of	of	ADP
fnp-2616	47	17	connective	connective	ADJ
fnp-2616	47	18	tissue	tissue	NOUN
fnp-2616	47	19	.	.	PUNCT
fnp-2616	48	1	within	within	ADP
fnp-2616	48	2	the	the	DET
fnp-2616	48	3	connective	connective	ADJ
fnp-2616	48	4	tissue	tissue	NOUN
fnp-2616	48	5	there	there	PRON
fnp-2616	48	6	are	be	VERB
fnp-2616	48	7	large	large	ADJ
fnp-2616	48	8	and	and	CCONJ
fnp-2616	48	9	small	small	ADJ
fnp-2616	48	10	vessels	vessel	NOUN
fnp-2616	48	11	,	,	PUNCT
fnp-2616	48	12	which	which	PRON
fnp-2616	48	13	are	be	AUX
fnp-2616	48	14	surrounded	surround	VERB
fnp-2616	48	15	by	by	ADP
fnp-2616	48	16	nerve	nerve	NOUN
fnp-2616	48	17	fibres	fibre	NOUN
fnp-2616	48	18	(	(	PUNCT
fnp-2616	48	19	a	a	NOUN
fnp-2616	48	20	-	-	PUNCT
fnp-2616	48	21	d	d	NOUN
fnp-2616	48	22	,	,	PUNCT
fnp-2616	48	23	neurofilament	neurofilament	ADJ
fnp-2616	48	24	immunohistochemistry	immunohistochemistry	PROPN
fnp-2616	48	25	)	)	PUNCT
fnp-2616	48	26	.	.	PUNCT
fnp-2616	49	1	nerve	nerve	NOUN
fnp-2616	49	2	fibres	fibre	NOUN
fnp-2616	49	3	are	be	AUX
fnp-2616	49	4	also	also	ADV
fnp-2616	49	5	identified	identify	VERB
fnp-2616	49	6	between	between	ADP
fnp-2616	49	7	the	the	DET
fnp-2616	49	8	lamellae	lamellae	NOUN
fnp-2616	49	9	and	and	CCONJ
fnp-2616	49	10	within	within	ADP
fnp-2616	49	11	the	the	DET
fnp-2616	49	12	connective	connective	ADJ
fnp-2616	49	13	tissue	tissue	NOUN
fnp-2616	49	14	(	(	PUNCT
fnp-2616	49	15	arrows	arrow	NOUN
fnp-2616	49	16	)	)	PUNCT
fnp-2616	49	17	.	.	PUNCT
fnp-2616	50	1	e	e	X
fnp-2616	50	2	-	-	PUNCT
fnp-2616	50	3	i	i	PRON
fnp-2616	50	4	:	:	PUNCT
fnp-2616	50	5	immunohistochemistry	immunohistochemistry	NOUN
fnp-2616	50	6	for	for	ADP
fnp-2616	50	7	phosphorylated	phosphorylate	VERB
fnp-2616	50	8	alpha	alpha	NOUN
fnp-2616	50	9	-	-	PUNCT
fnp-2616	50	10	synuclein	synuclein	NOUN
fnp-2616	50	11	at	at	ADP
fnp-2616	50	12	serine	serine	NOUN
fnp-2616	50	13	129	129	NUM
fnp-2616	50	14	and	and	CCONJ
fnp-2616	50	15	for	for	ADP
fnp-2616	50	16	oligomeric	oligomeric	ADJ
fnp-2616	50	17	forms	form	NOUN
fnp-2616	50	18	with	with	ADP
fnp-2616	50	19	the	the	DET
fnp-2616	50	20	5g4	5g4	NUM
fnp-2616	50	21	antibody	antibody	NOUN
fnp-2616	50	22	did	do	AUX
fnp-2616	50	23	not	not	PART
fnp-2616	50	24	show	show	VERB
fnp-2616	50	25	abnormal	abnormal	ADJ
fnp-2616	50	26	alpha	alpha	NOUN
fnp-2616	50	27	-	-	PUNCT
fnp-2616	50	28	synuclein	synuclein	NOUN
fnp-2616	50	29	aggregates	aggregate	NOUN
fnp-2616	50	30	in	in	ADP
fnp-2616	50	31	most	most	ADJ
fnp-2616	50	32	of	of	ADP
fnp-2616	50	33	the	the	DET
fnp-2616	50	34	studied	study	VERB
fnp-2616	50	35	cases	case	NOUN
fnp-2616	50	36	(	(	PUNCT
fnp-2616	50	37	fig	fig	NOUN
fnp-2616	50	38	.	.	PUNCT
fnp-2616	51	1	1e	1e	NOUN
fnp-2616	51	2	,	,	PUNCT
fnp-2616	51	3	f	f	X
fnp-2616	51	4	)	)	PUNCT
fnp-2616	51	5	.	.	PUNCT
fnp-2616	52	1	in	in	ADP
fnp-2616	52	2	one	one	NUM
fnp-2616	52	3	case	case	NOUN
fnp-2616	52	4	(	(	PUNCT
fnp-2616	52	5	case	case	NOUN
fnp-2616	52	6	#	#	SYM
fnp-2616	52	7	12	12	NUM
fnp-2616	52	8	table	table	NOUN
fnp-2616	52	9	1	1	NUM
fnp-2616	52	10	)	)	PUNCT
fnp-2616	52	11	,	,	PUNCT
fnp-2616	52	12	coarse	coarse	ADV
fnp-2616	52	13	(	(	PUNCT
fnp-2616	52	14	g	g	NOUN
fnp-2616	52	15	)	)	PUNCT
fnp-2616	52	16	and	and	CCONJ
fnp-2616	52	17	punctate	punctate	NOUN
fnp-2616	52	18	(	(	PUNCT
fnp-2616	52	19	h	h	NOUN
fnp-2616	52	20	)	)	PUNCT
fnp-2616	52	21	aggregates	aggregate	NOUN
fnp-2616	52	22	within	within	ADP
fnp-2616	52	23	nerve	nerve	NOUN
fnp-2616	52	24	fibres	fibre	NOUN
fnp-2616	52	25	and	and	CCONJ
fnp-2616	52	26	perivascular	perivascular	ADJ
fnp-2616	52	27	(	(	PUNCT
fnp-2616	52	28	i	i	NOUN
fnp-2616	52	29	)	)	PUNCT
fnp-2616	52	30	aggregates	aggregate	NOUN
fnp-2616	52	31	were	be	AUX
fnp-2616	52	32	identified	identify	VERB
fnp-2616	52	33	with	with	ADP
fnp-2616	52	34	the	the	DET
fnp-2616	52	35	5g4	5g4	NUM
fnp-2616	52	36	antibody	antibody	NOUN
fnp-2616	52	37	.	.	PUNCT
fnp-2616	53	1	detailed	detailed	ADJ
fnp-2616	53	2	immunohistochemical	immunohistochemical	ADJ
fnp-2616	53	3	analysis	analysis	NOUN
fnp-2616	53	4	of	of	ADP
fnp-2616	53	5	dura	dura	NOUN
fnp-2616	53	6	samples	sample	NOUN
fnp-2616	53	7	identified	identify	VERB
fnp-2616	53	8	pathological	pathological	ADJ
fnp-2616	53	9	alpha	alpha	NOUN
fnp-2616	53	10	-	-	PUNCT
fnp-2616	53	11	synuclein	synuclein	NOUN
fnp-2616	53	12	aggregates	aggregate	NOUN
fnp-2616	53	13	with	with	ADP
fnp-2616	53	14	the	the	DET
fnp-2616	53	15	5g4	5g4	NUM
fnp-2616	53	16	antibody	antibody	NOUN
fnp-2616	53	17	in	in	ADP
fnp-2616	53	18	one	one	NUM
fnp-2616	53	19	case	case	NOUN
fnp-2616	53	20	.	.	PUNCT
fnp-2616	54	1	these	these	DET
fnp-2616	54	2	aggregates	aggregate	NOUN
fnp-2616	54	3	consisted	consist	VERB
fnp-2616	54	4	of	of	ADP
fnp-2616	54	5	small	small	ADJ
fnp-2616	54	6	punctate	punctate	NOUN
fnp-2616	54	7	deposits	deposit	NOUN
fnp-2616	54	8	along	along	ADP
fnp-2616	54	9	nerve	nerve	NOUN
fnp-2616	54	10	fibres	fibre	NOUN
fnp-2616	54	11	(	(	PUNCT
fnp-2616	54	12	fig	fig	NOUN
fnp-2616	54	13	.	.	PUNCT
fnp-2616	55	1	1h	1h	NUM
fnp-2616	55	2	,	,	PUNCT
fnp-2616	55	3	2b	2b	NOUN
fnp-2616	55	4	,	,	PUNCT
fnp-2616	55	5	d	d	NOUN
fnp-2616	55	6	)	)	PUNCT
fnp-2616	55	7	,	,	PUNCT
fnp-2616	55	8	coarse	coarse	ADJ
fnp-2616	55	9	aggregates	aggregate	NOUN
fnp-2616	55	10	(	(	PUNCT
fnp-2616	55	11	fig	fig	NOUN
fnp-2616	55	12	.	.	PUNCT
fnp-2616	56	1	1	1	NUM
fnp-2616	56	2	g	g	NOUN
fnp-2616	56	3	,	,	PUNCT
fnp-2616	56	4	2f	2f	NUM
fnp-2616	56	5	)	)	PUNCT
fnp-2616	56	6	and	and	CCONJ
fnp-2616	56	7	perivascular	perivascular	ADJ
fnp-2616	56	8	deposits	deposit	NOUN
fnp-2616	56	9	(	(	PUNCT
fnp-2616	56	10	fig	fig	NOUN
fnp-2616	56	11	.	.	PUNCT
fnp-2616	57	1	1i	1i	NOUN
fnp-2616	57	2	,	,	PUNCT
fnp-2616	57	3	2a	2a	NUM
fnp-2616	57	4	)	)	PUNCT
fnp-2616	57	5	.	.	PUNCT
fnp-2616	58	1	we	we	PRON
fnp-2616	58	2	observed	observe	VERB
fnp-2616	58	3	a	a	DET
fnp-2616	58	4	variable	variable	ADJ
fnp-2616	58	5	staining	stain	VERB
fnp-2616	58	6	intensity	intensity	NOUN
fnp-2616	58	7	of	of	ADP
fnp-2616	58	8	axons	axon	NOUN
fnp-2616	58	9	among	among	ADP
fnp-2616	58	10	the	the	DET
fnp-2616	58	11	different	different	ADJ
fnp-2616	58	12	cases	case	NOUN
fnp-2616	58	13	and	and	CCONJ
fnp-2616	58	14	also	also	ADV
fnp-2616	58	15	within	within	ADP
fnp-2616	58	16	the	the	DET
fnp-2616	58	17	same	same	ADJ
fnp-2616	58	18	case	case	NOUN
fnp-2616	58	19	,	,	PUNCT
fnp-2616	58	20	which	which	PRON
fnp-2616	58	21	was	be	AUX
fnp-2616	58	22	not	not	PART
fnp-2616	58	23	related	relate	VERB
fnp-2616	58	24	to	to	ADP
fnp-2616	58	25	the	the	DET
fnp-2616	58	26	presence	presence	NOUN
fnp-2616	58	27	/	/	SYM
fnp-2616	58	28	absence	absence	NOUN
fnp-2616	58	29	of	of	ADP
fnp-2616	58	30	alpha	alpha	NOUN
fnp-2616	58	31	-	-	PUNCT
fnp-2616	58	32	synuclein	synuclein	NOUN
fnp-2616	58	33	.	.	PUNCT
fnp-2616	59	1	this	this	DET
fnp-2616	59	2	variability	variability	NOUN
fnp-2616	59	3	might	might	AUX
fnp-2616	59	4	have	have	AUX
fnp-2616	59	5	been	be	AUX
fnp-2616	59	6	related	relate	VERB
fnp-2616	59	7	to	to	ADP
fnp-2616	59	8	the	the	DET
fnp-2616	59	9	fixation	fixation	NOUN
fnp-2616	59	10	time	time	NOUN
fnp-2616	59	11	or	or	CCONJ
fnp-2616	59	12	tissue	tissue	NOUN
fnp-2616	59	13	quality	quality	NOUN
fnp-2616	59	14	,	,	PUNCT
fnp-2616	59	15	among	among	ADP
fnp-2616	59	16	other	other	ADJ
fnp-2616	59	17	potential	potential	ADJ
fnp-2616	59	18	variables	variable	NOUN
fnp-2616	59	19	,	,	PUNCT
fnp-2616	59	20	so	so	SCONJ
fnp-2616	59	21	we	we	PRON
fnp-2616	59	22	could	could	AUX
fnp-2616	59	23	not	not	PART
fnp-2616	59	24	reliably	reliably	ADV
fnp-2616	59	25	assess	assess	VERB
fnp-2616	59	26	axonal	axonal	ADJ
fnp-2616	59	27	preservation	preservation	NOUN
fnp-2616	59	28	in	in	ADP
fnp-2616	59	29	the	the	DET
fnp-2616	59	30	patient	patient	NOUN
fnp-2616	59	31	with	with	ADP
fnp-2616	59	32	alpha	alpha	NOUN
fnp-2616	59	33	-	-	PUNCT
fnp-2616	59	34	synuclein	synuclein	NOUN
fnp-2616	59	35	aggregates	aggregate	NOUN
fnp-2616	59	36	.	.	PUNCT
fnp-2616	60	1	we	we	PRON
fnp-2616	60	2	found	find	VERB
fnp-2616	60	3	no	no	DET
fnp-2616	60	4	tortuous	tortuous	ADJ
fnp-2616	60	5	axonal	axonal	ADJ
fnp-2616	60	6	profiles	profile	NOUN
fnp-2616	60	7	or	or	CCONJ
fnp-2616	60	8	axonal	axonal	ADJ
fnp-2616	60	9	swellings	swelling	NOUN
fnp-2616	60	10	.	.	PUNCT
fnp-2616	61	1	this	this	DET
fnp-2616	61	2	individual	individual	NOUN
fnp-2616	61	3	was	be	AUX
fnp-2616	61	4	an	an	DET
fnp-2616	61	5	85	85	NUM
fnp-2616	61	6	-	-	PUNCT
fnp-2616	61	7	year	year	NOUN
fnp-2616	61	8	-	-	PUNCT
fnp-2616	61	9	old	old	ADJ
fnp-2616	61	10	male	male	NOUN
fnp-2616	61	11	with	with	ADP
fnp-2616	61	12	coronary	coronary	ADJ
fnp-2616	61	13	disease	disease	NOUN
fnp-2616	61	14	with	with	ADP
fnp-2616	61	15	severe	severe	ADJ
fnp-2616	61	16	and	and	CCONJ
fnp-2616	61	17	generalized	generalized	ADJ
fnp-2616	61	18	atherosclerosis	atherosclerosis	NOUN
fnp-2616	61	19	,	,	PUNCT
fnp-2616	61	20	an	an	DET
fnp-2616	61	21	old	old	ADJ
fnp-2616	61	22	myocardial	myocardial	ADJ
fnp-2616	61	23	infarction	infarction	NOUN
fnp-2616	61	24	,	,	PUNCT
fnp-2616	61	25	as	as	ADV
fnp-2616	61	26	well	well	ADV
fnp-2616	61	27	as	as	ADP
fnp-2616	61	28	pulmonary	pulmonary	ADJ
fnp-2616	61	29	adenocarcinoma	adenocarcinoma	NOUN
fnp-2616	61	30	.	.	PUNCT
fnp-2616	62	1	no	no	DET
fnp-2616	62	2	parkinsonism	parkinsonism	NOUN
fnp-2616	62	3	or	or	CCONJ
fnp-2616	62	4	dementia	dementia	NOUN
fnp-2616	62	5	were	be	AUX
fnp-2616	62	6	clinically	clinically	ADV
fnp-2616	62	7	reported	report	VERB
fnp-2616	62	8	.	.	PUNCT
fnp-2616	63	1	neuropathological	neuropathological	ADJ
fnp-2616	63	2	examination	examination	NOUN
fnp-2616	63	3	revealed	reveal	VERB
fnp-2616	63	4	a	a	DET
fnp-2616	63	5	vascular	vascular	ADJ
fnp-2616	63	6	encephalopathy	encephalopathy	NOUN
fnp-2616	63	7	and	and	CCONJ
fnp-2616	63	8	braak	braak	NOUN
fnp-2616	63	9	stage	stage	VERB
fnp-2616	63	10	4	4	NUM
fnp-2616	63	11	lewy	lewy	ADJ
fnp-2616	63	12	-	-	PUNCT
fnp-2616	63	13	body	body	NOUN
fnp-2616	63	14	pathology	pathology	NOUN
fnp-2616	63	15	,	,	PUNCT
fnp-2616	63	16	with	with	ADP
fnp-2616	63	17	only	only	ADJ
fnp-2616	63	18	mild	mild	ADJ
fnp-2616	63	19	neurofibrillary	neurofibrillary	ADJ
fnp-2616	63	20	pathology	pathology	NOUN
fnp-2616	63	21	in	in	ADP
fnp-2616	63	22	the	the	DET
fnp-2616	63	23	limbic	limbic	ADJ
fnp-2616	63	24	system	system	NOUN
fnp-2616	63	25	and	and	CCONJ
fnp-2616	63	26	mild	mild	ADJ
fnp-2616	63	27	neuritic	neuritic	ADJ
fnp-2616	63	28	plaque	plaque	NOUN
fnp-2616	63	29	/	/	SYM
fnp-2616	63	30	aβ	aβ	NOUN
fnp-2616	63	31	pathology	pathology	NOUN
fnp-2616	63	32	(	(	PUNCT
fnp-2616	63	33	table	table	NOUN
fnp-2616	63	34	1	1	NUM
fnp-2616	63	35	,	,	PUNCT
fnp-2616	63	36	case	case	NOUN
fnp-2616	63	37	12	12	NUM
fnp-2616	63	38	)	)	PUNCT
fnp-2616	63	39	.	.	PUNCT
fnp-2616	64	1	in	in	ADP
fnp-2616	64	2	the	the	DET
fnp-2616	64	3	remaining	remain	VERB
fnp-2616	64	4	cases	case	NOUN
fnp-2616	64	5	included	include	VERB
fnp-2616	64	6	in	in	ADP
fnp-2616	64	7	our	our	PRON
fnp-2616	64	8	study	study	NOUN
fnp-2616	64	9	,	,	PUNCT
fnp-2616	64	10	with	with	ADP
fnp-2616	64	11	or	or	CCONJ
fnp-2616	64	12	without	without	ADP
fnp-2616	64	13	cns	cns	PROPN
fnp-2616	64	14	lewy	lewy	PROPN
fnp-2616	64	15	body	body	PROPN
fnp-2616	64	16	pathology	pathology	NOUN
fnp-2616	64	17	,	,	PUNCT
fnp-2616	64	18	there	there	PRON
fnp-2616	64	19	was	be	VERB
fnp-2616	64	20	a	a	DET
fnp-2616	64	21	complete	complete	ADJ
fnp-2616	64	22	lack	lack	NOUN
fnp-2616	64	23	of	of	ADP
fnp-2616	64	24	alpha	alpha	NOUN
fnp-2616	64	25	-	-	PUNCT
fnp-2616	64	26	synuclein	synuclein	NOUN
fnp-2616	64	27	immunoreactivity	immunoreactivity	NOUN
fnp-2616	64	28	in	in	ADP
fnp-2616	64	29	dural	dural	ADJ
fnp-2616	64	30	samples	sample	NOUN
fnp-2616	64	31	applying	apply	VERB
fnp-2616	64	32	both	both	DET
fnp-2616	64	33	antibodies	antibody	NOUN
fnp-2616	64	34	.	.	PUNCT
fnp-2616	65	1	figure	figure	NOUN
fnp-2616	65	2	2	2	NUM
fnp-2616	65	3	:	:	PUNCT
fnp-2616	65	4	immunofluorescence	immunofluorescence	NOUN
fnp-2616	65	5	images	image	NOUN
fnp-2616	65	6	a	a	DET
fnp-2616	65	7	,	,	PUNCT
fnp-2616	65	8	b	b	NOUN
fnp-2616	65	9	:	:	PUNCT
fnp-2616	65	10	double	double	ADJ
fnp-2616	65	11	immunofluorescence	immunofluorescence	NOUN
fnp-2616	65	12	for	for	ADP
fnp-2616	65	13	pgp	pgp	NOUN
fnp-2616	65	14	9.5	9.5	NUM
fnp-2616	65	15	depicts	depict	VERB
fnp-2616	65	16	delicate	delicate	ADJ
fnp-2616	65	17	perivascular	perivascular	ADJ
fnp-2616	65	18	fibres	fibre	NOUN
fnp-2616	65	19	(	(	PUNCT
fnp-2616	65	20	red	red	PROPN
fnp-2616	65	21	)	)	PUNCT
fnp-2616	65	22	which	which	PRON
fnp-2616	65	23	focally	focally	ADV
fnp-2616	65	24	also	also	ADV
fnp-2616	65	25	accumulate	accumulate	VERB
fnp-2616	65	26	alpha	alpha	NOUN
fnp-2616	65	27	-	-	PUNCT
fnp-2616	65	28	synuclein	synuclein	NOUN
fnp-2616	65	29	(	(	PUNCT
fnp-2616	65	30	5g4	5g4	NUM
fnp-2616	65	31	,	,	PUNCT
fnp-2616	65	32	green	green	ADJ
fnp-2616	65	33	)	)	PUNCT
fnp-2616	65	34	.	.	PUNCT
fnp-2616	66	1	other	other	ADJ
fnp-2616	66	2	regions	region	NOUN
fnp-2616	66	3	show	show	VERB
fnp-2616	66	4	nerve	nerve	NOUN
fnp-2616	66	5	fascicles	fascicle	NOUN
fnp-2616	66	6	with	with	ADP
fnp-2616	66	7	variable	variable	ADJ
fnp-2616	66	8	density	density	NOUN
fnp-2616	66	9	of	of	ADP
fnp-2616	66	10	axonal	axonal	ADJ
fnp-2616	66	11	profiles	profile	NOUN
fnp-2616	66	12	:	:	PUNCT
fnp-2616	66	13	some	some	PRON
fnp-2616	66	14	have	have	VERB
fnp-2616	66	15	abundant	abundant	ADJ
fnp-2616	66	16	axons	axon	NOUN
fnp-2616	66	17	(	(	PUNCT
fnp-2616	66	18	b	b	X
fnp-2616	66	19	,	,	PUNCT
fnp-2616	66	20	pgp	pgp	NOUN
fnp-2616	66	21	9.5	9.5	NUM
fnp-2616	66	22	,	,	PUNCT
fnp-2616	66	23	red	red	ADJ
fnp-2616	66	24	)	)	PUNCT
fnp-2616	66	25	and	and	CCONJ
fnp-2616	66	26	show	show	VERB
fnp-2616	66	27	only	only	ADV
fnp-2616	66	28	tiny	tiny	ADJ
fnp-2616	66	29	alpha	alpha	NOUN
fnp-2616	66	30	-	-	PUNCT
fnp-2616	66	31	synuclein	synuclein	NOUN
fnp-2616	66	32	accumulations	accumulation	NOUN
fnp-2616	66	33	(	(	PUNCT
fnp-2616	66	34	5g4	5g4	NUM
fnp-2616	66	35	,	,	PUNCT
fnp-2616	66	36	green	green	ADJ
fnp-2616	66	37	,	,	PUNCT
fnp-2616	66	38	white	white	ADJ
fnp-2616	66	39	arrow	arrow	NOUN
fnp-2616	66	40	)	)	PUNCT
fnp-2616	66	41	.	.	PUNCT
fnp-2616	67	1	c	c	X
fnp-2616	67	2	-	-	PUNCT
fnp-2616	67	3	f	f	X
fnp-2616	67	4	:	:	PUNCT
fnp-2616	67	5	in	in	ADP
fnp-2616	67	6	adjacent	adjacent	ADJ
fnp-2616	67	7	tissue	tissue	NOUN
fnp-2616	67	8	sections	section	NOUN
fnp-2616	67	9	some	some	DET
fnp-2616	67	10	nerve	nerve	NOUN
fnp-2616	67	11	fascicles	fascicle	NOUN
fnp-2616	67	12	have	have	VERB
fnp-2616	67	13	only	only	ADV
fnp-2616	67	14	few	few	ADJ
fnp-2616	67	15	axons	axon	NOUN
fnp-2616	67	16	(	(	PUNCT
fnp-2616	67	17	c	c	NOUN
fnp-2616	67	18	,	,	PUNCT
fnp-2616	67	19	nfp	nfp	PROPN
fnp-2616	67	20	)	)	PUNCT
fnp-2616	67	21	while	while	SCONJ
fnp-2616	67	22	others	other	NOUN
fnp-2616	67	23	show	show	VERB
fnp-2616	67	24	an	an	DET
fnp-2616	67	25	intermediate	intermediate	ADJ
fnp-2616	67	26	density	density	NOUN
fnp-2616	67	27	of	of	ADP
fnp-2616	67	28	axons	axon	NOUN
fnp-2616	67	29	(	(	PUNCT
fnp-2616	67	30	e	e	NOUN
fnp-2616	67	31	,	,	PUNCT
fnp-2616	67	32	nfp	nfp	X
fnp-2616	67	33	red	red	PROPN
fnp-2616	67	34	)	)	PUNCT
fnp-2616	67	35	with	with	ADP
fnp-2616	67	36	relatively	relatively	ADV
fnp-2616	67	37	abundant	abundant	ADJ
fnp-2616	67	38	and	and	CCONJ
fnp-2616	67	39	coarse	coarse	ADJ
fnp-2616	67	40	alpha	alpha	NOUN
fnp-2616	67	41	-	-	PUNCT
fnp-2616	67	42	synuclein	synuclein	NOUN
fnp-2616	67	43	aggregates	aggregate	NOUN
fnp-2616	67	44	(	(	PUNCT
fnp-2616	67	45	f	f	X
fnp-2616	67	46	,	,	PUNCT
fnp-2616	67	47	5g4	5g4	NUM
fnp-2616	67	48	)	)	PUNCT
fnp-2616	67	49	.	.	PUNCT
fnp-2616	68	1	discussion	discussion	NOUN
fnp-2616	68	2	in	in	ADP
fnp-2616	68	3	this	this	DET
fnp-2616	68	4	study	study	NOUN
fnp-2616	68	5	,	,	PUNCT
fnp-2616	68	6	we	we	PRON
fnp-2616	68	7	found	find	VERB
fnp-2616	68	8	alpha	alpha	NOUN
fnp-2616	68	9	-	-	PUNCT
fnp-2616	68	10	synuclein	synuclein	NOUN
fnp-2616	68	11	aggregates	aggregate	NOUN
fnp-2616	68	12	in	in	ADP
fnp-2616	68	13	dura	dura	NOUN
fnp-2616	68	14	mater	mater	NOUN
fnp-2616	68	15	samples	sample	NOUN
fnp-2616	68	16	from	from	ADP
fnp-2616	68	17	one	one	NUM
fnp-2616	68	18	patient	patient	NOUN
fnp-2616	68	19	with	with	ADP
fnp-2616	68	20	lewy	lewy	ADJ
fnp-2616	68	21	-	-	PUNCT
fnp-2616	68	22	body	body	NOUN
fnp-2616	68	23	pathology	pathology	NOUN
fnp-2616	68	24	(	(	PUNCT
fnp-2616	68	25	braak	braak	NOUN
fnp-2616	68	26	stage	stage	VERB
fnp-2616	68	27	4	4	NUM
fnp-2616	68	28	)	)	PUNCT
fnp-2616	68	29	(	(	PUNCT
fnp-2616	68	30	20	20	NUM
fnp-2616	68	31	)	)	PUNCT
fnp-2616	68	32	.	.	PUNCT
fnp-2616	69	1	alpha	alpha	PROPN
fnp-2616	69	2	-	-	PUNCT
fnp-2616	69	3	synuclein	synuclein	NOUN
fnp-2616	69	4	aggregates	aggregate	NOUN
fnp-2616	69	5	were	be	AUX
fnp-2616	69	6	not	not	PART
fnp-2616	69	7	identified	identify	VERB
fnp-2616	69	8	in	in	ADP
fnp-2616	69	9	the	the	DET
fnp-2616	69	10	dura	dura	NOUN
fnp-2616	69	11	mater	mater	NOUN
fnp-2616	69	12	of	of	ADP
fnp-2616	69	13	31	31	NUM
fnp-2616	69	14	other	other	ADJ
fnp-2616	69	15	cases	case	NOUN
fnp-2616	69	16	with	with	ADP
fnp-2616	69	17	different	different	ADJ
fnp-2616	69	18	stages	stage	NOUN
fnp-2616	69	19	of	of	ADP
fnp-2616	69	20	lbd	lbd	PROPN
fnp-2616	69	21	or	or	CCONJ
fnp-2616	69	22	in	in	ADP
fnp-2616	69	23	other	other	ADJ
fnp-2616	69	24	neurodegenerative	neurodegenerative	ADJ
fnp-2616	69	25	conditions	condition	NOUN
fnp-2616	69	26	.	.	PUNCT
fnp-2616	70	1	these	these	DET
fnp-2616	70	2	findings	finding	NOUN
fnp-2616	70	3	might	might	AUX
fnp-2616	70	4	have	have	VERB
fnp-2616	70	5	implications	implication	NOUN
fnp-2616	70	6	for	for	ADP
fnp-2616	70	7	public	public	ADJ
fnp-2616	70	8	health	health	NOUN
fnp-2616	70	9	as	as	ADV
fnp-2616	70	10	well	well	ADV
fnp-2616	70	11	as	as	ADP
fnp-2616	70	12	for	for	ADP
fnp-2616	70	13	the	the	DET
fnp-2616	70	14	understanding	understanding	NOUN
fnp-2616	70	15	of	of	ADP
fnp-2616	70	16	alpha	alpha	NOUN
fnp-2616	70	17	-	-	PUNCT
fnp-2616	70	18	synuclein	synuclein	NOUN
fnp-2616	70	19	propagation	propagation	NOUN
fnp-2616	70	20	.	.	PUNCT
fnp-2616	71	1	concerning	concern	VERB
fnp-2616	71	2	public	public	ADJ
fnp-2616	71	3	health	health	NOUN
fnp-2616	71	4	,	,	PUNCT
fnp-2616	71	5	individuals	individual	NOUN
fnp-2616	71	6	with	with	ADP
fnp-2616	71	7	symptomatic	symptomatic	ADJ
fnp-2616	71	8	or	or	CCONJ
fnp-2616	71	9	prodromal	prodromal	ADJ
fnp-2616	71	10	alpha	alpha	NOUN
fnp-2616	71	11	-	-	PUNCT
fnp-2616	71	12	synucleinopathies	synucleinopathie	NOUN
fnp-2616	71	13	may	may	AUX
fnp-2616	71	14	undergo	undergo	VERB
fnp-2616	71	15	neurosurgical	neurosurgical	ADJ
fnp-2616	71	16	interventions	intervention	NOUN
fnp-2616	71	17	contacting	contact	VERB
fnp-2616	71	18	the	the	DET
fnp-2616	71	19	dura	dura	NOUN
fnp-2616	71	20	mater	mater	NOUN
fnp-2616	71	21	(	(	PUNCT
fnp-2616	71	22	for	for	ADP
fnp-2616	71	23	example	example	NOUN
fnp-2616	71	24	,	,	PUNCT
fnp-2616	71	25	the	the	DET
fnp-2616	71	26	widespread	widespread	ADJ
fnp-2616	71	27	use	use	NOUN
fnp-2616	71	28	of	of	ADP
fnp-2616	71	29	deep	deep	ADJ
fnp-2616	71	30	brain	brain	NOUN
fnp-2616	71	31	stimulation	stimulation	NOUN
fnp-2616	71	32	in	in	ADP
fnp-2616	71	33	pd	pd	PROPN
fnp-2616	71	34	)	)	PUNCT
fnp-2616	71	35	.	.	PUNCT
fnp-2616	72	1	while	while	SCONJ
fnp-2616	72	2	there	there	PRON
fnp-2616	72	3	is	be	VERB
fnp-2616	72	4	still	still	ADV
fnp-2616	72	5	no	no	DET
fnp-2616	72	6	epidemiological	epidemiological	ADJ
fnp-2616	72	7	evidence	evidence	NOUN
fnp-2616	72	8	of	of	ADP
fnp-2616	72	9	human	human	NOUN
fnp-2616	72	10	-	-	PUNCT
fnp-2616	72	11	to	to	ADP
fnp-2616	72	12	-	-	PUNCT
fnp-2616	72	13	human	human	ADJ
fnp-2616	72	14	transmission	transmission	NOUN
fnp-2616	72	15	of	of	ADP
fnp-2616	72	16	alpha	alpha	NOUN
fnp-2616	72	17	-	-	PUNCT
fnp-2616	72	18	synuclein	synuclein	NOUN
fnp-2616	72	19	(	(	PUNCT
fnp-2616	72	20	17	17	NUM
fnp-2616	72	21	)	)	PUNCT
fnp-2616	72	22	,	,	PUNCT
fnp-2616	72	23	the	the	DET
fnp-2616	72	24	application	application	NOUN
fnp-2616	72	25	of	of	ADP
fnp-2616	72	26	appropriate	appropriate	ADJ
fnp-2616	72	27	prevention	prevention	NOUN
fnp-2616	72	28	measures	measure	NOUN
fnp-2616	72	29	will	will	AUX
fnp-2616	72	30	be	be	AUX
fnp-2616	72	31	increasingly	increasingly	ADV
fnp-2616	72	32	required	require	VERB
fnp-2616	72	33	if	if	SCONJ
fnp-2616	72	34	experimental	experimental	ADJ
fnp-2616	72	35	studies	study	NOUN
fnp-2616	72	36	strengthen	strengthen	VERB
fnp-2616	72	37	evidence	evidence	NOUN
fnp-2616	72	38	of	of	ADP
fnp-2616	72	39	the	the	DET
fnp-2616	72	40	potential	potential	ADJ
fnp-2616	72	41	transmissibility	transmissibility	NOUN
fnp-2616	72	42	of	of	ADP
fnp-2616	72	43	synucleinopathies	synucleinopathie	NOUN
fnp-2616	72	44	.	.	PUNCT
fnp-2616	73	1	this	this	PRON
fnp-2616	73	2	further	far	ADV
fnp-2616	73	3	emphasizes	emphasize	VERB
fnp-2616	73	4	the	the	DET
fnp-2616	73	5	need	need	NOUN
fnp-2616	73	6	for	for	ADP
fnp-2616	73	7	effective	effective	ADJ
fnp-2616	73	8	biomarkers	biomarker	NOUN
fnp-2616	73	9	for	for	ADP
fnp-2616	73	10	the	the	DET
fnp-2616	73	11	early	early	ADJ
fnp-2616	73	12	diagnosis	diagnosis	NOUN
fnp-2616	73	13	of	of	ADP
fnp-2616	73	14	alpha	alpha	NOUN
fnp-2616	73	15	-	-	PUNCT
fnp-2616	73	16	synuclein	synuclein	NOUN
fnp-2616	73	17	related	relate	VERB
fnp-2616	73	18	diseases	disease	NOUN
fnp-2616	73	19	(	(	PUNCT
fnp-2616	73	20	21	21	NUM
fnp-2616	73	21	-	-	SYM
fnp-2616	73	22	24	24	NUM
fnp-2616	73	23	)	)	PUNCT
fnp-2616	73	24	.	.	PUNCT
fnp-2616	74	1	furthermore	furthermore	ADV
fnp-2616	74	2	,	,	PUNCT
fnp-2616	74	3	there	there	PRON
fnp-2616	74	4	is	be	VERB
fnp-2616	74	5	a	a	DET
fnp-2616	74	6	clear	clear	ADJ
fnp-2616	74	7	need	need	NOUN
fnp-2616	74	8	for	for	ADP
fnp-2616	74	9	the	the	DET
fnp-2616	74	10	detailed	detailed	ADJ
fnp-2616	74	11	mapping	mapping	NOUN
fnp-2616	74	12	of	of	ADP
fnp-2616	74	13	tissues	tissue	NOUN
fnp-2616	74	14	that	that	PRON
fnp-2616	74	15	may	may	AUX
fnp-2616	74	16	harbor	harbor	VERB
fnp-2616	74	17	potential	potential	ADJ
fnp-2616	74	18	seeds	seed	NOUN
fnp-2616	74	19	.	.	PUNCT
fnp-2616	75	1	indeed	indeed	ADV
fnp-2616	75	2	,	,	PUNCT
fnp-2616	75	3	with	with	ADP
fnp-2616	75	4	respect	respect	NOUN
fnp-2616	75	5	to	to	ADP
fnp-2616	75	6	the	the	DET
fnp-2616	75	7	present	present	ADJ
fnp-2616	75	8	findings	finding	NOUN
fnp-2616	75	9	,	,	PUNCT
fnp-2616	75	10	since	since	SCONJ
fnp-2616	75	11	dura	dura	NOUN
fnp-2616	75	12	mater	mater	NOUN
fnp-2616	75	13	transplants	transplant	NOUN
fnp-2616	75	14	are	be	AUX
fnp-2616	75	15	in	in	ADP
fnp-2616	75	16	direct	direct	ADJ
fnp-2616	75	17	contact	contact	NOUN
fnp-2616	75	18	with	with	ADP
fnp-2616	75	19	brain	brain	NOUN
fnp-2616	75	20	tissues	tissue	NOUN
fnp-2616	75	21	,	,	PUNCT
fnp-2616	75	22	they	they	PRON
fnp-2616	75	23	might	might	AUX
fnp-2616	75	24	provide	provide	VERB
fnp-2616	75	25	an	an	DET
fnp-2616	75	26	increased	increase	VERB
fnp-2616	75	27	potential	potential	NOUN
fnp-2616	75	28	to	to	PART
fnp-2616	75	29	propagate	propagate	VERB
fnp-2616	75	30	seeds	seed	NOUN
fnp-2616	75	31	to	to	ADP
fnp-2616	75	32	the	the	DET
fnp-2616	75	33	recipient	recipient	NOUN
fnp-2616	75	34	’s	’s	PART
fnp-2616	75	35	cns	cns	NOUN
fnp-2616	75	36	.	.	PUNCT
fnp-2616	76	1	concerning	concern	VERB
fnp-2616	76	2	protein	protein	NOUN
fnp-2616	76	3	propagation	propagation	NOUN
fnp-2616	76	4	,	,	PUNCT
fnp-2616	76	5	the	the	DET
fnp-2616	76	6	dura	dura	NOUN
fnp-2616	76	7	mater	mater	NOUN
fnp-2616	76	8	has	have	AUX
fnp-2616	76	9	been	be	AUX
fnp-2616	76	10	a	a	DET
fnp-2616	76	11	source	source	NOUN
fnp-2616	76	12	of	of	ADP
fnp-2616	76	13	disease	disease	NOUN
fnp-2616	76	14	transmission	transmission	NOUN
fnp-2616	76	15	in	in	ADP
fnp-2616	76	16	human	human	ADJ
fnp-2616	76	17	prion	prion	NOUN
fnp-2616	76	18	disease	disease	NOUN
fnp-2616	76	19	(	(	PUNCT
fnp-2616	76	20	1	1	NUM
fnp-2616	76	21	)	)	PUNCT
fnp-2616	76	22	and	and	CCONJ
fnp-2616	76	23	is	be	AUX
fnp-2616	76	24	also	also	ADV
fnp-2616	76	25	a	a	DET
fnp-2616	76	26	source	source	NOUN
fnp-2616	76	27	for	for	ADP
fnp-2616	76	28	aβ	aβ	NOUN
fnp-2616	76	29	seeds	seed	NOUN
fnp-2616	76	30	(	(	PUNCT
fnp-2616	76	31	9	9	NUM
fnp-2616	76	32	,	,	PUNCT
fnp-2616	76	33	10	10	NUM
fnp-2616	76	34	)	)	PUNCT
fnp-2616	76	35	.	.	PUNCT
fnp-2616	77	1	recent	recent	ADJ
fnp-2616	77	2	studies	study	NOUN
fnp-2616	77	3	support	support	VERB
fnp-2616	77	4	the	the	DET
fnp-2616	77	5	notion	notion	NOUN
fnp-2616	77	6	that	that	SCONJ
fnp-2616	77	7	these	these	DET
fnp-2616	77	8	seeds	seed	NOUN
fnp-2616	77	9	are	be	AUX
fnp-2616	77	10	able	able	ADJ
fnp-2616	77	11	to	to	PART
fnp-2616	77	12	propagate	propagate	VERB
fnp-2616	77	13	pathological	pathological	ADJ
fnp-2616	77	14	proteins	protein	NOUN
fnp-2616	77	15	,	,	PUNCT
fnp-2616	77	16	even	even	ADV
fnp-2616	77	17	without	without	ADP
fnp-2616	77	18	inducing	induce	VERB
fnp-2616	77	19	the	the	DET
fnp-2616	77	20	classical	classical	ADJ
fnp-2616	77	21	alzheimer´s	alzheimer´s	NOUN
fnp-2616	77	22	phenotype	phenotype	NOUN
fnp-2616	77	23	.	.	PUNCT
fnp-2616	78	1	however	however	ADV
fnp-2616	78	2	,	,	PUNCT
fnp-2616	78	3	they	they	PRON
fnp-2616	78	4	can	can	AUX
fnp-2616	78	5	lead	lead	VERB
fnp-2616	78	6	to	to	ADP
fnp-2616	78	7	unexpectedly	unexpectedly	ADV
fnp-2616	78	8	increased	increase	VERB
fnp-2616	78	9	frequency	frequency	NOUN
fnp-2616	78	10	of	of	ADP
fnp-2616	78	11	cerebral	cerebral	ADJ
fnp-2616	78	12	amyloid	amyloid	NOUN
fnp-2616	78	13	angiopathy	angiopathy	ADJ
fnp-2616	78	14	and	and	CCONJ
fnp-2616	78	15	associated	associated	ADJ
fnp-2616	78	16	brain	brain	NOUN
fnp-2616	78	17	hemorrhages	hemorrhage	NOUN
fnp-2616	78	18	(	(	PUNCT
fnp-2616	78	19	9	9	NUM
fnp-2616	78	20	,	,	PUNCT
fnp-2616	78	21	10	10	NUM
fnp-2616	78	22	)	)	PUNCT
fnp-2616	78	23	.	.	PUNCT
fnp-2616	79	1	propagation	propagation	NOUN
fnp-2616	79	2	of	of	ADP
fnp-2616	79	3	human	human	ADJ
fnp-2616	79	4	alpha	alpha	NOUN
fnp-2616	79	5	-	-	PUNCT
fnp-2616	79	6	synuclein	synuclein	NOUN
fnp-2616	79	7	has	have	AUX
fnp-2616	79	8	been	be	AUX
fnp-2616	79	9	considered	consider	VERB
fnp-2616	79	10	since	since	SCONJ
fnp-2616	79	11	the	the	DET
fnp-2616	79	12	detection	detection	NOUN
fnp-2616	79	13	of	of	ADP
fnp-2616	79	14	alpha	alpha	NOUN
fnp-2616	79	15	-	-	PUNCT
fnp-2616	79	16	synuclein	synuclein	NOUN
fnp-2616	79	17	aggregates	aggregate	NOUN
fnp-2616	79	18	in	in	ADP
fnp-2616	79	19	grafted	graft	VERB
fnp-2616	79	20	fetal	fetal	ADJ
fnp-2616	79	21	mesencephalic	mesencephalic	ADJ
fnp-2616	79	22	neurons	neuron	NOUN
fnp-2616	79	23	in	in	ADP
fnp-2616	79	24	pd	pd	PROPN
fnp-2616	79	25	patients	patient	NOUN
fnp-2616	79	26	(	(	PUNCT
fnp-2616	79	27	14	14	NUM
fnp-2616	79	28	,	,	PUNCT
fnp-2616	79	29	15	15	NUM
fnp-2616	79	30	)	)	PUNCT
fnp-2616	79	31	.	.	PUNCT
fnp-2616	80	1	this	this	PRON
fnp-2616	80	2	has	have	AUX
fnp-2616	80	3	subsequently	subsequently	ADV
fnp-2616	80	4	been	be	AUX
fnp-2616	80	5	demonstrated	demonstrate	VERB
fnp-2616	80	6	in	in	ADP
fnp-2616	80	7	experimental	experimental	ADJ
fnp-2616	80	8	studies	study	NOUN
fnp-2616	80	9	(	(	PUNCT
fnp-2616	80	10	13	13	NUM
fnp-2616	80	11	)	)	PUNCT
fnp-2616	80	12	including	include	VERB
fnp-2616	80	13	inoculation	inoculation	NOUN
fnp-2616	80	14	of	of	ADP
fnp-2616	80	15	human	human	ADJ
fnp-2616	80	16	substantia	substantia	NOUN
fnp-2616	80	17	nigra	nigra	NOUN
fnp-2616	80	18	extracts	extract	NOUN
fnp-2616	80	19	containing	contain	VERB
fnp-2616	80	20	lewy	lewy	ADJ
fnp-2616	80	21	bodies	body	NOUN
fnp-2616	80	22	into	into	ADP
fnp-2616	80	23	wild	wild	ADJ
fnp-2616	80	24	-	-	PUNCT
fnp-2616	80	25	type	type	NOUN
fnp-2616	80	26	mice	mouse	NOUN
fnp-2616	80	27	and	and	CCONJ
fnp-2616	80	28	macaque	macaque	ADJ
fnp-2616	80	29	monkeys	monkey	NOUN
fnp-2616	80	30	(	(	PUNCT
fnp-2616	80	31	26	26	NUM
fnp-2616	80	32	)	)	PUNCT
fnp-2616	80	33	.	.	PUNCT
fnp-2616	81	1	in	in	ADP
fnp-2616	81	2	contrast	contrast	NOUN
fnp-2616	81	3	,	,	PUNCT
fnp-2616	81	4	the	the	DET
fnp-2616	81	5	inoculation	inoculation	NOUN
fnp-2616	81	6	of	of	ADP
fnp-2616	81	7	extracts	extract	NOUN
fnp-2616	81	8	of	of	ADP
fnp-2616	81	9	peripheral	peripheral	ADJ
fnp-2616	81	10	alpha	alpha	NOUN
fnp-2616	81	11	-	-	PUNCT
fnp-2616	81	12	synuclein	synuclein	NOUN
fnp-2616	81	13	from	from	ADP
fnp-2616	81	14	the	the	DET
fnp-2616	81	15	autonomic	autonomic	ADJ
fnp-2616	81	16	sympathetic	sympathetic	ADJ
fnp-2616	81	17	stellate	stellate	ADJ
fnp-2616	81	18	ganglion	ganglion	NOUN
fnp-2616	81	19	did	do	AUX
fnp-2616	81	20	not	not	PART
fnp-2616	81	21	induce	induce	VERB
fnp-2616	81	22	pathological	pathological	ADJ
fnp-2616	81	23	conversion	conversion	NOUN
fnp-2616	81	24	of	of	ADP
fnp-2616	81	25	endogenous	endogenous	ADJ
fnp-2616	81	26	alpha	alpha	NOUN
fnp-2616	81	27	-	-	PUNCT
fnp-2616	81	28	synuclein	synuclein	NOUN
fnp-2616	81	29	,	,	PUNCT
fnp-2616	81	30	alpha	alpha	NOUN
fnp-2616	81	31	-	-	PUNCT
fnp-2616	81	32	synuclein	synuclein	NOUN
fnp-2616	81	33	propagation	propagation	NOUN
fnp-2616	81	34	,	,	PUNCT
fnp-2616	81	35	or	or	CCONJ
fnp-2616	81	36	neurodegeneration	neurodegeneration	NOUN
fnp-2616	81	37	in	in	ADP
fnp-2616	81	38	mice	mouse	NOUN
fnp-2616	81	39	(	(	PUNCT
fnp-2616	81	40	27	27	NUM
fnp-2616	81	41	)	)	PUNCT
fnp-2616	81	42	.	.	PUNCT
fnp-2616	82	1	thus	thus	ADV
fnp-2616	82	2	,	,	PUNCT
fnp-2616	82	3	central	central	ADJ
fnp-2616	82	4	and	and	CCONJ
fnp-2616	82	5	peripheral	peripheral	ADJ
fnp-2616	82	6	nervous	nervous	ADJ
fnp-2616	82	7	system	system	NOUN
fnp-2616	82	8	-	-	PUNCT
fnp-2616	82	9	related	relate	VERB
fnp-2616	82	10	alpha	alpha	NOUN
fnp-2616	82	11	-	-	PUNCT
fnp-2616	82	12	synuclein	synuclein	NOUN
fnp-2616	82	13	might	might	AUX
fnp-2616	82	14	have	have	VERB
fnp-2616	82	15	different	different	ADJ
fnp-2616	82	16	propagation	propagation	NOUN
fnp-2616	82	17	potential	potential	NOUN
fnp-2616	82	18	and	and	CCONJ
fnp-2616	82	19	therefore	therefore	ADV
fnp-2616	82	20	different	different	ADJ
fnp-2616	82	21	transmissibility	transmissibility	NOUN
fnp-2616	82	22	.	.	PUNCT
fnp-2616	83	1	the	the	DET
fnp-2616	83	2	dura	dura	NOUN
fnp-2616	83	3	mater	mater	NOUN
fnp-2616	83	4	is	be	AUX
fnp-2616	83	5	thoroughly	thoroughly	ADV
fnp-2616	83	6	innervated	innervate	VERB
fnp-2616	83	7	by	by	ADP
fnp-2616	83	8	afferent	afferent	ADJ
fnp-2616	83	9	fibres	fibre	NOUN
fnp-2616	83	10	arising	arise	VERB
fnp-2616	83	11	from	from	ADP
fnp-2616	83	12	the	the	DET
fnp-2616	83	13	ipsilateral	ipsilateral	ADJ
fnp-2616	83	14	trigeminal	trigeminal	ADJ
fnp-2616	83	15	ganglion	ganglion	NOUN
fnp-2616	83	16	and	and	CCONJ
fnp-2616	83	17	nerve	nerve	NOUN
fnp-2616	83	18	(	(	PUNCT
fnp-2616	83	19	including	include	VERB
fnp-2616	83	20	its	its	PRON
fnp-2616	83	21	ophthalmic	ophthalmic	ADJ
fnp-2616	83	22	,	,	PUNCT
fnp-2616	83	23	maxillary	maxillary	NOUN
fnp-2616	83	24	and	and	CCONJ
fnp-2616	83	25	mandibular	mandibular	ADJ
fnp-2616	83	26	divisions	division	NOUN
fnp-2616	83	27	)	)	PUNCT
fnp-2616	83	28	and	and	CCONJ
fnp-2616	83	29	by	by	ADP
fnp-2616	83	30	sympathetic	sympathetic	ADJ
fnp-2616	83	31	fibres	fibre	NOUN
fnp-2616	83	32	arising	arise	VERB
fnp-2616	83	33	from	from	ADP
fnp-2616	83	34	the	the	DET
fnp-2616	83	35	ipsilateral	ipsilateral	ADJ
fnp-2616	83	36	superior	superior	ADJ
fnp-2616	83	37	cervical	cervical	ADJ
fnp-2616	83	38	ganglion	ganglion	NOUN
fnp-2616	83	39	.	.	PUNCT
fnp-2616	84	1	the	the	DET
fnp-2616	84	2	posterior	posterior	ADJ
fnp-2616	84	3	cranial	cranial	ADJ
fnp-2616	84	4	fossa	fossa	ADJ
fnp-2616	84	5	dura	dura	NOUN
fnp-2616	84	6	mater	mater	NOUN
fnp-2616	84	7	receives	receive	VERB
fnp-2616	84	8	sensory	sensory	ADJ
fnp-2616	84	9	meningeal	meningeal	ADJ
fnp-2616	84	10	branches	branch	NOUN
fnp-2616	84	11	from	from	ADP
fnp-2616	84	12	the	the	DET
fnp-2616	84	13	vagus	vagus	NOUN
fnp-2616	84	14	and	and	CCONJ
fnp-2616	84	15	glossopharyngeal	glossopharyngeal	ADJ
fnp-2616	84	16	nerves	nerve	NOUN
fnp-2616	84	17	.	.	PUNCT
fnp-2616	85	1	the	the	DET
fnp-2616	85	2	sympathetic	sympathetic	ADJ
fnp-2616	85	3	ganglion	ganglion	NOUN
fnp-2616	85	4	is	be	AUX
fnp-2616	85	5	upstream	upstream	ADJ
fnp-2616	85	6	from	from	ADP
fnp-2616	85	7	the	the	DET
fnp-2616	85	8	stellate	stellate	ADJ
fnp-2616	85	9	ganglion	ganglion	NOUN
fnp-2616	85	10	,	,	PUNCT
fnp-2616	85	11	which	which	PRON
fnp-2616	85	12	has	have	AUX
fnp-2616	85	13	been	be	AUX
fnp-2616	85	14	shown	show	VERB
fnp-2616	85	15	to	to	PART
fnp-2616	85	16	harbor	harbor	VERB
fnp-2616	85	17	prominent	prominent	ADJ
fnp-2616	85	18	alpha	alpha	NOUN
fnp-2616	85	19	-	-	PUNCT
fnp-2616	85	20	synuclein	synuclein	NOUN
fnp-2616	85	21	or	or	CCONJ
fnp-2616	85	22	lewy	lewy	ADJ
fnp-2616	85	23	-	-	PUNCT
fnp-2616	85	24	type	type	NOUN
fnp-2616	85	25	pathology	pathology	NOUN
fnp-2616	85	26	in	in	ADP
fnp-2616	85	27	postmortem	postmortem	NOUN
fnp-2616	85	28	studies	study	NOUN
fnp-2616	85	29	of	of	ADP
fnp-2616	85	30	patients	patient	NOUN
fnp-2616	85	31	with	with	ADP
fnp-2616	85	32	pd	pd	PROPN
fnp-2616	85	33	and	and	CCONJ
fnp-2616	85	34	dementia	dementia	NOUN
fnp-2616	85	35	with	with	ADP
fnp-2616	85	36	lewy	lewy	ADJ
fnp-2616	85	37	bodies	body	NOUN
fnp-2616	85	38	(	(	PUNCT
fnp-2616	85	39	23	23	NUM
fnp-2616	85	40	,	,	PUNCT
fnp-2616	85	41	24	24	NUM
fnp-2616	85	42	)	)	PUNCT
fnp-2616	85	43	,	,	PUNCT
fnp-2616	85	44	along	along	ADP
fnp-2616	85	45	with	with	ADP
fnp-2616	85	46	the	the	DET
fnp-2616	85	47	dorsal	dorsal	NOUN
fnp-2616	85	48	motor	motor	NOUN
fnp-2616	85	49	nucleus	nucleus	NOUN
fnp-2616	85	50	of	of	ADP
fnp-2616	85	51	the	the	DET
fnp-2616	85	52	vagal	vagal	ADJ
fnp-2616	85	53	nerve	nerve	NOUN
fnp-2616	85	54	in	in	ADP
fnp-2616	85	55	the	the	DET
fnp-2616	85	56	cns	cns	NOUN
fnp-2616	85	57	(	(	PUNCT
fnp-2616	85	58	20	20	NUM
fnp-2616	85	59	)	)	PUNCT
fnp-2616	85	60	.	.	PUNCT
fnp-2616	86	1	therefore	therefore	ADV
fnp-2616	86	2	,	,	PUNCT
fnp-2616	86	3	it	it	PRON
fnp-2616	86	4	might	might	AUX
fnp-2616	86	5	be	be	AUX
fnp-2616	86	6	reasonable	reasonable	ADJ
fnp-2616	86	7	to	to	PART
fnp-2616	86	8	consider	consider	VERB
fnp-2616	86	9	that	that	SCONJ
fnp-2616	86	10	these	these	DET
fnp-2616	86	11	sympathetic	sympathetic	ADJ
fnp-2616	86	12	and	and	CCONJ
fnp-2616	86	13	parasympathetic	parasympathetic	ADJ
fnp-2616	86	14	fibres	fibre	NOUN
fnp-2616	86	15	innervating	innervate	VERB
fnp-2616	86	16	the	the	DET
fnp-2616	86	17	dura	dura	NOUN
fnp-2616	86	18	mater	mater	NOUN
fnp-2616	86	19	might	might	AUX
fnp-2616	86	20	also	also	ADV
fnp-2616	86	21	accumulate	accumulate	VERB
fnp-2616	86	22	alpha	alpha	NOUN
fnp-2616	86	23	-	-	PUNCT
fnp-2616	86	24	synuclein	synuclein	NOUN
fnp-2616	86	25	.	.	PUNCT
fnp-2616	87	1	although	although	SCONJ
fnp-2616	87	2	in	in	ADP
fnp-2616	87	3	that	that	DET
fnp-2616	87	4	particular	particular	ADJ
fnp-2616	87	5	case	case	NOUN
fnp-2616	87	6	where	where	SCONJ
fnp-2616	87	7	we	we	PRON
fnp-2616	87	8	found	find	VERB
fnp-2616	87	9	alpha	alpha	NOUN
fnp-2616	87	10	-	-	PUNCT
fnp-2616	87	11	synuclein	synuclein	NOUN
fnp-2616	87	12	in	in	ADP
fnp-2616	87	13	the	the	DET
fnp-2616	87	14	dura	dura	NOUN
fnp-2616	87	15	mater	mater	NOUN
fnp-2616	87	16	,	,	PUNCT
fnp-2616	87	17	we	we	PRON
fnp-2616	87	18	did	do	AUX
fnp-2616	87	19	not	not	PART
fnp-2616	87	20	have	have	VERB
fnp-2616	87	21	the	the	DET
fnp-2616	87	22	opportunity	opportunity	NOUN
fnp-2616	87	23	to	to	PART
fnp-2616	87	24	stain	stain	VERB
fnp-2616	87	25	the	the	DET
fnp-2616	87	26	trigeminal	trigeminal	ADJ
fnp-2616	87	27	ganglion	ganglion	NOUN
fnp-2616	87	28	or	or	CCONJ
fnp-2616	87	29	nerve	nerve	NOUN
fnp-2616	87	30	nor	nor	CCONJ
fnp-2616	87	31	the	the	DET
fnp-2616	87	32	stellate	stellate	ADJ
fnp-2616	87	33	ganglion	ganglion	NOUN
fnp-2616	87	34	,	,	PUNCT
fnp-2616	87	35	we	we	PRON
fnp-2616	87	36	have	have	AUX
fnp-2616	87	37	previously	previously	ADV
fnp-2616	87	38	evaluated	evaluate	VERB
fnp-2616	87	39	the	the	DET
fnp-2616	87	40	trigeminus	trigeminu	NOUN
fnp-2616	87	41	nerve	nerve	NOUN
fnp-2616	87	42	using	use	VERB
fnp-2616	87	43	immunostaining	immunostaine	VERB
fnp-2616	87	44	for	for	ADP
fnp-2616	87	45	alpha	alpha	NOUN
fnp-2616	87	46	-	-	PUNCT
fnp-2616	87	47	synuclein	synuclein	NOUN
fnp-2616	87	48	.	.	PUNCT
fnp-2616	88	1	in	in	ADP
fnp-2616	88	2	that	that	DET
fnp-2616	88	3	study	study	NOUN
fnp-2616	88	4	we	we	PRON
fnp-2616	88	5	found	find	VERB
fnp-2616	88	6	alpha	alpha	NOUN
fnp-2616	88	7	-	-	PUNCT
fnp-2616	88	8	synuclein	synuclein	NOUN
fnp-2616	88	9	immunoreactivity	immunoreactivity	NOUN
fnp-2616	88	10	in	in	ADP
fnp-2616	88	11	two	two	NUM
fnp-2616	88	12	out	out	ADP
fnp-2616	88	13	of	of	ADP
fnp-2616	88	14	four	four	NUM
fnp-2616	88	15	pd	pd	PROPN
fnp-2616	88	16	/	/	SYM
fnp-2616	88	17	lbd	lbd	PROPN
fnp-2616	88	18	cases	case	NOUN
fnp-2616	88	19	where	where	SCONJ
fnp-2616	88	20	a	a	DET
fnp-2616	88	21	total	total	NOUN
fnp-2616	88	22	of	of	ADP
fnp-2616	88	23	six	six	NUM
fnp-2616	88	24	trigeminal	trigeminal	ADJ
fnp-2616	88	25	nerves	nerve	NOUN
fnp-2616	88	26	(	(	PUNCT
fnp-2616	88	27	in	in	ADP
fnp-2616	88	28	two	two	NUM
fnp-2616	88	29	cases	case	NOUN
fnp-2616	88	30	both	both	DET
fnp-2616	88	31	sides	side	NOUN
fnp-2616	88	32	available	available	ADJ
fnp-2616	88	33	)	)	PUNCT
fnp-2616	88	34	were	be	AUX
fnp-2616	88	35	examined	examine	VERB
fnp-2616	88	36	(	(	PUNCT
fnp-2616	88	37	28	28	NUM
fnp-2616	88	38	)	)	PUNCT
fnp-2616	88	39	.	.	PUNCT
fnp-2616	89	1	alternatively	alternatively	ADV
fnp-2616	89	2	,	,	PUNCT
fnp-2616	89	3	we	we	PRON
fnp-2616	89	4	have	have	AUX
fnp-2616	89	5	previously	previously	ADV
fnp-2616	89	6	reported	report	VERB
fnp-2616	89	7	that	that	SCONJ
fnp-2616	89	8	the	the	DET
fnp-2616	89	9	presence	presence	NOUN
fnp-2616	89	10	of	of	ADP
fnp-2616	89	11	lymphatic	lymphatic	ADJ
fnp-2616	89	12	vessels	vessel	NOUN
fnp-2616	89	13	in	in	ADP
fnp-2616	89	14	dura	dura	NOUN
fnp-2616	89	15	mater	mater	NOUN
fnp-2616	89	16	might	might	AUX
fnp-2616	89	17	be	be	AUX
fnp-2616	89	18	a	a	DET
fnp-2616	89	19	drainage	drainage	NOUN
fnp-2616	89	20	route	route	NOUN
fnp-2616	89	21	for	for	ADP
fnp-2616	89	22	molecules	molecule	NOUN
fnp-2616	89	23	from	from	ADP
fnp-2616	89	24	the	the	DET
fnp-2616	89	25	brain	brain	NOUN
fnp-2616	89	26	parenchyma	parenchyma	NOUN
fnp-2616	89	27	in	in	ADP
fnp-2616	89	28	neurodegenerative	neurodegenerative	ADJ
fnp-2616	89	29	disorders	disorder	NOUN
fnp-2616	89	30	,	,	PUNCT
fnp-2616	89	31	including	include	VERB
fnp-2616	89	32	alpha	alpha	NOUN
fnp-2616	89	33	-	-	PUNCT
fnp-2616	89	34	synuclein	synuclein	NOUN
fnp-2616	89	35	in	in	ADP
fnp-2616	89	36	lbd	lbd	PROPN
fnp-2616	89	37	(	(	PUNCT
fnp-2616	89	38	25	25	NUM
fnp-2616	89	39	)	)	PUNCT
fnp-2616	89	40	.	.	PUNCT
fnp-2616	90	1	although	although	SCONJ
fnp-2616	90	2	we	we	PRON
fnp-2616	90	3	found	find	VERB
fnp-2616	90	4	discrete	discrete	ADJ
fnp-2616	90	5	perivascular	perivascular	ADJ
fnp-2616	90	6	alpha	alpha	NOUN
fnp-2616	90	7	-	-	PUNCT
fnp-2616	90	8	synuclein	synuclein	NOUN
fnp-2616	90	9	aggregates	aggregate	NOUN
fnp-2616	90	10	in	in	ADP
fnp-2616	90	11	dura	dura	NOUN
fnp-2616	90	12	mater	mater	NOUN
fnp-2616	90	13	samples	sample	NOUN
fnp-2616	90	14	,	,	PUNCT
fnp-2616	90	15	we	we	PRON
fnp-2616	90	16	were	be	AUX
fnp-2616	90	17	not	not	PART
fnp-2616	90	18	able	able	ADJ
fnp-2616	90	19	to	to	PART
fnp-2616	90	20	confirm	confirm	VERB
fnp-2616	90	21	whether	whether	SCONJ
fnp-2616	90	22	these	these	PRON
fnp-2616	90	23	represent	represent	VERB
fnp-2616	90	24	lymphatic	lymphatic	ADJ
fnp-2616	90	25	vessels	vessel	NOUN
fnp-2616	90	26	,	,	PUNCT
fnp-2616	90	27	possibly	possibly	ADV
fnp-2616	90	28	due	due	ADP
fnp-2616	90	29	to	to	ADP
fnp-2616	90	30	the	the	DET
fnp-2616	90	31	prolonged	prolonged	ADJ
fnp-2616	90	32	fixation	fixation	NOUN
fnp-2616	90	33	time	time	NOUN
fnp-2616	90	34	of	of	ADP
fnp-2616	90	35	this	this	DET
fnp-2616	90	36	dura	dura	NOUN
fnp-2616	90	37	mater	mater	NOUN
fnp-2616	90	38	sample	sample	NOUN
fnp-2616	90	39	(	(	PUNCT
fnp-2616	90	40	<	<	X
fnp-2616	90	41	6	6	NUM
fnp-2616	90	42	years	year	NOUN
fnp-2616	90	43	)	)	PUNCT
fnp-2616	90	44	,	,	PUNCT
fnp-2616	90	45	and	and	CCONJ
fnp-2616	90	46	therefore	therefore	ADV
fnp-2616	90	47	this	this	DET
fnp-2616	90	48	question	question	NOUN
fnp-2616	90	49	deserves	deserve	VERB
fnp-2616	90	50	further	further	ADJ
fnp-2616	90	51	study	study	NOUN
fnp-2616	90	52	.	.	PUNCT
fnp-2616	91	1	the	the	DET
fnp-2616	91	2	present	present	ADJ
fnp-2616	91	3	study	study	NOUN
fnp-2616	91	4	has	have	VERB
fnp-2616	91	5	some	some	DET
fnp-2616	91	6	limitations	limitation	NOUN
fnp-2616	91	7	.	.	PUNCT
fnp-2616	92	1	first	first	ADV
fnp-2616	92	2	,	,	PUNCT
fnp-2616	92	3	as	as	SCONJ
fnp-2616	92	4	mentioned	mention	VERB
fnp-2616	92	5	above	above	ADV
fnp-2616	92	6	,	,	PUNCT
fnp-2616	92	7	the	the	DET
fnp-2616	92	8	dura	dura	NOUN
fnp-2616	92	9	mater	mater	NOUN
fnp-2616	92	10	samples	sample	NOUN
fnp-2616	92	11	were	be	AUX
fnp-2616	92	12	obtained	obtain	VERB
fnp-2616	92	13	after	after	ADP
fnp-2616	92	14	a	a	DET
fnp-2616	92	15	prolonged	prolong	VERB
fnp-2616	92	16	fixation	fixation	NOUN
fnp-2616	92	17	time	time	NOUN
fnp-2616	92	18	,	,	PUNCT
fnp-2616	92	19	which	which	PRON
fnp-2616	92	20	may	may	AUX
fnp-2616	92	21	influence	influence	VERB
fnp-2616	92	22	immunohistochemical	immunohistochemical	ADJ
fnp-2616	92	23	results	result	NOUN
fnp-2616	92	24	,	,	PUNCT
fnp-2616	92	25	not	not	PART
fnp-2616	92	26	only	only	ADV
fnp-2616	92	27	for	for	ADP
fnp-2616	92	28	cd34	cd34	PROPN
fnp-2616	92	29	,	,	PUNCT
fnp-2616	92	30	podoplanin	podoplanin	PROPN
fnp-2616	92	31	and	and	CCONJ
fnp-2616	92	32	th	th	NOUN
fnp-2616	92	33	,	,	PUNCT
fnp-2616	92	34	but	but	CCONJ
fnp-2616	92	35	for	for	ADP
fnp-2616	92	36	phospho	phospho	NOUN
fnp-2616	92	37	-	-	PUNCT
fnp-2616	92	38	synuclein	synuclein	NOUN
fnp-2616	92	39	as	as	ADV
fnp-2616	92	40	well	well	ADV
fnp-2616	92	41	(	(	PUNCT
fnp-2616	92	42	29	29	NUM
fnp-2616	92	43	)	)	PUNCT
fnp-2616	92	44	.	.	PUNCT
fnp-2616	93	1	therefore	therefore	ADV
fnp-2616	93	2	,	,	PUNCT
fnp-2616	93	3	the	the	DET
fnp-2616	93	4	interpretation	interpretation	NOUN
fnp-2616	93	5	concerning	concern	VERB
fnp-2616	93	6	the	the	DET
fnp-2616	93	7	perivascular	perivascular	ADJ
fnp-2616	93	8	association	association	NOUN
fnp-2616	93	9	of	of	ADP
fnp-2616	93	10	alpha	alpha	PROPN
fnp-2616	93	11	-	-	PUNCT
fnp-2616	93	12	synuclein	synuclein	NOUN
fnp-2616	93	13	aggregates	aggregate	NOUN
fnp-2616	93	14	needs	need	VERB
fnp-2616	93	15	some	some	DET
fnp-2616	93	16	caution	caution	NOUN
fnp-2616	93	17	.	.	PUNCT
fnp-2616	94	1	we	we	PRON
fnp-2616	94	2	could	could	AUX
fnp-2616	94	3	also	also	ADV
fnp-2616	94	4	not	not	PART
fnp-2616	94	5	reliably	reliably	ADV
fnp-2616	94	6	assess	assess	VERB
fnp-2616	94	7	axonal	axonal	ADJ
fnp-2616	94	8	preservation	preservation	NOUN
fnp-2616	94	9	in	in	ADP
fnp-2616	94	10	the	the	DET
fnp-2616	94	11	case	case	NOUN
fnp-2616	94	12	harboring	harbor	VERB
fnp-2616	94	13	alpha	alpha	NOUN
fnp-2616	94	14	-	-	PUNCT
fnp-2616	94	15	synuclein	synuclein	NOUN
fnp-2616	94	16	aggregates	aggregate	NOUN
fnp-2616	94	17	.	.	PUNCT
fnp-2616	95	1	the	the	DET
fnp-2616	95	2	prolonged	prolonged	ADJ
fnp-2616	95	3	fixation	fixation	NOUN
fnp-2616	95	4	also	also	ADV
fnp-2616	95	5	does	do	AUX
fnp-2616	95	6	not	not	PART
fnp-2616	95	7	allow	allow	VERB
fnp-2616	95	8	complementary	complementary	ADJ
fnp-2616	95	9	molecular	molecular	ADJ
fnp-2616	95	10	/	/	SYM
fnp-2616	95	11	biochemical	biochemical	ADJ
fnp-2616	95	12	studies	study	NOUN
fnp-2616	95	13	.	.	PUNCT
fnp-2616	96	1	while	while	SCONJ
fnp-2616	96	2	the	the	DET
fnp-2616	96	3	identification	identification	NOUN
fnp-2616	96	4	of	of	ADP
fnp-2616	96	5	characteristic	characteristic	ADJ
fnp-2616	96	6	pathological	pathological	ADJ
fnp-2616	96	7	aggregates	aggregate	NOUN
fnp-2616	96	8	of	of	ADP
fnp-2616	96	9	alpha	alpha	NOUN
fnp-2616	96	10	-	-	PUNCT
fnp-2616	96	11	synuclein	synuclein	NOUN
fnp-2616	96	12	with	with	ADP
fnp-2616	96	13	only	only	ADV
fnp-2616	96	14	one	one	NUM
fnp-2616	96	15	antibody	antibody	NOUN
fnp-2616	96	16	is	be	AUX
fnp-2616	96	17	limiting	limit	VERB
fnp-2616	96	18	,	,	PUNCT
fnp-2616	96	19	the	the	DET
fnp-2616	96	20	5g4	5g4	NUM
fnp-2616	96	21	antibody	antibody	NOUN
fnp-2616	96	22	has	have	AUX
fnp-2616	96	23	shown	show	VERB
fnp-2616	96	24	to	to	PART
fnp-2616	96	25	be	be	AUX
fnp-2616	96	26	a	a	DET
fnp-2616	96	27	robust	robust	ADJ
fnp-2616	96	28	marker	marker	NOUN
fnp-2616	96	29	of	of	ADP
fnp-2616	96	30	early	early	ADJ
fnp-2616	96	31	alpha	alpha	NOUN
fnp-2616	96	32	-	-	PUNCT
fnp-2616	96	33	synuclein	synuclein	NOUN
fnp-2616	96	34	pathology	pathology	NOUN
fnp-2616	96	35	,	,	PUNCT
fnp-2616	96	36	even	even	ADV
fnp-2616	96	37	in	in	ADP
fnp-2616	96	38	brains	brain	NOUN
fnp-2616	96	39	with	with	ADP
fnp-2616	96	40	prolonged	prolonged	ADJ
fnp-2616	96	41	fixation	fixation	NOUN
fnp-2616	96	42	time	time	NOUN
fnp-2616	96	43	(	(	PUNCT
fnp-2616	96	44	30	30	NUM
fnp-2616	96	45	)	)	PUNCT
fnp-2616	96	46	.	.	PUNCT
fnp-2616	97	1	second	second	ADJ
fnp-2616	97	2	,	,	PUNCT
fnp-2616	97	3	the	the	DET
fnp-2616	97	4	level	level	NOUN
fnp-2616	97	5	of	of	ADP
fnp-2616	97	6	pathological	pathological	ADJ
fnp-2616	97	7	forms	form	NOUN
fnp-2616	97	8	of	of	ADP
fnp-2616	97	9	alpha	alpha	NOUN
fnp-2616	97	10	-	-	PUNCT
fnp-2616	97	11	synuclein	synuclein	NOUN
fnp-2616	97	12	detectable	detectable	ADJ
fnp-2616	97	13	by	by	ADP
fnp-2616	97	14	conventional	conventional	ADJ
fnp-2616	97	15	immunohistochemistry	immunohistochemistry	NOUN
fnp-2616	97	16	may	may	AUX
fnp-2616	97	17	be	be	AUX
fnp-2616	97	18	low	low	ADJ
fnp-2616	97	19	.	.	PUNCT
fnp-2616	98	1	moreover	moreover	ADV
fnp-2616	98	2	,	,	PUNCT
fnp-2616	98	3	the	the	DET
fnp-2616	98	4	analysis	analysis	NOUN
fnp-2616	98	5	of	of	ADP
fnp-2616	98	6	the	the	DET
fnp-2616	98	7	supratentorial	supratentorial	ADJ
fnp-2616	98	8	,	,	PUNCT
fnp-2616	98	9	rather	rather	ADV
fnp-2616	98	10	than	than	ADP
fnp-2616	98	11	the	the	DET
fnp-2616	98	12	infratentorial	infratentorial	ADJ
fnp-2616	98	13	dura	dura	NOUN
fnp-2616	98	14	could	could	AUX
fnp-2616	98	15	also	also	ADV
fnp-2616	98	16	have	have	AUX
fnp-2616	98	17	been	be	AUX
fnp-2616	98	18	a	a	DET
fnp-2616	98	19	limiting	limit	VERB
fnp-2616	98	20	factor	factor	NOUN
fnp-2616	98	21	due	due	ADP
fnp-2616	98	22	to	to	ADP
fnp-2616	98	23	differences	difference	NOUN
fnp-2616	98	24	in	in	ADP
fnp-2616	98	25	their	their	PRON
fnp-2616	98	26	innervation	innervation	NOUN
fnp-2616	98	27	;	;	PUNCT
fnp-2616	98	28	however	however	ADV
fnp-2616	98	29	,	,	PUNCT
fnp-2616	98	30	the	the	DET
fnp-2616	98	31	supratentorial	supratentorial	ADJ
fnp-2616	98	32	dura	dura	NOUN
fnp-2616	98	33	mater	mater	NOUN
fnp-2616	98	34	also	also	ADV
fnp-2616	98	35	receives	receive	VERB
fnp-2616	98	36	sympathetic	sympathetic	ADJ
fnp-2616	98	37	and	and	CCONJ
fnp-2616	98	38	parasympathetic	parasympathetic	ADJ
fnp-2616	98	39	innervation	innervation	NOUN
fnp-2616	98	40	,	,	PUNCT
fnp-2616	98	41	and	and	CCONJ
fnp-2616	98	42	thus	thus	ADV
fnp-2616	98	43	could	could	AUX
fnp-2616	98	44	also	also	ADV
fnp-2616	98	45	be	be	AUX
fnp-2616	98	46	exposed	expose	VERB
fnp-2616	98	47	to	to	ADP
fnp-2616	98	48	transport	transport	NOUN
fnp-2616	98	49	of	of	ADP
fnp-2616	98	50	misfolded	misfolde	VERB
fnp-2616	98	51	proteins	protein	NOUN
fnp-2616	98	52	.	.	PUNCT
fnp-2616	99	1	the	the	DET
fnp-2616	99	2	negative	negative	ADJ
fnp-2616	99	3	findings	finding	NOUN
fnp-2616	99	4	in	in	ADP
fnp-2616	99	5	the	the	DET
fnp-2616	99	6	other	other	ADJ
fnp-2616	99	7	lbd	lbd	PROPN
fnp-2616	99	8	cases	case	NOUN
fnp-2616	99	9	of	of	ADP
fnp-2616	99	10	the	the	DET
fnp-2616	99	11	series	series	NOUN
fnp-2616	99	12	might	might	AUX
fnp-2616	99	13	reflect	reflect	VERB
fnp-2616	99	14	a	a	DET
fnp-2616	99	15	sampling	sample	VERB
fnp-2616	99	16	limitation	limitation	NOUN
fnp-2616	99	17	,	,	PUNCT
fnp-2616	99	18	as	as	SCONJ
fnp-2616	99	19	it	it	PRON
fnp-2616	99	20	was	be	AUX
fnp-2616	99	21	not	not	PART
fnp-2616	99	22	feasible	feasible	ADJ
fnp-2616	99	23	to	to	PART
fnp-2616	99	24	examine	examine	VERB
fnp-2616	99	25	the	the	DET
fnp-2616	99	26	whole	whole	ADJ
fnp-2616	99	27	dura	dura	NOUN
fnp-2616	99	28	mater	mater	NOUN
fnp-2616	99	29	.	.	PUNCT
fnp-2616	100	1	alternatively	alternatively	ADV
fnp-2616	100	2	,	,	PUNCT
fnp-2616	100	3	the	the	DET
fnp-2616	100	4	lack	lack	NOUN
fnp-2616	100	5	of	of	ADP
fnp-2616	100	6	staining	stain	VERB
fnp-2616	100	7	could	could	AUX
fnp-2616	100	8	also	also	ADV
fnp-2616	100	9	reflect	reflect	VERB
fnp-2616	100	10	the	the	DET
fnp-2616	100	11	diverse	diverse	ADJ
fnp-2616	100	12	innervation	innervation	NOUN
fnp-2616	100	13	of	of	ADP
fnp-2616	100	14	the	the	DET
fnp-2616	100	15	dura	dura	NOUN
fnp-2616	100	16	and	and	CCONJ
fnp-2616	100	17	different	different	ADJ
fnp-2616	100	18	pathogenic	pathogenic	ADJ
fnp-2616	100	19	capacities	capacity	NOUN
fnp-2616	100	20	of	of	ADP
fnp-2616	100	21	central	central	ADJ
fnp-2616	100	22	and	and	CCONJ
fnp-2616	100	23	peripheral	peripheral	ADJ
fnp-2616	100	24	alpha	alpha	NOUN
fnp-2616	100	25	-	-	PUNCT
fnp-2616	100	26	synuclein	synuclein	NOUN
fnp-2616	100	27	,	,	PUNCT
fnp-2616	100	28	or	or	CCONJ
fnp-2616	100	29	it	it	PRON
fnp-2616	100	30	could	could	AUX
fnp-2616	100	31	also	also	ADV
fnp-2616	100	32	indicate	indicate	VERB
fnp-2616	100	33	that	that	SCONJ
fnp-2616	100	34	the	the	DET
fnp-2616	100	35	dura	dura	NOUN
fnp-2616	100	36	mater	mater	NOUN
fnp-2616	100	37	is	be	AUX
fnp-2616	100	38	not	not	PART
fnp-2616	100	39	a	a	DET
fnp-2616	100	40	primary	primary	ADJ
fnp-2616	100	41	vulnerable	vulnerable	ADJ
fnp-2616	100	42	region	region	NOUN
fnp-2616	100	43	for	for	ADP
fnp-2616	100	44	alpha	alpha	NOUN
fnp-2616	100	45	-	-	PUNCT
fnp-2616	100	46	synuclein	synuclein	NOUN
fnp-2616	100	47	aggregation	aggregation	NOUN
fnp-2616	100	48	and	and	CCONJ
fnp-2616	100	49	could	could	AUX
fnp-2616	100	50	be	be	AUX
fnp-2616	100	51	considered	consider	VERB
fnp-2616	100	52	to	to	PART
fnp-2616	100	53	be	be	AUX
fnp-2616	100	54	a	a	DET
fnp-2616	100	55	low	low	ADJ
fnp-2616	100	56	risk	risk	NOUN
fnp-2616	100	57	tissue	tissue	NOUN
fnp-2616	100	58	for	for	ADP
fnp-2616	100	59	the	the	DET
fnp-2616	100	60	accumulation	accumulation	NOUN
fnp-2616	100	61	of	of	ADP
fnp-2616	100	62	potentially	potentially	ADV
fnp-2616	100	63	transmissible	transmissible	ADJ
fnp-2616	100	64	seeds	seed	NOUN
fnp-2616	100	65	.	.	PUNCT
fnp-2616	101	1	it	it	PRON
fnp-2616	101	2	must	must	AUX
fnp-2616	101	3	be	be	AUX
fnp-2616	101	4	emphasized	emphasize	VERB
fnp-2616	101	5	that	that	SCONJ
fnp-2616	101	6	this	this	DET
fnp-2616	101	7	study	study	NOUN
fnp-2616	101	8	raises	raise	VERB
fnp-2616	101	9	a	a	DET
fnp-2616	101	10	potentially	potentially	ADV
fnp-2616	101	11	important	important	ADJ
fnp-2616	101	12	issue	issue	NOUN
fnp-2616	101	13	but	but	CCONJ
fnp-2616	101	14	is	be	AUX
fnp-2616	101	15	unable	unable	ADJ
fnp-2616	101	16	to	to	PART
fnp-2616	101	17	provide	provide	VERB
fnp-2616	101	18	a	a	DET
fnp-2616	101	19	conclusion	conclusion	NOUN
fnp-2616	101	20	on	on	ADP
fnp-2616	101	21	the	the	DET
fnp-2616	101	22	risk	risk	NOUN
fnp-2616	101	23	of	of	ADP
fnp-2616	101	24	transmission	transmission	NOUN
fnp-2616	101	25	of	of	ADP
fnp-2616	101	26	alpha	alpha	NOUN
fnp-2616	101	27	-	-	PUNCT
fnp-2616	101	28	synuclein	synuclein	NOUN
fnp-2616	101	29	via	via	ADP
fnp-2616	101	30	dura	dura	NOUN
fnp-2616	101	31	mater	mater	NOUN
fnp-2616	101	32	grafts	graft	NOUN
fnp-2616	101	33	or	or	CCONJ
fnp-2616	101	34	neurosurgical	neurosurgical	ADJ
fnp-2616	101	35	procedures	procedure	NOUN
fnp-2616	101	36	.	.	PUNCT
fnp-2616	102	1	this	this	DET
fnp-2616	102	2	observation	observation	NOUN
fnp-2616	102	3	would	would	AUX
fnp-2616	102	4	ideally	ideally	ADV
fnp-2616	102	5	be	be	AUX
fnp-2616	102	6	complemented	complement	VERB
fnp-2616	102	7	by	by	ADP
fnp-2616	102	8	experimental	experimental	ADJ
fnp-2616	102	9	studies	study	NOUN
fnp-2616	102	10	using	use	VERB
fnp-2616	102	11	prospectively	prospectively	ADV
fnp-2616	102	12	collected	collect	VERB
fnp-2616	102	13	freshly	freshly	ADV
fnp-2616	102	14	harvested	harvest	VERB
fnp-2616	102	15	,	,	PUNCT
fnp-2616	102	16	short	short	ADJ
fnp-2616	102	17	fixed	fix	VERB
fnp-2616	102	18	and	and	CCONJ
fnp-2616	102	19	frozen	frozen	ADJ
fnp-2616	102	20	dura	dura	NOUN
fnp-2616	102	21	samples	sample	NOUN
fnp-2616	102	22	,	,	PUNCT
fnp-2616	102	23	including	include	VERB
fnp-2616	102	24	a	a	DET
fnp-2616	102	25	larger	large	ADJ
fnp-2616	102	26	cohort	cohort	NOUN
fnp-2616	102	27	of	of	ADP
fnp-2616	102	28	patients	patient	NOUN
fnp-2616	102	29	of	of	ADP
fnp-2616	102	30	different	different	ADJ
fnp-2616	102	31	age	age	NOUN
fnp-2616	102	32	groups	group	NOUN
fnp-2616	102	33	.	.	PUNCT
fnp-2616	103	1	conclusion	conclusion	NOUN
fnp-2616	103	2	disease	disease	NOUN
fnp-2616	103	3	-	-	PUNCT
fnp-2616	103	4	associated	associate	VERB
fnp-2616	103	5	alpha	alpha	NOUN
fnp-2616	103	6	-	-	PUNCT
fnp-2616	103	7	synuclein	synuclein	NOUN
fnp-2616	103	8	is	be	AUX
fnp-2616	103	9	detectable	detectable	ADJ
fnp-2616	103	10	by	by	ADP
fnp-2616	103	11	conventional	conventional	ADJ
fnp-2616	103	12	immunohistochemistry	immunohistochemistry	NOUN
fnp-2616	103	13	in	in	ADP
fnp-2616	103	14	postmortem	postmortem	NOUN
fnp-2616	103	15	supratentorial	supratentorial	ADJ
fnp-2616	103	16	dura	dura	NOUN
fnp-2616	103	17	mater	mater	NOUN
fnp-2616	103	18	,	,	PUNCT
fnp-2616	103	19	here	here	ADV
fnp-2616	103	20	in	in	ADP
fnp-2616	103	21	a	a	DET
fnp-2616	103	22	single	single	ADJ
fnp-2616	103	23	patient	patient	NOUN
fnp-2616	103	24	with	with	ADP
fnp-2616	103	25	lewy	lewy	ADJ
fnp-2616	103	26	-	-	PUNCT
fnp-2616	103	27	body	body	NOUN
fnp-2616	103	28	-	-	PUNCT
fnp-2616	103	29	type	type	NOUN
fnp-2616	103	30	alpha	alpha	NOUN
fnp-2616	103	31	-	-	PUNCT
fnp-2616	103	32	synucleinopathy	synucleinopathy	NOUN
fnp-2616	103	33	in	in	ADP
fnp-2616	103	34	the	the	DET
fnp-2616	103	35	cns	cns	NOUN
fnp-2616	103	36	.	.	PUNCT
fnp-2616	104	1	this	this	PRON
fnp-2616	104	2	suggests	suggest	VERB
fnp-2616	104	3	propagation	propagation	NOUN
fnp-2616	104	4	of	of	ADP
fnp-2616	104	5	alpha	alpha	NOUN
fnp-2616	104	6	-	-	PUNCT
fnp-2616	104	7	synuclein	synuclein	NOUN
fnp-2616	104	8	from	from	ADP
fnp-2616	104	9	the	the	DET
fnp-2616	104	10	brain	brain	NOUN
fnp-2616	104	11	and	and	CCONJ
fnp-2616	104	12	may	may	AUX
fnp-2616	104	13	indicate	indicate	VERB
fnp-2616	104	14	that	that	SCONJ
fnp-2616	104	15	dura	dura	NOUN
fnp-2616	104	16	mater	mater	NOUN
fnp-2616	104	17	could	could	AUX
fnp-2616	104	18	be	be	AUX
fnp-2616	104	19	a	a	DET
fnp-2616	104	20	potential	potential	ADJ
fnp-2616	104	21	risk	risk	NOUN
fnp-2616	104	22	tissue	tissue	NOUN
fnp-2616	104	23	for	for	ADP
fnp-2616	104	24	inadvertent	inadvertent	ADJ
fnp-2616	104	25	transmission	transmission	NOUN
fnp-2616	104	26	of	of	ADP
fnp-2616	104	27	alpha	alpha	NOUN
fnp-2616	104	28	-	-	PUNCT
fnp-2616	104	29	synuclein	synuclein	NOUN
fnp-2616	104	30	by	by	ADP
fnp-2616	104	31	dura	dura	NOUN
fnp-2616	104	32	mater	mater	NOUN
fnp-2616	104	33	grafts	graft	NOUN
fnp-2616	104	34	or	or	CCONJ
fnp-2616	104	35	surgery	surgery	NOUN
fnp-2616	104	36	.	.	PUNCT
fnp-2616	105	1	further	far	ADV
fnp-2616	105	2	experimental	experimental	ADJ
fnp-2616	105	3	and	and	CCONJ
fnp-2616	105	4	biochemical	biochemical	ADJ
fnp-2616	105	5	studies	study	NOUN
fnp-2616	105	6	are	be	AUX
fnp-2616	105	7	needed	need	VERB
fnp-2616	105	8	to	to	PART
fnp-2616	105	9	assess	assess	VERB
fnp-2616	105	10	the	the	DET
fnp-2616	105	11	risk	risk	NOUN
fnp-2616	105	12	of	of	ADP
fnp-2616	105	13	alpha	alpha	NOUN
fnp-2616	105	14	-	-	PUNCT
fnp-2616	105	15	synuclein	synuclein	NOUN
fnp-2616	105	16	transmission	transmission	NOUN
fnp-2616	105	17	via	via	ADP
fnp-2616	105	18	dura	dura	NOUN
fnp-2616	105	19	mater	mater	NOUN
fnp-2616	105	20	and	and	CCONJ
fnp-2616	105	21	its	its	PRON
fnp-2616	105	22	relationship	relationship	NOUN
fnp-2616	105	23	with	with	ADP
fnp-2616	105	24	human	human	ADJ
fnp-2616	105	25	disease	disease	NOUN
fnp-2616	105	26	.	.	PUNCT
fnp-2616	106	1	acknowledgements	acknowledgement	NOUN
fnp-2616	106	2	we	we	PRON
fnp-2616	106	3	are	be	AUX
fnp-2616	106	4	grateful	grateful	ADJ
fnp-2616	106	5	to	to	ADP
fnp-2616	106	6	susi	susi	PROPN
fnp-2616	106	7	schmid	schmid	PROPN
fnp-2616	106	8	,	,	PUNCT
fnp-2616	106	9	irene	irene	PROPN
fnp-2616	106	10	ebner	ebner	PROPN
fnp-2616	106	11	,	,	PUNCT
fnp-2616	106	12	gerda	gerda	PROPN
fnp-2616	106	13	ricken	ricken	VERB
fnp-2616	106	14	and	and	CCONJ
fnp-2616	106	15	sigrid	sigrid	VERB
fnp-2616	106	16	klotz	klotz	PROPN
fnp-2616	106	17	from	from	ADP
fnp-2616	106	18	the	the	DET
fnp-2616	106	19	division	division	NOUN
fnp-2616	106	20	of	of	ADP
fnp-2616	106	21	neuropathology	neuropathology	NOUN
fnp-2616	106	22	and	and	CCONJ
fnp-2616	106	23	neurochemistry	neurochemistry	NOUN
fnp-2616	106	24	,	,	PUNCT
fnp-2616	106	25	department	department	NOUN
fnp-2616	106	26	of	of	ADP
fnp-2616	106	27	neurology	neurology	NOUN
fnp-2616	106	28	,	,	PUNCT
fnp-2616	106	29	medical	medical	ADJ
fnp-2616	106	30	university	university	PROPN
fnp-2616	106	31	of	of	ADP
fnp-2616	106	32	vienna	vienna	PROPN
fnp-2616	106	33	,	,	PUNCT
fnp-2616	106	34	for	for	ADP
fnp-2616	106	35	excellent	excellent	ADJ
fnp-2616	106	36	technical	technical	ADJ
fnp-2616	106	37	support	support	NOUN
fnp-2616	106	38	.	.	PUNCT
fnp-2616	107	1	we	we	PRON
fnp-2616	107	2	are	be	AUX
fnp-2616	107	3	indebted	indebte	VERB
fnp-2616	107	4	to	to	ADP
fnp-2616	107	5	brain	brain	NOUN
fnp-2616	107	6	donors	donor	NOUN
fnp-2616	107	7	and	and	CCONJ
fnp-2616	107	8	their	their	PRON
fnp-2616	107	9	family	family	NOUN
fnp-2616	107	10	of	of	ADP
fnp-2616	107	11	the	the	DET
fnp-2616	107	12	vienna	vienna	PROPN
fnp-2616	107	13	transdanube	transdanube	NOUN
fnp-2616	107	14	study	study	NOUN
fnp-2616	107	15	(	(	PUNCT
fnp-2616	107	16	vita	vita	NOUN
fnp-2616	107	17	)	)	PUNCT
fnp-2616	107	18	for	for	ADP
fnp-2616	107	19	generous	generous	ADJ
fnp-2616	107	20	brain	brain	NOUN
fnp-2616	107	21	and	and	CCONJ
fnp-2616	107	22	sample	sample	NOUN
fnp-2616	107	23	donation	donation	NOUN
fnp-2616	107	24	for	for	ADP
fnp-2616	107	25	research	research	NOUN
fnp-2616	107	26	.	.	PUNCT
fnp-2616	108	1	this	this	DET
fnp-2616	108	2	work	work	NOUN
fnp-2616	108	3	has	have	AUX
fnp-2616	108	4	been	be	AUX
fnp-2616	108	5	supported	support	VERB
fnp-2616	108	6	by	by	ADP
fnp-2616	108	7	the	the	DET
fnp-2616	108	8	bishop	bishop	PROPN
fnp-2616	108	9	karl	karl	PROPN
fnp-2616	108	10	golser	golser	PROPN
fnp-2616	108	11	award	award	PROPN
fnp-2616	108	12	to	to	ADP
fnp-2616	108	13	ggk	ggk	PROPN
fnp-2616	108	14	.	.	PROPN
fnp-2616	108	15	references	reference	NOUN
fnp-2616	108	16	1	1	NUM
fnp-2616	108	17	.	.	PUNCT
fnp-2616	108	18	brown	brown	PROPN
fnp-2616	108	19	p	p	NOUN
fnp-2616	108	20	,	,	PUNCT
fnp-2616	108	21	brandel	brandel	PROPN
fnp-2616	108	22	jp	jp	PROPN
fnp-2616	108	23	,	,	PUNCT
fnp-2616	108	24	sato	sato	PROPN
fnp-2616	108	25	t	t	PROPN
fnp-2616	108	26	,	,	PUNCT
fnp-2616	108	27	et	et	PROPN
fnp-2616	108	28	al	al	PROPN
fnp-2616	108	29	.	.	PROPN
fnp-2616	108	30	iatrogenic	iatrogenic	ADJ
fnp-2616	108	31	creutzfeldt	creutzfeldt	ADJ
fnp-2616	108	32	-	-	PUNCT
fnp-2616	108	33	jakob	jakob	ADJ
fnp-2616	108	34	disease	disease	NOUN
fnp-2616	108	35	,	,	PUNCT
fnp-2616	108	36	final	final	ADJ
fnp-2616	108	37	assessment	assessment	NOUN
fnp-2616	108	38	.	.	PUNCT
fnp-2616	109	1	emerg	emerg	PROPN
fnp-2616	109	2	infect	infect	PROPN
fnp-2616	109	3	dis	dis	PROPN
fnp-2616	109	4	.	.	PUNCT
fnp-2616	110	1	2012	2012	NUM
fnp-2616	110	2	;	;	PUNCT
fnp-2616	110	3	18:901	18:901	NUM
fnp-2616	110	4	-	-	SYM
fnp-2616	110	5	907	907	NUM
fnp-2616	110	6	.	.	NOUN
fnp-2616	111	1	2	2	NUM
fnp-2616	111	2	.	.	X
fnp-2616	111	3	duyckaerts	duyckaert	NOUN
fnp-2616	111	4	c	c	PROPN
fnp-2616	111	5	,	,	PUNCT
fnp-2616	111	6	clavaguera	clavaguera	NOUN
fnp-2616	111	7	f	f	PROPN
fnp-2616	111	8	,	,	PUNCT
fnp-2616	111	9	potier	potier	PROPN
fnp-2616	111	10	mc	mc	PROPN
fnp-2616	111	11	.	.	PUNCT
fnp-2616	112	1	the	the	DET
fnp-2616	112	2	prion	prion	NOUN
fnp-2616	112	3	-	-	PUNCT
fnp-2616	112	4	like	like	ADJ
fnp-2616	112	5	propagation	propagation	NOUN
fnp-2616	112	6	hypothesis	hypothesis	NOUN
fnp-2616	112	7	in	in	ADP
fnp-2616	112	8	alzheimer	alzheimer	PROPN
fnp-2616	112	9	's	's	PART
fnp-2616	112	10	and	and	CCONJ
fnp-2616	112	11	parkinson	parkinson	NOUN
fnp-2616	112	12	's	's	PART
fnp-2616	112	13	disease	disease	NOUN
fnp-2616	112	14	.	.	PUNCT
fnp-2616	113	1	curr	curr	PROPN
fnp-2616	113	2	opin	opin	PROPN
fnp-2616	113	3	neurol	neurol	NOUN
fnp-2616	113	4	.	.	PUNCT
fnp-2616	114	1	2019	2019	NUM
fnp-2616	114	2	;	;	PUNCT
fnp-2616	114	3	32:266	32:266	NUM
fnp-2616	114	4	-	-	SYM
fnp-2616	114	5	271	271	NUM
fnp-2616	114	6	.	.	NOUN
fnp-2616	115	1	3	3	X
fnp-2616	115	2	.	.	X
fnp-2616	115	3	jaunmuktane	jaunmuktane	PROPN
fnp-2616	115	4	z	z	PROPN
fnp-2616	115	5	,	,	PUNCT
fnp-2616	115	6	mead	mead	PROPN
fnp-2616	115	7	s	s	PROPN
fnp-2616	115	8	,	,	PUNCT
fnp-2616	115	9	ellis	ellis	PROPN
fnp-2616	115	10	m	m	PROPN
fnp-2616	115	11	,	,	PUNCT
fnp-2616	115	12	et	et	PROPN
fnp-2616	115	13	al	al	PROPN
fnp-2616	115	14	.	.	PROPN
fnp-2616	115	15	evidence	evidence	NOUN
fnp-2616	115	16	for	for	ADP
fnp-2616	115	17	human	human	ADJ
fnp-2616	115	18	transmission	transmission	NOUN
fnp-2616	115	19	of	of	ADP
fnp-2616	115	20	amyloid	amyloid	NOUN
fnp-2616	115	21	-	-	PUNCT
fnp-2616	115	22	β	β	X
fnp-2616	115	23	pathology	pathology	NOUN
fnp-2616	115	24	and	and	CCONJ
fnp-2616	115	25	cerebral	cerebral	ADJ
fnp-2616	115	26	amyloid	amyloid	NOUN
fnp-2616	115	27	angiopathy	angiopathy	NOUN
fnp-2616	115	28	.	.	PUNCT
fnp-2616	116	1	nature	nature	NOUN
fnp-2616	116	2	.	.	PUNCT
fnp-2616	117	1	2015	2015	NUM
fnp-2616	117	2	;	;	PUNCT
fnp-2616	117	3	525:247	525:247	PROPN
fnp-2616	117	4	-	-	SYM
fnp-2616	117	5	250	250	NUM
fnp-2616	117	6	.	.	PUNCT
fnp-2616	118	1	4	4	X
fnp-2616	118	2	.	.	X
fnp-2616	118	3	frontzek	frontzek	PROPN
fnp-2616	118	4	k	k	PROPN
fnp-2616	118	5	,	,	PUNCT
fnp-2616	118	6	lutz	lutz	PROPN
fnp-2616	118	7	mi	mi	PROPN
fnp-2616	118	8	,	,	PUNCT
fnp-2616	118	9	aguzzi	aguzzi	NOUN
fnp-2616	118	10	a	a	PROPN
fnp-2616	118	11	,	,	PUNCT
fnp-2616	118	12	et	et	PROPN
fnp-2616	118	13	al	al	PROPN
fnp-2616	118	14	.	.	PUNCT
fnp-2616	118	15	amyloid	amyloid	PROPN
fnp-2616	118	16	-	-	PUNCT
fnp-2616	118	17	β	β	X
fnp-2616	118	18	pathology	pathology	NOUN
fnp-2616	118	19	and	and	CCONJ
fnp-2616	118	20	cerebral	cerebral	ADJ
fnp-2616	118	21	amyloid	amyloid	NOUN
fnp-2616	118	22	angiopathy	angiopathy	NOUN
fnp-2616	118	23	are	be	AUX
fnp-2616	118	24	frequent	frequent	ADJ
fnp-2616	118	25	in	in	ADP
fnp-2616	118	26	iatrogenic	iatrogenic	ADJ
fnp-2616	118	27	creutzfeldt	creutzfeldt	ADJ
fnp-2616	118	28	-	-	PUNCT
fnp-2616	118	29	jakob	jakob	ADJ
fnp-2616	118	30	disease	disease	NOUN
fnp-2616	118	31	after	after	ADP
fnp-2616	118	32	dural	dural	ADJ
fnp-2616	118	33	grafting	grafting	NOUN
fnp-2616	118	34	.	.	PUNCT
fnp-2616	119	1	swiss	swiss	ADJ
fnp-2616	119	2	med	med	ADJ
fnp-2616	119	3	wkly	wkly	ADV
fnp-2616	119	4	.	.	PUNCT
fnp-2616	120	1	2016	2016	NUM
fnp-2616	120	2	;	;	PUNCT
fnp-2616	120	3	146	146	NUM
fnp-2616	120	4	:	:	SYM
fnp-2616	120	5	w14287	w14287	PROPN
fnp-2616	120	6	.	.	PROPN
fnp-2616	121	1	5	5	NUM
fnp-2616	121	2	.	.	X
fnp-2616	121	3	silvia	silvia	PROPN
fnp-2616	121	4	a.	a.	NOUN
fnp-2616	121	5	purro	purro	PROPN
fnp-2616	121	6	,	,	PUNCT
fnp-2616	121	7	mark	mark	PROPN
fnp-2616	121	8	a.	a.	PROPN
fnp-2616	121	9	farrow	farrow	PROPN
fnp-2616	121	10	,	,	PUNCT
fnp-2616	121	11	jacqueline	jacqueline	PROPN
fnp-2616	121	12	linehan	linehan	PROPN
fnp-2616	121	13	,	,	PUNCT
fnp-2616	121	14	et	et	PROPN
fnp-2616	121	15	al	al	PROPN
fnp-2616	121	16	.	.	PUNCT
fnp-2616	122	1	transmission	transmission	NOUN
fnp-2616	122	2	of	of	ADP
fnp-2616	122	3	amyloid	amyloid	NOUN
fnp-2616	122	4	-	-	PUNCT
fnp-2616	122	5	β	β	X
fnp-2616	122	6	protein	protein	NOUN
fnp-2616	122	7	pathology	pathology	NOUN
fnp-2616	122	8	from	from	ADP
fnp-2616	122	9	cadaveric	cadaveric	ADJ
fnp-2616	122	10	pituitary	pituitary	ADJ
fnp-2616	122	11	growth	growth	NOUN
fnp-2616	122	12	hormone	hormone	NOUN
fnp-2616	122	13	.	.	PUNCT
fnp-2616	123	1	nature	nature	NOUN
fnp-2616	123	2	.	.	PUNCT
fnp-2616	124	1	2018	2018	NUM
fnp-2616	124	2	;	;	PUNCT
fnp-2616	124	3	564:415	564:415	NUM
fnp-2616	124	4	-	-	PUNCT
fnp-2616	124	5	419	419	NUM
fnp-2616	124	6	.	.	NOUN
fnp-2616	125	1	6	6	NUM
fnp-2616	125	2	.	.	PUNCT
fnp-2616	125	3	burwinkel	burwinkel	PROPN
fnp-2616	125	4	m	m	PROPN
fnp-2616	125	5	,	,	PUNCT
fnp-2616	125	6	lutzenberger	lutzenberger	NOUN
fnp-2616	125	7	m	m	PROPN
fnp-2616	125	8	,	,	PUNCT
fnp-2616	125	9	heppner	heppner	PROPN
fnp-2616	125	10	fl	fl	PROPN
fnp-2616	125	11	,	,	PUNCT
fnp-2616	125	12	et	et	PROPN
fnp-2616	125	13	al	al	PROPN
fnp-2616	125	14	.	.	PROPN
fnp-2616	126	1	intravenous	intravenous	ADJ
fnp-2616	126	2	injection	injection	NOUN
fnp-2616	126	3	of	of	ADP
fnp-2616	126	4	beta	beta	NOUN
fnp-2616	126	5	-	-	PUNCT
fnp-2616	126	6	amyloid	amyloid	NOUN
fnp-2616	126	7	seeds	seed	NOUN
fnp-2616	126	8	promotes	promote	VERB
fnp-2616	126	9	cerebral	cerebral	ADJ
fnp-2616	126	10	amyloid	amyloid	NOUN
fnp-2616	126	11	angiopathy	angiopathy	ADJ
fnp-2616	126	12	(	(	PUNCT
fnp-2616	126	13	caa	caa	NOUN
fnp-2616	126	14	)	)	PUNCT
fnp-2616	126	15	.	.	PUNCT
fnp-2616	127	1	acta	acta	PROPN
fnp-2616	127	2	neuropathol	neuropathol	PROPN
fnp-2616	127	3	commun	commun	PROPN
fnp-2616	127	4	.	.	PUNCT
fnp-2616	127	5	2018	2018	NUM
fnp-2616	127	6	;	;	PUNCT
fnp-2616	127	7	6:23	6:23	NUM
fnp-2616	127	8	.	.	NOUN
fnp-2616	128	1	7	7	NUM
fnp-2616	128	2	.	.	X
fnp-2616	128	3	kovacs	kovacs	PROPN
fnp-2616	128	4	gg	gg	PROPN
fnp-2616	128	5	,	,	PUNCT
fnp-2616	128	6	lutz	lutz	PROPN
fnp-2616	128	7	mi	mi	PROPN
fnp-2616	128	8	,	,	PUNCT
fnp-2616	128	9	ricken	ricken	VERB
fnp-2616	128	10	g	g	PROPN
fnp-2616	128	11	,	,	PUNCT
fnp-2616	128	12	et	et	PROPN
fnp-2616	128	13	al	al	PROPN
fnp-2616	128	14	.	.	PUNCT
fnp-2616	129	1	dura	dura	NOUN
fnp-2616	129	2	mater	mater	NOUN
fnp-2616	129	3	is	be	AUX
fnp-2616	129	4	a	a	DET
fnp-2616	129	5	potential	potential	ADJ
fnp-2616	129	6	source	source	NOUN
fnp-2616	129	7	of	of	ADP
fnp-2616	129	8	aβ	aβ	DET
fnp-2616	129	9	seeds	seed	NOUN
fnp-2616	129	10	.	.	PUNCT
fnp-2616	130	1	acta	acta	PROPN
fnp-2616	130	2	neuropathol	neuropathol	PROPN
fnp-2616	130	3	.	.	PUNCT
fnp-2616	131	1	2016	2016	NUM
fnp-2616	131	2	;	;	PUNCT
fnp-2616	132	1	131:911	131:911	X
fnp-2616	132	2	-	-	SYM
fnp-2616	132	3	923	923	NUM
fnp-2616	132	4	.	.	NOUN
fnp-2616	132	5	8	8	NUM
fnp-2616	132	6	.	.	X
fnp-2616	133	1	hamaguchi	hamaguchi	PROPN
fnp-2616	133	2	t	t	PROPN
fnp-2616	133	3	,	,	PUNCT
fnp-2616	133	4	taniguchi	taniguchi	PROPN
fnp-2616	133	5	y	y	PROPN
fnp-2616	133	6	,	,	PUNCT
fnp-2616	133	7	sakai	sakai	PROPN
fnp-2616	133	8	k	k	PROPN
fnp-2616	133	9	,	,	PUNCT
fnp-2616	133	10	et	et	PROPN
fnp-2616	133	11	al	al	PROPN
fnp-2616	133	12	.	.	PUNCT
fnp-2616	133	13	significant	significant	PROPN
fnp-2616	133	14	association	association	NOUN
fnp-2616	133	15	of	of	ADP
fnp-2616	133	16	cadaveric	cadaveric	ADJ
fnp-2616	133	17	dura	dura	NOUN
fnp-2616	133	18	mater	mater	NOUN
fnp-2616	133	19	grafting	graft	VERB
fnp-2616	133	20	with	with	ADP
fnp-2616	133	21	subpial	subpial	ADJ
fnp-2616	133	22	aβ	aβ	NOUN
fnp-2616	133	23	deposition	deposition	NOUN
fnp-2616	133	24	and	and	CCONJ
fnp-2616	133	25	meningeal	meningeal	ADJ
fnp-2616	133	26	amyloid	amyloid	NOUN
fnp-2616	133	27	angiopathy	angiopathy	NOUN
fnp-2616	133	28	.	.	PUNCT
fnp-2616	134	1	acta	acta	PROPN
fnp-2616	134	2	neuropathol	neuropathol	PROPN
fnp-2616	134	3	.	.	PUNCT
fnp-2616	135	1	2016	2016	NUM
fnp-2616	135	2	;	;	PUNCT
fnp-2616	135	3	132:313	132:313	NUM
fnp-2616	135	4	-	-	SYM
fnp-2616	135	5	315	315	NUM
fnp-2616	135	6	.	.	NOUN
fnp-2616	136	1	9	9	NUM
fnp-2616	136	2	.	.	X
fnp-2616	136	3	jaunmuktane	jaunmuktane	PROPN
fnp-2616	136	4	z	z	PROPN
fnp-2616	136	5	,	,	PUNCT
fnp-2616	136	6	quaegebeur	quaegebeur	X
fnp-2616	136	7	a	a	PRON
fnp-2616	136	8	,	,	PUNCT
fnp-2616	136	9	taipa	taipa	ADJ
fnp-2616	136	10	r	r	NOUN
fnp-2616	136	11	,	,	PUNCT
fnp-2616	136	12	et	et	PROPN
fnp-2616	136	13	al	al	PROPN
fnp-2616	136	14	.	.	PROPN
fnp-2616	136	15	evidence	evidence	NOUN
fnp-2616	136	16	of	of	ADP
fnp-2616	136	17	amyloid	amyloid	NOUN
fnp-2616	136	18	-	-	PUNCT
fnp-2616	136	19	β	β	X
fnp-2616	136	20	cerebral	cerebral	ADJ
fnp-2616	136	21	amyloid	amyloid	NOUN
fnp-2616	136	22	angiopathy	angiopathy	ADJ
fnp-2616	136	23	transmission	transmission	NOUN
fnp-2616	136	24	through	through	ADP
fnp-2616	136	25	neurosurgery	neurosurgery	NOUN
fnp-2616	136	26	.	.	PUNCT
fnp-2616	137	1	acta	acta	PROPN
fnp-2616	137	2	neuropathol	neuropathol	PROPN
fnp-2616	137	3	.	.	PUNCT
fnp-2616	138	1	2018	2018	NUM
fnp-2616	138	2	;	;	PUNCT
fnp-2616	138	3	135:671	135:671	NUM
fnp-2616	138	4	-	-	PUNCT
fnp-2616	138	5	679	679	NUM
fnp-2616	138	6	.	.	PUNCT
fnp-2616	139	1	10	10	NUM
fnp-2616	139	2	.	.	PUNCT
fnp-2616	140	1	banerjee	banerjee	PROPN
fnp-2616	140	2	g	g	PROPN
fnp-2616	140	3	,	,	PUNCT
fnp-2616	140	4	adams	adams	PROPN
fnp-2616	140	5	me	i	PRON
fnp-2616	140	6	,	,	PUNCT
fnp-2616	140	7	jaunmuktane	jaunmuktane	NOUN
fnp-2616	140	8	z	z	PROPN
fnp-2616	140	9	,	,	PUNCT
fnp-2616	140	10	et	et	PROPN
fnp-2616	140	11	al	al	PROPN
fnp-2616	140	12	.	.	PROPN
fnp-2616	141	1	early	early	ADJ
fnp-2616	141	2	onset	onset	VERB
fnp-2616	141	3	cerebral	cerebral	ADJ
fnp-2616	141	4	amyloid	amyloid	NOUN
fnp-2616	141	5	angiopathy	angiopathy	NOUN
fnp-2616	141	6	following	follow	VERB
fnp-2616	141	7	childhood	childhood	NOUN
fnp-2616	141	8	exposure	exposure	NOUN
fnp-2616	141	9	to	to	ADP
fnp-2616	141	10	cadaveric	cadaveric	ADJ
fnp-2616	141	11	dura	dura	NOUN
fnp-2616	141	12	.	.	PUNCT
fnp-2616	142	1	ann	ann	PROPN
fnp-2616	142	2	neurol	neurol	PROPN
fnp-2616	142	3	.	.	PUNCT
fnp-2616	143	1	2019	2019	NUM
fnp-2616	143	2	;	;	PUNCT
fnp-2616	143	3	85:284	85:284	NUM
fnp-2616	143	4	-	-	SYM
fnp-2616	143	5	290	290	NUM
fnp-2616	143	6	.	.	PUNCT
fnp-2616	143	7	11	11	NUM
fnp-2616	143	8	.	.	PUNCT
fnp-2616	144	1	recasens	recasen	NOUN
fnp-2616	144	2	a	a	PRON
fnp-2616	144	3	,	,	PUNCT
fnp-2616	144	4	dehay	dehay	PROPN
fnp-2616	144	5	b	b	PROPN
fnp-2616	144	6	,	,	PUNCT
fnp-2616	144	7	bové	bové	PROPN
fnp-2616	144	8	j	j	PROPN
fnp-2616	144	9	,	,	PUNCT
fnp-2616	144	10	et	et	PROPN
fnp-2616	144	11	al	al	PROPN
fnp-2616	144	12	.	.	PROPN
fnp-2616	145	1	lewy	lewy	PROPN
fnp-2616	145	2	body	body	NOUN
fnp-2616	145	3	extracts	extract	NOUN
fnp-2616	145	4	from	from	ADP
fnp-2616	145	5	parkinson	parkinson	NOUN
fnp-2616	145	6	disease	disease	NOUN
fnp-2616	145	7	brains	brain	NOUN
fnp-2616	145	8	trigger	trigger	VERB
fnp-2616	145	9	α	α	NOUN
fnp-2616	145	10	-	-	PUNCT
fnp-2616	145	11	synuclein	synuclein	NOUN
fnp-2616	145	12	pathology	pathology	NOUN
fnp-2616	145	13	and	and	CCONJ
fnp-2616	145	14	neurodegeneration	neurodegeneration	NOUN
fnp-2616	145	15	in	in	ADP
fnp-2616	145	16	mice	mouse	NOUN
fnp-2616	145	17	and	and	CCONJ
fnp-2616	145	18	monkeys	monkey	NOUN
fnp-2616	145	19	.	.	PUNCT
fnp-2616	146	1	ann	ann	PROPN
fnp-2616	146	2	neurol	neurol	PROPN
fnp-2616	146	3	.	.	PUNCT
fnp-2616	147	1	2014	2014	NUM
fnp-2616	147	2	;	;	PUNCT
fnp-2616	147	3	75:351	75:351	NUM
fnp-2616	147	4	-	-	SYM
fnp-2616	147	5	362	362	NUM
fnp-2616	147	6	.	.	PUNCT
fnp-2616	148	1	12	12	NUM
fnp-2616	148	2	.	.	PUNCT
fnp-2616	149	1	karpowicz	karpowicz	PROPN
fnp-2616	149	2	rj	rj	PROPN
fnp-2616	149	3	jr	jr	PROPN
fnp-2616	149	4	,	,	PUNCT
fnp-2616	149	5	trojanowski	trojanowski	PROPN
fnp-2616	149	6	jq	jq	PROPN
fnp-2616	149	7	,	,	PUNCT
fnp-2616	149	8	lee	lee	PROPN
fnp-2616	149	9	vm	vm	PROPN
fnp-2616	149	10	.	.	PROPN
fnp-2616	149	11	transmission	transmission	NOUN
fnp-2616	149	12	of	of	ADP
fnp-2616	149	13	α	α	NOUN
fnp-2616	149	14	-	-	PUNCT
fnp-2616	149	15	synuclein	synuclein	NOUN
fnp-2616	149	16	seeds	seed	NOUN
fnp-2616	149	17	in	in	ADP
fnp-2616	149	18	neurodegenerative	neurodegenerative	ADJ
fnp-2616	149	19	disease	disease	NOUN
fnp-2616	149	20	:	:	PUNCT
fnp-2616	149	21	recent	recent	ADJ
fnp-2616	149	22	developments	development	NOUN
fnp-2616	149	23	.	.	PUNCT
fnp-2616	150	1	lab	lab	NOUN
fnp-2616	150	2	invest	inv	ADJ
fnp-2616	150	3	.	.	PUNCT
fnp-2616	151	1	2019	2019	NUM
fnp-2616	151	2	;	;	PUNCT
fnp-2616	152	1	99:971	99:971	NUM
fnp-2616	152	2	-	-	SYM
fnp-2616	152	3	981	981	NUM
fnp-2616	152	4	.	.	NOUN
fnp-2616	152	5	13	13	NUM
fnp-2616	152	6	.	.	PUNCT
fnp-2616	153	1	desplats	desplat	NOUN
fnp-2616	153	2	p	p	NUM
fnp-2616	153	3	,	,	PUNCT
fnp-2616	153	4	lee	lee	PROPN
fnp-2616	153	5	hj	hj	PROPN
fnp-2616	153	6	,	,	PUNCT
fnp-2616	153	7	bae	bae	PROPN
fnp-2616	153	8	ej	ej	PROPN
fnp-2616	153	9	,	,	PUNCT
fnp-2616	153	10	et	et	PROPN
fnp-2616	153	11	al	al	PROPN
fnp-2616	153	12	.	.	PROPN
fnp-2616	154	1	inclusion	inclusion	NOUN
fnp-2616	154	2	formation	formation	NOUN
fnp-2616	154	3	and	and	CCONJ
fnp-2616	154	4	neuronal	neuronal	ADJ
fnp-2616	154	5	cell	cell	NOUN
fnp-2616	154	6	death	death	NOUN
fnp-2616	154	7	through	through	ADP
fnp-2616	154	8	neuron	neuron	PROPN
fnp-2616	154	9	-	-	PUNCT
fnp-2616	154	10	to	to	ADP
fnp-2616	154	11	-	-	PUNCT
fnp-2616	154	12	neuron	neuron	NOUN
fnp-2616	154	13	transmission	transmission	NOUN
fnp-2616	154	14	of	of	ADP
fnp-2616	154	15	alpha	alpha	NOUN
fnp-2616	154	16	-	-	PUNCT
fnp-2616	154	17	synuclein	synuclein	NOUN
fnp-2616	154	18	.	.	PUNCT
fnp-2616	155	1	proc	proc	PROPN
fnp-2616	155	2	natl	natl	PROPN
fnp-2616	155	3	acad	acad	PROPN
fnp-2616	155	4	sci	sci	PROPN
fnp-2616	155	5	u	u	PROPN
fnp-2616	155	6	s	s	NOUN
fnp-2616	155	7	a.	a.	NOUN
fnp-2616	155	8	2009	2009	NUM
fnp-2616	155	9	;	;	PUNCT
fnp-2616	155	10	106:13010	106:13010	NUM
fnp-2616	155	11	-	-	SYM
fnp-2616	155	12	13015	13015	NUM
fnp-2616	155	13	.	.	PUNCT
fnp-2616	156	1	14	14	NUM
fnp-2616	156	2	.	.	PUNCT
fnp-2616	157	1	kordower	kordower	PROPN
fnp-2616	157	2	jh	jh	PROPN
fnp-2616	157	3	,	,	PUNCT
fnp-2616	157	4	chu	chu	PROPN
fnp-2616	157	5	y	y	PROPN
fnp-2616	157	6	,	,	PUNCT
fnp-2616	157	7	hauser	hauser	PROPN
fnp-2616	157	8	ra	ra	PROPN
fnp-2616	157	9	,	,	PUNCT
fnp-2616	157	10	et	et	PROPN
fnp-2616	157	11	al	al	PROPN
fnp-2616	157	12	.	.	PROPN
fnp-2616	157	13	lewy	lewy	PROPN
fnp-2616	157	14	body	body	PROPN
fnp-2616	157	15	-	-	PUNCT
fnp-2616	157	16	like	like	ADJ
fnp-2616	157	17	pathology	pathology	NOUN
fnp-2616	157	18	in	in	ADP
fnp-2616	157	19	long	long	ADJ
fnp-2616	157	20	-	-	PUNCT
fnp-2616	157	21	term	term	NOUN
fnp-2616	157	22	embryonic	embryonic	ADJ
fnp-2616	157	23	nigral	nigral	ADJ
fnp-2616	157	24	transplants	transplant	NOUN
fnp-2616	157	25	in	in	ADP
fnp-2616	157	26	parkinson	parkinson	NOUN
fnp-2616	157	27	's	's	PART
fnp-2616	157	28	disease	disease	NOUN
fnp-2616	157	29	.	.	PUNCT
fnp-2616	158	1	nat	nat	PROPN
fnp-2616	158	2	med	med	PROPN
fnp-2616	158	3	.	.	PROPN
fnp-2616	158	4	2008	2008	NUM
fnp-2616	158	5	;	;	PUNCT
fnp-2616	158	6	14:504	14:504	NUM
fnp-2616	158	7	-	-	SYM
fnp-2616	158	8	506	506	NUM
fnp-2616	158	9	.	.	NOUN
fnp-2616	158	10	15	15	NUM
fnp-2616	158	11	.	.	PUNCT
fnp-2616	159	1	li	li	PROPN
fnp-2616	159	2	jy	jy	PROPN
fnp-2616	159	3	,	,	PUNCT
fnp-2616	159	4	englund	englund	PROPN
fnp-2616	159	5	e	e	PROPN
fnp-2616	159	6	,	,	PUNCT
fnp-2616	159	7	holton	holton	PROPN
fnp-2616	159	8	jl	jl	PROPN
fnp-2616	159	9	,	,	PUNCT
fnp-2616	159	10	et	et	PROPN
fnp-2616	159	11	al	al	PROPN
fnp-2616	159	12	.	.	PROPN
fnp-2616	160	1	lewy	lewy	PROPN
fnp-2616	160	2	bodies	body	NOUN
fnp-2616	160	3	in	in	ADP
fnp-2616	160	4	grafted	graft	VERB
fnp-2616	160	5	neurons	neuron	NOUN
fnp-2616	160	6	in	in	ADP
fnp-2616	160	7	subjects	subject	NOUN
fnp-2616	160	8	with	with	ADP
fnp-2616	160	9	parkinson	parkinson	NOUN
fnp-2616	160	10	's	's	PART
fnp-2616	160	11	disease	disease	NOUN
fnp-2616	160	12	suggest	suggest	VERB
fnp-2616	160	13	host	host	NOUN
fnp-2616	160	14	-	-	PUNCT
fnp-2616	160	15	to	to	ADP
fnp-2616	160	16	-	-	PUNCT
fnp-2616	160	17	graft	graft	NOUN
fnp-2616	160	18	disease	disease	NOUN
fnp-2616	160	19	propagation	propagation	NOUN
fnp-2616	160	20	.	.	PUNCT
fnp-2616	161	1	nat	nat	PROPN
fnp-2616	161	2	med	med	PROPN
fnp-2616	161	3	.	.	PROPN
fnp-2616	161	4	2008	2008	NUM
fnp-2616	161	5	;	;	PUNCT
fnp-2616	161	6	14:501	14:501	NUM
fnp-2616	161	7	-	-	SYM
fnp-2616	161	8	503	503	NUM
fnp-2616	161	9	.	.	PUNCT
fnp-2616	162	1	16	16	NUM
fnp-2616	162	2	.	.	PUNCT
fnp-2616	163	1	woerman	woerman	PROPN
fnp-2616	163	2	al	al	PROPN
fnp-2616	163	3	,	,	PUNCT
fnp-2616	163	4	oehler	oehler	NOUN
fnp-2616	163	5	a	a	X
fnp-2616	163	6	,	,	PUNCT
fnp-2616	163	7	kazmi	kazmi	PROPN
fnp-2616	163	8	sa	sa	PROPN
fnp-2616	163	9	,	,	PUNCT
fnp-2616	163	10	et	et	PROPN
fnp-2616	163	11	al	al	PROPN
fnp-2616	163	12	.	.	PUNCT
fnp-2616	163	13	multiple	multiple	ADJ
fnp-2616	163	14	system	system	NOUN
fnp-2616	163	15	atrophy	atrophy	NOUN
fnp-2616	163	16	prions	prion	NOUN
fnp-2616	163	17	retain	retain	VERB
fnp-2616	163	18	strain	strain	NOUN
fnp-2616	163	19	specificity	specificity	NOUN
fnp-2616	163	20	after	after	ADP
fnp-2616	163	21	serial	serial	ADJ
fnp-2616	163	22	propagation	propagation	NOUN
fnp-2616	163	23	in	in	ADP
fnp-2616	163	24	two	two	NUM
fnp-2616	163	25	different	different	ADJ
fnp-2616	163	26	tg(snca*a53	tg(snca*a53	PROPN
fnp-2616	163	27	t	t	PROPN
fnp-2616	163	28	)	)	PUNCT
fnp-2616	163	29	mouse	mouse	NOUN
fnp-2616	163	30	lines	line	NOUN
fnp-2616	163	31	.	.	PUNCT
fnp-2616	164	1	acta	acta	PROPN
fnp-2616	164	2	neuropathol	neuropathol	PROPN
fnp-2616	164	3	.	.	PUNCT
fnp-2616	165	1	2019	2019	NUM
fnp-2616	165	2	;	;	PUNCT
fnp-2616	165	3	137:437	137:437	NUM
fnp-2616	165	4	-	-	SYM
fnp-2616	165	5	454	454	NUM
fnp-2616	165	6	.	.	PUNCT
fnp-2616	166	1	17	17	NUM
fnp-2616	166	2	.	.	X
fnp-2616	167	1	de	de	ADP
fnp-2616	167	2	pablo	pablo	NOUN
fnp-2616	167	3	-	-	PUNCT
fnp-2616	167	4	fernandez	fernandez	PROPN
fnp-2616	167	5	e	e	NOUN
fnp-2616	167	6	,	,	PUNCT
fnp-2616	167	7	cerdán	cerdán	PROPN
fnp-2616	167	8	santacruz	santacruz	PROPN
fnp-2616	167	9	d	d	PROPN
fnp-2616	167	10	,	,	PUNCT
fnp-2616	167	11	warner	warner	PROPN
fnp-2616	167	12	tt	tt	PROPN
fnp-2616	167	13	,	,	PUNCT
fnp-2616	167	14	et	et	PROPN
fnp-2616	167	15	al	al	PROPN
fnp-2616	167	16	.	.	PUNCT
fnp-2616	168	1	no	no	DET
fnp-2616	168	2	evidence	evidence	NOUN
fnp-2616	168	3	of	of	ADP
fnp-2616	168	4	iatrogenic	iatrogenic	ADJ
fnp-2616	168	5	human	human	ADJ
fnp-2616	168	6	transmission	transmission	NOUN
fnp-2616	168	7	in	in	ADP
fnp-2616	168	8	autopsy	autopsy	ADJ
fnp-2616	168	9	confirmed	confirm	VERB
fnp-2616	168	10	multiple	multiple	ADJ
fnp-2616	168	11	system	system	NOUN
fnp-2616	168	12	atrophy	atrophy	NOUN
fnp-2616	168	13	.	.	PUNCT
fnp-2616	169	1	mov	mov	NOUN
fnp-2616	169	2	disord	disord	NOUN
fnp-2616	169	3	.	.	PUNCT
fnp-2616	170	1	2018	2018	NUM
fnp-2616	170	2	;	;	PUNCT
fnp-2616	170	3	33:1183	33:1183	NUM
fnp-2616	170	4	-	-	SYM
fnp-2616	170	5	1184	1184	NUM
fnp-2616	170	6	.	.	PUNCT
fnp-2616	171	1	18	18	NUM
fnp-2616	171	2	.	.	X
fnp-2616	171	3	de	de	PROPN
fnp-2616	171	4	sousa	sousa	PROPN
fnp-2616	171	5	pa	pa	PROPN
fnp-2616	171	6	,	,	PUNCT
fnp-2616	171	7	ritchie	ritchie	PROPN
fnp-2616	171	8	d	d	PROPN
fnp-2616	171	9	,	,	PUNCT
fnp-2616	171	10	green	green	PROPN
fnp-2616	171	11	a	a	X
fnp-2616	171	12	,	,	PUNCT
fnp-2616	171	13	et	et	PROPN
fnp-2616	171	14	al	al	PROPN
fnp-2616	171	15	.	.	PROPN
fnp-2616	171	16	renewed	renew	VERB
fnp-2616	171	17	assessment	assessment	NOUN
fnp-2616	171	18	of	of	ADP
fnp-2616	171	19	the	the	DET
fnp-2616	171	20	risk	risk	NOUN
fnp-2616	171	21	of	of	ADP
fnp-2616	171	22	emergent	emergent	ADJ
fnp-2616	171	23	advanced	advanced	ADJ
fnp-2616	171	24	cell	cell	NOUN
fnp-2616	171	25	therapies	therapy	NOUN
fnp-2616	171	26	to	to	PART
fnp-2616	171	27	transmit	transmit	VERB
fnp-2616	171	28	neuroproteinopathies	neuroproteinopathie	NOUN
fnp-2616	171	29	acta	acta	PROPN
fnp-2616	171	30	neuropathol	neuropathol	PROPN
fnp-2616	171	31	.	.	PUNCT
fnp-2616	172	1	2018	2018	NUM
fnp-2616	172	2	;	;	PUNCT
fnp-2616	173	1	137:363	137:363	PROPN
fnp-2616	173	2	-	-	SYM
fnp-2616	173	3	377	377	NUM
fnp-2616	173	4	.	.	NOUN
fnp-2616	173	5	19	19	NUM
fnp-2616	173	6	.	.	PUNCT
fnp-2616	174	1	fischer	fischer	PROPN
fnp-2616	174	2	p	p	X
fnp-2616	174	3	,	,	PUNCT
fnp-2616	174	4	jungwirth	jungwirth	NOUN
fnp-2616	174	5	s	s	PROPN
fnp-2616	174	6	,	,	PUNCT
fnp-2616	174	7	krampla	krampla	PROPN
fnp-2616	174	8	w	w	PROPN
fnp-2616	174	9	,	,	PUNCT
fnp-2616	174	10	et	et	PROPN
fnp-2616	174	11	al	al	PROPN
fnp-2616	174	12	.	.	PROPN
fnp-2616	175	1	vienna	vienna	PROPN
fnp-2616	175	2	transdanube	transdanube	NOUN
fnp-2616	175	3	aging	age	VERB
fnp-2616	175	4	"	"	PUNCT
fnp-2616	175	5	vita	vita	NOUN
fnp-2616	175	6	"	"	PUNCT
fnp-2616	175	7	:	:	PUNCT
fnp-2616	175	8	study	study	NOUN
fnp-2616	175	9	design	design	NOUN
fnp-2616	175	10	,	,	PUNCT
fnp-2616	175	11	recruitment	recruitment	NOUN
fnp-2616	175	12	strategies	strategy	NOUN
fnp-2616	175	13	and	and	CCONJ
fnp-2616	175	14	level	level	NOUN
fnp-2616	175	15	of	of	ADP
fnp-2616	175	16	participation	participation	NOUN
fnp-2616	175	17	.	.	PUNCT
fnp-2616	176	1	j	j	PROPN
fnp-2616	176	2	neural	neural	PROPN
fnp-2616	176	3	transm	transm	PROPN
fnp-2616	176	4	suppl	suppl	PROPN
fnp-2616	176	5	.	.	PUNCT
fnp-2616	176	6	2002	2002	NUM
fnp-2616	176	7	;	;	PUNCT
fnp-2616	176	8	62:105	62:105	NOUN
fnp-2616	176	9	-	-	SYM
fnp-2616	176	10	116	116	NUM
fnp-2616	176	11	.	.	NOUN
fnp-2616	176	12	20	20	NUM
fnp-2616	176	13	.	.	PUNCT
fnp-2616	177	1	braak	braak	PROPN
fnp-2616	177	2	h	h	PROPN
fnp-2616	177	3	,	,	PUNCT
fnp-2616	177	4	del	del	PROPN
fnp-2616	177	5	tredici	tredici	PROPN
fnp-2616	177	6	k	k	PROPN
fnp-2616	177	7	,	,	PUNCT
fnp-2616	177	8	rüb	rüb	X
fnp-2616	177	9	u	u	NOUN
fnp-2616	177	10	,	,	PUNCT
fnp-2616	177	11	et	et	PROPN
fnp-2616	177	12	al	al	PROPN
fnp-2616	177	13	.	.	PROPN
fnp-2616	177	14	staging	staging	NOUN
fnp-2616	177	15	of	of	ADP
fnp-2616	177	16	brain	brain	NOUN
fnp-2616	177	17	pathology	pathology	NOUN
fnp-2616	177	18	related	relate	VERB
fnp-2616	177	19	to	to	ADP
fnp-2616	177	20	sporadic	sporadic	ADJ
fnp-2616	177	21	parkinson	parkinson	NOUN
fnp-2616	177	22	's	's	PART
fnp-2616	177	23	disease	disease	NOUN
fnp-2616	177	24	.	.	PUNCT
fnp-2616	178	1	neurobiol	neurobiol	PROPN
fnp-2616	178	2	aging	aging	NOUN
fnp-2616	178	3	.	.	PUNCT
fnp-2616	179	1	2003	2003	NUM
fnp-2616	179	2	;	;	PUNCT
fnp-2616	179	3	24:197	24:197	NUM
fnp-2616	179	4	-	-	SYM
fnp-2616	179	5	211	211	NUM
fnp-2616	179	6	.	.	PUNCT
fnp-2616	180	1	21	21	NUM
fnp-2616	180	2	.	.	PUNCT
fnp-2616	181	1	vilas	vilas	PROPN
fnp-2616	181	2	d	d	PROPN
fnp-2616	181	3	,	,	PUNCT
fnp-2616	181	4	iranzo	iranzo	PROPN
fnp-2616	181	5	a	a	PRON
fnp-2616	181	6	,	,	PUNCT
fnp-2616	181	7	tolosa	tolosa	NOUN
fnp-2616	181	8	e	e	NOUN
fnp-2616	181	9	,	,	PUNCT
fnp-2616	181	10	et	et	PROPN
fnp-2616	181	11	al	al	PROPN
fnp-2616	181	12	.	.	PROPN
fnp-2616	181	13	assessment	assessment	NOUN
fnp-2616	181	14	of	of	ADP
fnp-2616	181	15	α	α	NOUN
fnp-2616	181	16	-	-	PUNCT
fnp-2616	181	17	synuclein	synuclein	NOUN
fnp-2616	181	18	in	in	ADP
fnp-2616	181	19	submandibular	submandibular	ADJ
fnp-2616	181	20	glands	gland	NOUN
fnp-2616	181	21	of	of	ADP
fnp-2616	181	22	patients	patient	NOUN
fnp-2616	181	23	with	with	ADP
fnp-2616	181	24	idiopathic	idiopathic	ADJ
fnp-2616	181	25	rapid	rapid	ADJ
fnp-2616	181	26	-	-	PUNCT
fnp-2616	181	27	eye	eye	NOUN
fnp-2616	181	28	-	-	PUNCT
fnp-2616	181	29	movement	movement	NOUN
fnp-2616	181	30	sleep	sleep	NOUN
fnp-2616	181	31	behaviour	behaviour	NOUN
fnp-2616	181	32	disorder	disorder	NOUN
fnp-2616	181	33	:	:	PUNCT
fnp-2616	181	34	a	a	DET
fnp-2616	181	35	case	case	NOUN
fnp-2616	181	36	-	-	PUNCT
fnp-2616	181	37	control	control	NOUN
fnp-2616	181	38	study	study	NOUN
fnp-2616	181	39	.	.	PUNCT
fnp-2616	182	1	lancet	lancet	PROPN
fnp-2616	182	2	neurol	neurol	PROPN
fnp-2616	182	3	.	.	PUNCT
fnp-2616	183	1	2016	2016	NUM
fnp-2616	183	2	;	;	PUNCT
fnp-2616	183	3	15:708	15:708	NUM
fnp-2616	183	4	-	-	SYM
fnp-2616	183	5	718	718	NUM
fnp-2616	183	6	.	.	PUNCT
fnp-2616	184	1	22	22	NUM
fnp-2616	184	2	.	.	PUNCT
fnp-2616	185	1	tolosa	tolosa	PROPN
fnp-2616	185	2	e	e	NOUN
fnp-2616	185	3	,	,	PUNCT
fnp-2616	185	4	gaig	gaig	PROPN
fnp-2616	185	5	c	c	PROPN
fnp-2616	185	6	,	,	PUNCT
fnp-2616	185	7	santamaría	santamaría	VERB
fnp-2616	185	8	j	j	PROPN
fnp-2616	185	9	,	,	PUNCT
fnp-2616	185	10	et	et	PROPN
fnp-2616	185	11	al	al	PROPN
fnp-2616	185	12	.	.	PUNCT
fnp-2616	185	13	diagnosis	diagnosis	NOUN
fnp-2616	185	14	and	and	CCONJ
fnp-2616	185	15	the	the	DET
fnp-2616	185	16	premotor	premotor	NOUN
fnp-2616	185	17	phase	phase	NOUN
fnp-2616	185	18	of	of	ADP
fnp-2616	185	19	parkinson	parkinson	NOUN
fnp-2616	185	20	disease	disease	NOUN
fnp-2616	185	21	.	.	PUNCT
fnp-2616	186	1	neurology	neurology	NOUN
fnp-2616	186	2	.	.	PUNCT
fnp-2616	187	1	2009	2009	NUM
fnp-2616	187	2	;	;	PUNCT
fnp-2616	188	1	72(7	72(7	PROPN
fnp-2616	188	2	suppl):s12	suppl):s12	PROPN
fnp-2616	188	3	-	-	PUNCT
fnp-2616	188	4	20	20	NUM
fnp-2616	188	5	.	.	PUNCT
fnp-2616	188	6	23	23	NUM
fnp-2616	188	7	.	.	PUNCT
fnp-2616	189	1	gelpi	gelpi	NOUN
fnp-2616	189	2	e	e	NOUN
fnp-2616	189	3	,	,	PUNCT
fnp-2616	189	4	navarro	navarro	PROPN
fnp-2616	189	5	-	-	PUNCT
fnp-2616	189	6	otano	otano	PROPN
fnp-2616	189	7	j	j	PROPN
fnp-2616	189	8	,	,	PUNCT
fnp-2616	189	9	tolosa	tolosa	PROPN
fnp-2616	189	10	e	e	NOUN
fnp-2616	189	11	,	,	PUNCT
fnp-2616	189	12	et	et	PROPN
fnp-2616	189	13	al	al	PROPN
fnp-2616	189	14	.	.	PUNCT
fnp-2616	189	15	multiple	multiple	ADJ
fnp-2616	189	16	organ	organ	NOUN
fnp-2616	189	17	involvement	involvement	NOUN
fnp-2616	189	18	by	by	ADP
fnp-2616	189	19	alpha	alpha	NOUN
fnp-2616	189	20	-	-	PUNCT
fnp-2616	189	21	synuclein	synuclein	NOUN
fnp-2616	189	22	pathology	pathology	NOUN
fnp-2616	189	23	in	in	ADP
fnp-2616	189	24	lewy	lewy	PROPN
fnp-2616	189	25	body	body	NOUN
fnp-2616	189	26	disorders	disorder	NOUN
fnp-2616	189	27	.	.	PUNCT
fnp-2616	190	1	mov	mov	NOUN
fnp-2616	190	2	disord	disord	NOUN
fnp-2616	190	3	.	.	PUNCT
fnp-2616	191	1	2014	2014	NUM
fnp-2616	191	2	;	;	PUNCT
fnp-2616	191	3	29:1010	29:1010	NOUN
fnp-2616	191	4	-	-	SYM
fnp-2616	191	5	1018	1018	NUM
fnp-2616	191	6	.	.	PUNCT
fnp-2616	192	1	24	24	NUM
fnp-2616	192	2	.	.	PUNCT
fnp-2616	192	3	beach	beach	PROPN
fnp-2616	192	4	tg	tg	PROPN
fnp-2616	192	5	,	,	PUNCT
fnp-2616	192	6	adler	adler	PROPN
fnp-2616	192	7	ch	ch	PROPN
fnp-2616	192	8	,	,	PUNCT
fnp-2616	192	9	sue	sue	PROPN
fnp-2616	192	10	li	li	PROPN
fnp-2616	192	11	,	,	PUNCT
fnp-2616	192	12	et	et	PROPN
fnp-2616	192	13	al	al	PROPN
fnp-2616	192	14	;	;	PUNCT
fnp-2616	192	15	arizona	arizona	PROPN
fnp-2616	192	16	parkinson	parkinson	NOUN
fnp-2616	192	17	's	's	PART
fnp-2616	192	18	disease	disease	NOUN
fnp-2616	192	19	consortium	consortium	NOUN
fnp-2616	192	20	.	.	PUNCT
fnp-2616	193	1	multi	multi	ADJ
fnp-2616	193	2	-	-	ADJ
fnp-2616	193	3	organ	organ	ADJ
fnp-2616	193	4	distribution	distribution	NOUN
fnp-2616	193	5	of	of	ADP
fnp-2616	193	6	phosphorylated	phosphorylate	VERB
fnp-2616	193	7	alpha	alpha	NOUN
fnp-2616	193	8	-	-	PUNCT
fnp-2616	193	9	synuclein	synuclein	NOUN
fnp-2616	193	10	histopathology	histopathology	NOUN
fnp-2616	193	11	in	in	ADP
fnp-2616	193	12	subjects	subject	NOUN
fnp-2616	193	13	with	with	ADP
fnp-2616	193	14	lewy	lewy	ADJ
fnp-2616	193	15	body	body	NOUN
fnp-2616	193	16	disorders	disorder	NOUN
fnp-2616	193	17	.	.	PUNCT
fnp-2616	194	1	acta	acta	PROPN
fnp-2616	194	2	neuropathol	neuropathol	PROPN
fnp-2616	194	3	.	.	PUNCT
fnp-2616	195	1	2010	2010	NUM
fnp-2616	195	2	;	;	PUNCT
fnp-2616	196	1	119:689	119:689	NUM
fnp-2616	196	2	-	-	SYM
fnp-2616	196	3	702	702	NUM
fnp-2616	196	4	.	.	NOUN
fnp-2616	196	5	25	25	NUM
fnp-2616	196	6	.	.	NOUN
fnp-2616	196	7	visanji	visanji	PROPN
fnp-2616	197	1	np	np	PROPN
fnp-2616	197	2	,	,	PUNCT
fnp-2616	197	3	lang	lang	PROPN
fnp-2616	197	4	ae	ae	PROPN
fnp-2616	197	5	,	,	PUNCT
fnp-2616	197	6	munoz	munoz	PROPN
fnp-2616	197	7	dg	dg	PROPN
fnp-2616	197	8	.	.	PUNCT
fnp-2616	198	1	lymphatic	lymphatic	ADJ
fnp-2616	198	2	vasculature	vasculature	NOUN
fnp-2616	198	3	in	in	ADP
fnp-2616	198	4	human	human	ADJ
fnp-2616	198	5	dorsal	dorsal	NOUN
fnp-2616	198	6	superior	superior	ADJ
fnp-2616	198	7	sagittal	sagittal	ADJ
fnp-2616	198	8	sinus	sinu	NOUN
fnp-2616	198	9	:	:	PUNCT
fnp-2616	198	10	implications	implication	NOUN
fnp-2616	198	11	for	for	ADP
fnp-2616	198	12	neurodegenerative	neurodegenerative	ADJ
fnp-2616	198	13	proteinopathies	proteinopathie	NOUN
fnp-2616	198	14	.	.	PUNCT
fnp-2616	199	1	neurosci	neurosci	PROPN
fnp-2616	199	2	lett	lett	PROPN
fnp-2616	199	3	.	.	PROPN
fnp-2616	199	4	2018	2018	NUM
fnp-2616	199	5	;	;	PUNCT
fnp-2616	199	6	665:18	665:18	X
fnp-2616	199	7	-	-	SYM
fnp-2616	199	8	21	21	NUM
fnp-2616	199	9	.	.	PUNCT
fnp-2616	199	10	26	26	NUM
fnp-2616	199	11	.	.	PUNCT
fnp-2616	200	1	recasens	recasen	NOUN
fnp-2616	200	2	a	a	DET
fnp-2616	200	3	,	,	PUNCT
fnp-2616	200	4	dehay	dehay	PROPN
fnp-2616	200	5	b	b	PROPN
fnp-2616	200	6	,	,	PUNCT
fnp-2616	200	7	bové	bové	PROPN
fnp-2616	200	8	j	j	PROPN
fnp-2616	200	9	,	,	PUNCT
fnp-2616	200	10	et	et	PROPN
fnp-2616	200	11	al	al	PROPN
fnp-2616	200	12	.	.	PROPN
fnp-2616	201	1	lewy	lewy	PROPN
fnp-2616	201	2	body	body	NOUN
fnp-2616	201	3	extracts	extract	NOUN
fnp-2616	201	4	from	from	ADP
fnp-2616	201	5	parkinson	parkinson	NOUN
fnp-2616	201	6	disease	disease	NOUN
fnp-2616	201	7	brains	brain	NOUN
fnp-2616	201	8	trigger	trigger	VERB
fnp-2616	201	9	α	α	NOUN
fnp-2616	201	10	-	-	PUNCT
fnp-2616	201	11	synuclein	synuclein	NOUN
fnp-2616	201	12	pathology	pathology	NOUN
fnp-2616	201	13	and	and	CCONJ
fnp-2616	201	14	neurodegeneration	neurodegeneration	NOUN
fnp-2616	201	15	in	in	ADP
fnp-2616	201	16	mice	mouse	NOUN
fnp-2616	201	17	and	and	CCONJ
fnp-2616	201	18	monkeys	monkey	NOUN
fnp-2616	201	19	.	.	PUNCT
fnp-2616	202	1	ann	ann	PROPN
fnp-2616	202	2	neurol	neurol	PROPN
fnp-2616	202	3	.	.	PUNCT
fnp-2616	203	1	2014	2014	NUM
fnp-2616	203	2	;	;	PUNCT
fnp-2616	203	3	75:351	75:351	NUM
fnp-2616	203	4	-	-	SYM
fnp-2616	203	5	362	362	NUM
fnp-2616	203	6	.	.	PUNCT
fnp-2616	204	1	27	27	NUM
fnp-2616	204	2	.	.	PUNCT
fnp-2616	205	1	recasens	recasen	NOUN
fnp-2616	205	2	a	a	PRON
fnp-2616	205	3	,	,	PUNCT
fnp-2616	205	4	carballo	carballo	NOUN
fnp-2616	205	5	-	-	PUNCT
fnp-2616	205	6	carbajal	carbajal	NOUN
fnp-2616	206	1	i	i	NOUN
fnp-2616	206	2	,	,	PUNCT
fnp-2616	206	3	parent	parent	PROPN
fnp-2616	206	4	a	a	NOUN
fnp-2616	206	5	,	,	PUNCT
fnp-2616	206	6	et	et	PROPN
fnp-2616	206	7	al	al	PROPN
fnp-2616	206	8	.	.	PROPN
fnp-2616	206	9	lack	lack	NOUN
fnp-2616	206	10	of	of	ADP
fnp-2616	206	11	pathogenic	pathogenic	ADJ
fnp-2616	206	12	potential	potential	NOUN
fnp-2616	206	13	of	of	ADP
fnp-2616	206	14	peripheral	peripheral	ADJ
fnp-2616	206	15	α	α	NOUN
fnp-2616	206	16	-	-	PUNCT
fnp-2616	206	17	synuclein	synuclein	NOUN
fnp-2616	206	18	aggregates	aggregate	NOUN
fnp-2616	206	19	from	from	ADP
fnp-2616	206	20	parkinson	parkinson	NOUN
fnp-2616	206	21	's	's	PART
fnp-2616	206	22	disease	disease	NOUN
fnp-2616	206	23	patients	patient	NOUN
fnp-2616	206	24	.	.	PUNCT
fnp-2616	207	1	acta	acta	PROPN
fnp-2616	207	2	neuropathol	neuropathol	PROPN
fnp-2616	207	3	commun	commun	PROPN
fnp-2616	207	4	.	.	PUNCT
fnp-2616	207	5	2018	2018	NUM
fnp-2616	207	6	;	;	PUNCT
fnp-2616	208	1	6:8	6:8	NUM
fnp-2616	208	2	.	.	PUNCT
fnp-2616	209	1	28	28	NUM
fnp-2616	209	2	kovacs	kovacs	PROPN
fnp-2616	209	3	gg	gg	PROPN
fnp-2616	209	4	,	,	PUNCT
fnp-2616	209	5	breydo	breydo	PROPN
fnp-2616	209	6	l	l	NOUN
fnp-2616	209	7	,	,	PUNCT
fnp-2616	209	8	green	green	ADJ
fnp-2616	209	9	r	r	NOUN
fnp-2616	209	10	,	,	PUNCT
fnp-2616	209	11	et	et	PROPN
fnp-2616	209	12	al	al	PROPN
fnp-2616	209	13	.	.	PROPN
fnp-2616	209	14	intracellular	intracellular	ADJ
fnp-2616	209	15	processing	processing	NOUN
fnp-2616	209	16	of	of	ADP
fnp-2616	209	17	disease	disease	NOUN
fnp-2616	209	18	-	-	PUNCT
fnp-2616	209	19	associated	associate	VERB
fnp-2616	209	20	α	α	NOUN
fnp-2616	209	21	-	-	NOUN
fnp-2616	209	22	synuclein	synuclein	NOUN
fnp-2616	209	23	in	in	ADP
fnp-2616	209	24	the	the	DET
fnp-2616	209	25	human	human	ADJ
fnp-2616	209	26	brain	brain	NOUN
fnp-2616	209	27	suggests	suggest	VERB
fnp-2616	209	28	prion	prion	NOUN
fnp-2616	209	29	-	-	PUNCT
fnp-2616	209	30	like	like	ADJ
fnp-2616	209	31	cell	cell	NOUN
fnp-2616	209	32	-	-	PUNCT
fnp-2616	209	33	to	to	ADP
fnp-2616	209	34	-	-	PUNCT
fnp-2616	209	35	cell	cell	NOUN
fnp-2616	209	36	spread	spread	NOUN
fnp-2616	209	37	.	.	PUNCT
fnp-2616	210	1	neurobiol	neurobiol	PROPN
fnp-2616	210	2	dis	dis	PROPN
fnp-2616	210	3	.	.	PUNCT
fnp-2616	210	4	2014	2014	NUM
fnp-2616	210	5	;	;	PUNCT
fnp-2616	210	6	69:76	69:76	NUM
fnp-2616	210	7	-	-	SYM
fnp-2616	210	8	92	92	NUM
fnp-2616	210	9	.	.	PUNCT
fnp-2616	210	10	29	29	NUM
fnp-2616	210	11	.	.	PUNCT
fnp-2616	210	12	pikkarainen	pikkarainen	PROPN
fnp-2616	210	13	m	m	PROPN
fnp-2616	210	14	,	,	PUNCT
fnp-2616	210	15	martikainen	martikainen	NOUN
fnp-2616	210	16	p	p	NOUN
fnp-2616	210	17	,	,	PUNCT
fnp-2616	210	18	alafuzoff	alafuzoff	NOUN
fnp-2616	210	19	i.	i.	NOUN
fnp-2616	210	20	the	the	DET
fnp-2616	210	21	effect	effect	NOUN
fnp-2616	210	22	of	of	ADP
fnp-2616	210	23	prolonged	prolonged	ADJ
fnp-2616	210	24	fixation	fixation	NOUN
fnp-2616	210	25	time	time	NOUN
fnp-2616	210	26	on	on	ADP
fnp-2616	210	27	immunohistochemical	immunohistochemical	ADJ
fnp-2616	210	28	staining	staining	NOUN
fnp-2616	210	29	of	of	ADP
fnp-2616	210	30	common	common	ADJ
fnp-2616	210	31	neurodegenerative	neurodegenerative	ADJ
fnp-2616	210	32	disease	disease	NOUN
fnp-2616	210	33	markers	marker	NOUN
fnp-2616	210	34	.	.	PUNCT
fnp-2616	211	1	j	j	PROPN
fnp-2616	211	2	neuropathol	neuropathol	PROPN
fnp-2616	211	3	exp	exp	PROPN
fnp-2616	211	4	neurol	neurol	PROPN
fnp-2616	211	5	.	.	PUNCT
fnp-2616	212	1	2010	2010	NUM
fnp-2616	212	2	;	;	PUNCT
fnp-2616	212	3	69:40	69:40	NUM
fnp-2616	212	4	-	-	SYM
fnp-2616	212	5	52	52	NUM
fnp-2616	212	6	.	.	PUNCT
fnp-2616	213	1	30	30	NUM
fnp-2616	213	2	.	.	PUNCT
fnp-2616	214	1	kovacs	kovacs	PROPN
fnp-2616	214	2	gg	gg	PROPN
fnp-2616	214	3	,	,	PUNCT
fnp-2616	214	4	wagner	wagner	PROPN
fnp-2616	214	5	u	u	PROPN
fnp-2616	214	6	,	,	PUNCT
fnp-2616	214	7	dumont	dumont	NOUN
fnp-2616	214	8	b	b	NUM
fnp-2616	214	9	,	,	PUNCT
fnp-2616	214	10	et	et	PROPN
fnp-2616	214	11	al	al	PROPN
fnp-2616	214	12	.	.	PUNCT
fnp-2616	215	1	an	an	DET
fnp-2616	215	2	antibody	antibody	NOUN
fnp-2616	215	3	with	with	ADP
fnp-2616	215	4	high	high	ADJ
fnp-2616	215	5	reactivity	reactivity	NOUN
fnp-2616	215	6	for	for	ADP
fnp-2616	215	7	disease	disease	NOUN
fnp-2616	215	8	-	-	PUNCT
fnp-2616	215	9	associated	associate	VERB
fnp-2616	215	10	α	α	NOUN
fnp-2616	215	11	-	-	PUNCT
fnp-2616	215	12	synuclein	synuclein	NOUN
fnp-2616	215	13	reveals	reveal	VERB
fnp-2616	215	14	extensive	extensive	ADJ
fnp-2616	215	15	brain	brain	NOUN
fnp-2616	215	16	pathology	pathology	NOUN
fnp-2616	215	17	.	.	PUNCT
fnp-2616	216	1	acta	acta	PROPN
fnp-2616	216	2	neuropathol	neuropathol	PROPN
fnp-2616	216	3	.	.	PUNCT
fnp-2616	217	1	2012	2012	NUM
fnp-2616	217	2	;	;	PUNCT
fnp-2616	217	3	124:37	124:37	NUM
fnp-2616	217	4	-	-	SYM
fnp-2616	217	5	50	50	NUM
fnp-2616	217	6	.	.	PUNCT
fnp-2616	218	1	copyright	copyright	NOUN
fnp-2616	218	2	:	:	PUNCT
fnp-2616	218	3	©	©	PROPN
fnp-2616	218	4	2020	2020	NUM
fnp-2616	218	5	the	the	DET
fnp-2616	218	6	author(s	author(s	NOUN
fnp-2616	218	7	)	)	PUNCT
fnp-2616	218	8	.	.	PUNCT
fnp-2616	219	1	this	this	PRON
fnp-2616	219	2	is	be	AUX
fnp-2616	219	3	an	an	DET
fnp-2616	219	4	open	open	ADJ
fnp-2616	219	5	access	access	NOUN
fnp-2616	219	6	article	article	NOUN
fnp-2616	219	7	distributed	distribute	VERB
fnp-2616	219	8	under	under	ADP
fnp-2616	219	9	the	the	DET
fnp-2616	219	10	terms	term	NOUN
fnp-2616	219	11	of	of	ADP
fnp-2616	219	12	the	the	DET
fnp-2616	219	13	creative	creative	ADJ
fnp-2616	219	14	commons	common	NOUN
fnp-2616	219	15	attribution	attribution	NOUN
fnp-2616	219	16	4.0	4.0	NUM
fnp-2616	219	17	international	international	ADJ
fnp-2616	219	18	license	license	NOUN
fnp-2616	219	19	(	(	PUNCT
fnp-2616	219	20	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
fnp-2616	219	21	)	)	PUNCT
fnp-2616	219	22	,	,	PUNCT
fnp-2616	219	23	which	which	PRON
fnp-2616	219	24	permits	permit	VERB
fnp-2616	219	25	unrestricted	unrestricted	ADJ
fnp-2616	219	26	use	use	NOUN
fnp-2616	219	27	,	,	PUNCT
fnp-2616	219	28	distribution	distribution	NOUN
fnp-2616	219	29	,	,	PUNCT
fnp-2616	219	30	and	and	CCONJ
fnp-2616	219	31	reproduction	reproduction	NOUN
fnp-2616	219	32	in	in	ADP
fnp-2616	219	33	any	any	DET
fnp-2616	219	34	medium	medium	NOUN
fnp-2616	219	35	,	,	PUNCT
fnp-2616	219	36	provided	provide	VERB
fnp-2616	219	37	the	the	DET
fnp-2616	219	38	original	original	ADJ
fnp-2616	219	39	author	author	NOUN
fnp-2616	219	40	and	and	CCONJ
fnp-2616	219	41	source	source	NOUN
fnp-2616	219	42	are	be	AUX
fnp-2616	219	43	credited	credit	VERB
fnp-2616	219	44	,	,	PUNCT
fnp-2616	219	45	a	a	DET
fnp-2616	219	46	link	link	NOUN
fnp-2616	219	47	to	to	ADP
fnp-2616	219	48	the	the	DET
fnp-2616	219	49	creative	creative	ADJ
fnp-2616	219	50	commons	common	NOUN
fnp-2616	219	51	license	license	NOUN
fnp-2616	219	52	is	be	AUX
fnp-2616	219	53	provided	provide	VERB
fnp-2616	219	54	,	,	PUNCT
fnp-2616	219	55	and	and	CCONJ
fnp-2616	219	56	any	any	DET
fnp-2616	219	57	changes	change	NOUN
fnp-2616	219	58	are	be	AUX
fnp-2616	219	59	indicated	indicate	VERB
fnp-2616	219	60	.	.	PUNCT
fnp-2616	220	1	the	the	DET
fnp-2616	220	2	creative	creative	ADJ
fnp-2616	220	3	commons	common	NOUN
fnp-2616	220	4	public	public	ADJ
fnp-2616	220	5	domain	domain	NOUN
fnp-2616	220	6	dedication	dedication	NOUN
fnp-2616	220	7	waiver	waiver	NOUN
fnp-2616	220	8	(	(	PUNCT
fnp-2616	220	9	https://creativecommons.org/publicdomain/zero/1.0/	https://creativecommons.org/publicdomain/zero/1.0/	PROPN
fnp-2616	220	10	)	)	PUNCT
fnp-2616	220	11	applies	apply	VERB
fnp-2616	220	12	to	to	ADP
fnp-2616	220	13	the	the	DET
fnp-2616	220	14	data	datum	NOUN
fnp-2616	220	15	made	make	VERB
fnp-2616	220	16	available	available	ADJ
fnp-2616	220	17	in	in	ADP
fnp-2616	220	18	this	this	DET
fnp-2616	220	19	article	article	NOUN
fnp-2616	220	20	,	,	PUNCT
fnp-2616	220	21	unless	unless	SCONJ
fnp-2616	220	22	otherwise	otherwise	ADV
fnp-2616	220	23	stated	state	VERB
fnp-2616	220	24	.	.	PUNCT